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Abstract
Objectives: To determine the risk of early onset Parkinson’s disease (PD) associated 
with well water consumption and other risk factors.
Design: A case control study with strata matching by age group, gender and current 
urban or rural residence.
Setting: Republic of Ireland, between 1993 to 1995.
Participants: Cases with Parkinson’s disease, fulfilling at least two of the four 
cardinal features, with date of birth from 1st January 1926 and disease onset before 
56 years. Controls were selected using stratified random sampling from the electoral 
register.
Outcome measures: Odds ratio and 95% confidence interval for well water 
consumption and other risk factors.
Results: Increased risk was associated with well water consumption (odds ratio per 
20 years exposure 1.33, 95% Cl 1.00 to 1.77), family history of PD (odds ratio 2.15, 
95% Cl 1.09 to 4.27), and serious head injury (odds ratio 3.08, 95% Cl 1.66 to 5.71). 
Decreased risk was associated with childhood contact with a dog (odds ratio 0.44, 
0.25 to 0.78), recall of chicken pox (odds ratio 0.51, 95% Cl 0.32 to 0.83), smoking 
status (odds ratio for 30 or more pack years for smokers 0.19, 95% Cl 0.07 to 0.57), 
exposure to insecticides (odds ratio 0.44, 95% Cl 0.25 to 0.77), glue (odds ratio 0.52, 
95% Cl 0.29 to 0.93), paints (odds ratio 0.37, 95% Cl 0.22 to 0.60) and cumulative 
socioeconomic position (odds ratio for a point reduction in socioeconomic position
0.74,95% Cl 0.61 to 0.90).
Conclusions: These results have identified a wide range of exposures from childhood 
to adulthood that may influence the risk of PD across the life course. Because of 
potential biases, it is important that these results are replicated in other designs such 
as occupational or population based cohort studies.
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1. Introduction
the writer will repine at no censure which the precipitate publication of mere 
conjectural suggestions may incur: but shall think himself fully rewarded by having 
excited the attention of those, who may point out the most appropriate means of 
relieving a tedious and most distressing malady.”
James Parkinson1
Over 180 years ago, James Parkinson first described a series of patients with a 
condition now known as Parkinson's disease (PD). His own astute clinical 
observations were unable to discern any obvious aetiology. “On the subject indeed o f  
remote causes, no satisfactory accounts has yet been obtainedfrom any o f the 
sufferers”1. He noted an indulgence in alcohol, lying on damp ground and a possible 
role for trauma. The occupational status for three of his cases was reported; one case 
was a gardener, another a sailor and the third a magistrate. Even in 1817, the disease 
clearly affected a broad social spectrum of society.
We have made some but limited progress in elucidating potential risk/protective 
factors that may play a role in the causation of PD over this period. Indeed, the role 
of trauma in the aetiology of PD, postulated almost two centuries ago, still remains 
uncertain and disputed2'4.
Epidemiological research has steadily increased, particularly over the last thirty 
years, and more research has been directed towards analytical studies rather than just 
descriptive studies (see Figure 1). Most research on aetiological risk factors has 
relied on using case-control methods with still relatively few published results from
13
cohort studies. This will certainly change in the future as more cohort studies, such 
as the Whitehall 1 study5, mature and the number of elderly PD cases becomes 
sufficiently large for analysis. More recently, work in the area of genetic 
epidemiology6 has stimulated researchers to focus on both molecular and 
environmental risk factors and possible interactions.
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2. Background to the epidemiology of Parkinson’s disease
Parkinson’s disease is a neurodegenerative disorder due to cell loss of dopaminergic 
neurons mainly from the ventrolateral part of the substantia nigra pars compacta, 
although many other neuronal structures can also be damaged. The pathological 
hallmark of the disease is the intraneuronal Lewy body, which is present in all PD 
brains but is non-specific as it can also be found in other disease states as well as 
asymptomatic “normal” brains. Normal ageing is associated with a linear reduction 
of pigmented neurons in the pars compacta of the caudal substantia nigra. However, 
the lateral ventral tier is relatively spared compared with the medial ventral tier and 
the dorsal tier. In PD cases, loss of pigmented neurons appears to be exponential and 
the regional pattern is the opposite to that seen in ageing; greatest loss in the lateral 
ventral tier followed by the medial ventral tier and the dorsal tier. This regional 
selectivity is also seen with striatonigral degeneration but not with Steele-
n
Richardson-Olszewski syndrome, another parkinsonian syndrome.
2.1 Clinical diagnosis of Parkinson’s disease
"The first symptoms perceived are, a slight sense of weakness, with a proneness to 
trembling in some particular part; sometimes in the head, but most commonly in one
of the hands and arms After a few more months the patient is found to be less
strict than usual in preserving an upright posture: this being most observable whilst
walking, Walking becomes a task which cannot be performed without
considerable attention. The legs are not raised to that height, or with that promptitude 
which the will directs, so that the utmost care is necessary to prevent frequent
falls writing can now be hardly be accomplished; and reading, from the tremulous
motion is accomplished with difficulty The propensity to lean forward becomes
invincible, irresistibly impelled to take much quicker and short steps, and thereby to
adopt unwillingly a running pace The bowels,..., demand stimulating medicines
of very considerable power.. .As the disease proceeds towards its last stage, the trunk
15
is almost permanently bowed.. .The patient walks now with great difficulty, .. .His 
words are now scarcely intelligible; . . .the saliva .... is continually draining from the 
mouth.. .The chin is now almost immoveably bent down upon the sternum...; and at 
the last, constant sleepiness, with slight delirium, and other marks of extreme 
exhaustion, announce the wished-for release."
James Parkinson1
The case definition for PD is based on clinical criteria as there is no simple 
diagnostic test. The gold standard for diagnosis still remains neuropathological 
confirmation. James Parkinson provided the classical description of the disease's 
natural history (see above). His description has remained essentially unchallenged 
over the years; though over the last decade there has been far greater recognition of 
other parkinsonian disorders such as multiple system atrophy8 and Steele- 
Richardson-Olszewski syndrome9, which cause diagnostic difficulties.
Hoehn and Yahr, in their seminal paper, described initial symptoms for their case 
series of 183 patients.10 In 71% of cases, tremor was the initial symptom. Similarly, 
31% of cases complained of a gait disturbance, stiffness or slowness at presentation. 
Only 10% of patients were free of tremor and 10% were free of rigidity.
The most commonly used set of diagnostic criteria are at least two cardinal signs 
from the following four signs: resting tremor, bradykinesia, rigidity and impaired 
postural reflexes, although others have been suggested. A recent re-analysis of three 
population based community prevalence studies examined the effect of eight 
suggested different diagnostic sets of criteria on the estimated prevalence rate11 The 
more restrictive the criteria the lower the prevalence rate. In particular the insistence 
that the signs display asymmetry resulted in a three-fold reduction in the prevalence
16
of subjects aged 70-79 from the Sicily study. The presence or absence of impaired 
postural reflexes had no effect on rates and the authors recommended simplifying 
criteria to at least two features from resting tremor, bradykinesia, and rigidity.
2.2 Validity of diagnostic criteria
The criteria used for prevalence studies are designed to maximise ascertaining all 
cases, including early mild disease, and thus require non-restrictive criteria with high 
sensitivity (few false negatives) at the expense of specificity (more false positives). 
The use of such criteria for analytical studies or trials of therapeutic agents may be 
less optimal as it may be more important to be certain that all recruited subjects 
definitely have PD so that sensitivity is sacrificed at the price of high specificity.
The use of a doctor diagnosis of PD is of some but limited value. Only two-thirds of 
potential cases of PD recruited directly from primary care may truly have the disease
17as validated by post-mortem diagnosis . Prevalence studies from various countries 
have demonstrated that potential cases will include patients with benign essential 
tremor, dementia and cerebrovascular disease 13'15. In the Aberdeen study, 15% of 
potential cases were excluded after specialist examination15. A recent primary care 
based prevalence study in the South of England16, where all potential cases were 
examined by a movement disorder specialist, similarly observed that around 15% of 
patients, as in the Aberdeen study, with a diagnosis of PD did not fulfil strict clinical 
criteria for PD. In addition, approximately 20% of patients with another diagnosis in 
their records, such as tremor, vascular parkinsonism or no specific diagnosis but had
I
been given a trial of levodopa, were confirmed as having a diagnosis of PD.
17
Even a clinical diagnosis made by a neurologist or geriatrician with an interest in 
movement disorder will include non-PD patients. The UK Parkinson's Disease 
Society Brain Bank has been able to recruit patients with a pre-mortem diagnosis of 
PD and confirm the diagnosis with centralised neuropathological examination. These 
results initially demonstrated that the predictive value of an “expert” diagnosis was 
76%18. Misdiagnosed cases included progressive supranuclear palsy (6%), 
Alzheimer's disease (6%), multiple system atrophy (5%), vascular disease (3%), 
isolated nigral atrophy without Lewy bodies (2%), postencephalitic parkinsonism 
(1%) and unknown diagnosis (1%).
When the UK Parkinson's Disease Society Brain Bank diagnostic criteria (see table
1) were applied to the case histories, derived from hospital notes and standardised 
pro-forma sheets, the predictive value was improved to 82%. Further analysis of all 
clinical data using multivariable logistic models found that the best predictive model 
included the following features: no atypical features for PD, an asymmetrical onset, 
and no suggestion of a cause for another parkinsonian syndrome. These additional 
features increased the predictive value to 88% but the decrease in sensitivity meant 
that 35% of pathologically confirmed cases would have been excluded (see Figure
2).
18
Table 1: UK Parkinson’s Disease Society Brain Bank clinical diagnostic criteria 
Step 1 Diagnosis of Parkinsonian syndrome
• Bradykinesia (slowness of initiation of voluntary movement with progressive reduction in speed and amplitude of repetitive actions)
• And at least one of the following: muscular rigidity, 4-6 Hz rest tremor, postural instability not caused by primary visual, vestibular, cerebellar, 
or proprioceptive dysfunction
Step 2 Exclusion criteria for Parkinson’s disease Step 3 Supportive prospective criteria for Parkinson’s disease
• History of repeated strokes with stepwise progression of • Unilateral onset
parkinsonian features • Rest tremor present
• History of repeated head injuries • Progressive disorder
• History of definite encephalitis • Persistent asymmetry affecting side of onset most
• Oculogyric crises • Excellent response (70-100%) to levodopa
• Neuroleptic treatment at onset of symptoms • Severe levodopa-induced chorea
• More than one affected relative • Levodopa response for 5 years or more
• Sustained remission • Clinical course of 10 years or more
• Strictly unilateral features after 3 years
• Supranuclear gaze palsy
• Cerebellar signs
• Early severe autonomic involvement
• Early severe dementia with disturbances of memory, 
language and praxis
• Babinski sign
• Presence of cerebral tumour or communicating hydrocephalus on 
CT scan
• Negative response to large doses of levodopa (if malabsorption 
excluded)
• MPTP exposure
• (taken from reference18)
19
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Figure 2: The effect of including different criteria on the sensitivity and predictive value 
of pathologically proven PD
0 = consultant diagnosis (study group) 4 = 3 plus rigidity as disease feature
1 = 0 plus no atypical features for PD 5 = 4 plus bradykinesia as a disease feature
2 = 1 plus asymmetrical onset 6 = 5 plus akinetic/rigid dominant
3 = 2 plus no other possible cause
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The cost of excluding so many genuine cases makes the use of these criteria only really 
of value for therapeutic trials19. More recent data from the same UK Brain bank has 
shown an improvement of the positive predictive value of a clinical diagnosis of PD to 
around 90% and suggests a secular improvement in diagnostic accuracy amongst 
specialists.
It is unclear, however, whether the proportion of other diseases masquerading as 
parkinsonism is typical given the very select nature of recruitment of patients for the 
UKPDS Brain Bank. Patients with more rapid disease progression are more likely to be 
referred to a specialist and so such a case series will over-represent diseases such as 
progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), which have 
far have worse prognosis than PD.21,22. However, surprisingly, a population based 
prevalence survey of MSA and PSP found that proportion of all parkinsonian patients 
represented by these rare diseases was only slightly less than that seen in the Brain Bank
23series .
A clinicopathological study of Lewy body disease, PD and dementia with diffuse Lewy 
body disease also examined both the reliability and validity of a diagnosis of PD.24 Case 
vignettes were produced from pathologically confirmed cases and given to six 
neurologists of varying degrees of seniority. The reliability of the diagnosis varied from 
a kappa (k ) coefficient of 0.54 to 0.64 for diagnosis at first visit as compared to last 
visit. The median sensitivity was 73% at the first visit and 80% at the last visit. The best 
predictor variable for all rates was asymmetrical disease (tremor or rigidity). Other 
identified variables were levodopa responsiveness, rest tremor, no pyramidal or 
oculomotor signs.
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More sophisticated investigations, such as PET scanning, may be helpful for early 
disease and pre-clinical abnormalities, but are usually not suitable for large scale 
epidemiological studies. Pragmatically, it is necessary to accept that any 
epidemiological study of Parkinson’s disease will certainly include other conditions, 
which closely mimic it, such as multiple system atrophy. This is particularly true for 
incident cases or those still within the first five years of diagnosis, as it often takes some 
time for atypical features to emerge26. The implications of this type of misclassification 
of disease outcome will depend on the relationship between the non-PD diseases and the 
exposure of interest. If the association between these other conditions and the exposure 
is no different to that found for PD, the results are not biased. However, it is more 
reasonable to assume that these other conditions do not share the same aetiological 
factors. In this case, it is likely that misclassification will bias the results towards the 
null; it will be harder to demonstrate a relationship between exposure and disease, even 
if it truly exists.
2.3 The preclinical phase of PD: what does it tell us about environmental factors?
There is a growing awareness that many chronic diseases, such as ischaemic heart 
disease, may be influenced by risk factors acting across the life course, from the intra­
uterine period until old age.27 As yet, it remains unclear as to when in the life course an 
exposure may be of importance in the aetiology of PD and several different models are 
plausible (see Figure 3 - modified from reference28). Clinical symptoms are believed to 
start once cell loss has reached a threshold level of 70% to 80%. Normal age-related cell 
loss is not thought to result in disease unless current life expectancy is prolonged as 
shown in (a). A genetic model (b) might propose that cell loss from birth occurred in
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some individuals at a faster than normal rate due to “ageing genes”29.
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Figure 3: Schematic figure illustrating possible patterns of nigral cell loss.
(rate of cell death shown as linear decline for simplicity)
Intrauterine events, such as infection, placental abnormalities or intrauterine growth 
retardation30'32, might result in an individual being bom with a depleted cell count (c) 
and normal age-related loss would ensure that disease would appear in later life. This 
developmental model has been proposed to explain the discordance rate seen for 
monozygotic twins31, due to placental variations in fetal nutrition. Environmental 
factors could act through an acute mechanism (d) destroying a finite number of cells, for 
example a head injury, followed by normal age-related loss (two-stage hypothesis)33. 
Alternatively a low level chronic exposure (e) may simply act by slightly accelerating 
the rate of cell death, for example exposure to a low level neurotoxin34 or a diet 
relatively deficient in anti-oxidants. Finally an acute event, for example exposure to a
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toxic chemical, may act by triggering cell death, which results in a cascade of events 
and accelerated cell death (f). This final model would suggest that a long latency period 
may not be essential for disease aetiology and would focus attention to later life. These 
models are not mutually exclusive and it is possible and even likely that causation is 
heterogeneous. Any one of these various models might operate in different individuals 
to produce cell loss and produce a clinically indistinguishable picture.
Currently the general consensus is that a long latency period for PD is probably the 
most likely model ’ ' . If this is true, than as Caine and colleagues point out 
“epidemiological attention should be focussed on the environment in early rather than 
late life” However there is conflicting evidence that challenges both the concept of 
PD as a long latency disease and the two-stage model. Feamley and Lees demonstrated 
that the neuroanatomical pattern of cell loss in the subtantia nigra is different for normal 
ageing and argued that age-related cell loss could not explain PD.7 They calculated that 
normal age-related cell loss is around 4.7% per decade, whilst the rate for PD cases was 
exponential with around 45% loss in the first decade. They concluded that “PD is a 
relatively acute monophasic illness” with a pre-symptomatic period or around 4.7 years. 
This analysis was based on 16 cases and may have been skewed by two cases with short 
duration disease and relatively little cell loss. Excluding these cases, one might conclude 
that rate of cell death was linear with a long pre-symptomatic period. Post-mortem 
binding of a-dihydrotetrabenazine also indicated an exponential rate of dopamine 
deficiency unaccounted for by normal ageing but concluded a pre-symptomatic period 
of around 20-30 years.38 The presence of six times more HLA-DR-positive microglia 
phagocytosing dopamine neurons in autopsy brain material also indicates an active
IQ
pathological process.
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Positron emission tomography has produced conflicting evidence. Studies on normal 
subjects show either a significant linear decline in uptake of [18F]6-fluoro-L-dopa with 
age40 or no difference in uptake with age.41. Studies of PD progression are also
1Acontradictory. Results have either shown (a) similar rates of decline in [ F]6-fluoro-L- 
dopa uptake with controls, (b) increased but slow rates of decline for PD patients but 
with a long preclinical period (40 years), or (c) increased and fast rates of decline with a 
short preclinical period (6 years). This last finding is compatible with the results of 
Feamley and Lees.7 Brooks has argued that these contradictory findings can be 
explained by methodological differences. Those studies which show small or no 
differences with controls have measured whole striatal areas whilst that showing rapid 
degeneration was based on a more sensitive measure of putamen influx constants. The 
calculation of the preclinical period, however, was based on a linear back extrapolation 
of two measurements made only 18 months apart. If the disease process itself causes an 
active acceleration of cell death via a positive feedback mechanism, it is possible to 
have a long preclinical period, which after clinical presentation moves onto a phase of 
more rapid accelerated cell death.
This possibility however is only partially supported by various mathematical models of 
neurodegeneration in PD.42 Such models had to make several important, and possibly 
questionable, assumptions to enable the calculation of disease progression. The 
empirical results were ambiguous as both an “event” that kills some neurons and 
reduces the life expectancy of others and a “process” which continuously kills healthy 
neurons at a constant rate were possible.
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Another modelling attempt, by the same lead investigator, has examined the hazard 
function of PD and whether this is dependent on the age of onset in the affected parent 
(genetic model) or the age of the index case at the time the affected parent developed 
PD (environmental model).43 The results indicated that age of onset of index cases 
correlated with their age at the time the affected parent developed PD, but not with the 
age of onset in the affected parent. The model did not fit a lognormal function, as one 
would expect for a genetic model, but was best estimated by a Weibull model. The 
younger the child when the parent develops symptoms, the more likely that they would 
have shared the same environment. The authors concluded that “...the cause o f most 
cases ofPD, both sporadic andfamilial, is the accumulation o f a small number o f 
transient environmental events randomly distributed through life.” 43
A recent intriguing report from the Honolulu Heart Program noted a marked increase 
risk of developing PD for men with less than one bowel movement per day compared to 
those with more than two per day (hazard ratio 4.1, 95% Cl 1.7 to 9.6, p=0.001) 
measured up to 24 years before disease onset (mean 12 years).44 This symptom may 
represent an early pre-motor manifestation of the disease and would favour a longer 
latency period.
One cannot draw firm conclusions from this body of conflicting evidence. It is clear that 
clinical presentation of PD could follow both a short or long latency period. It is 
possible that the latency period is heterogeneous even in clinically identical phenotypes. 
As such, any search for environmental risk factors must attempt to examine potential 
exposures across the whole life course as it is unclear as to what factors may initiate 
disease and/or promote disease progression.
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2.4 The role of genes interacting with environmental factors
The debate around the relative importance of nature and nurture has fluctuated over the 
last hundred years, with the current pendulum swinging heavily towards elucidating 
genetic mechanisms for disease aetiology given the remarkable achievement of the 
Human Genome Project. In some respects, the debate is sterile as the relative 
importance of any risk factor is not a fixed static phenomenon but is dependent on its 
frequency in the population, which may change45. For example, as Rose pointed out, if 
smoking twenty cigarettes a day was a universal phenomenon, there would still be 
geographical variations in the rates of lung cancer which would depend on genetic and 
other environmental risk factors46. Similarly, if the genetic defect for phenylketonuria 
was common and phenylalanine was not found in all diets, we would assume that diet 
was the major cause of phenylketonuria rather than a genetic defect.
2.4.1 Twin, family and migrant studies
Opinions vary as to the importance of genetic factors in the aetiology of PD47,48 
Conventional epidemiological methods to try and disentangle the relative importance of 
genes versus environment are twin, sibling and migrant studies. Classical twin studies 
compare the concordance rates of monozygotic (MZ) versus dizygotic (DZ) twins; a 
higher concordance rate for the former conventionally suggests the greater importance 
of genetic factors. However this interpretation has been challenged by the foetal 
programming hypothesis, which argues that differences between twins may also result 
from variations in placental circulation, which could have a programming effect on 
foetal anatomy and/or physiology with subsequent adverse consequences in adult life 49
Most of the twin studies have been based on relative small sample sizes and several are 
not population-based. The findings are however remarkably consistent and show that
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concordance rates are no greater for monozygotic than dizygotic twins (difference in 
proportions for MZ versus DZ twins -1.8%, 95% Cl -9.0% to 5.4%, p-value=0.62).
First author, date
concordance rates of PD (%) in
Monozygotic twins Dizygotic twins
Ward, 198350 1/43 (2.3) 1/19(5.3)
Marsden, 198651 1/11 (9.1) 1/11 (9.1)
Martilla, 198852 0/18 (0) 1/14(7.1)
Vieregge, 199953 3/9 (33.3) 5/12(41.7)
Tanner, 199954 11/71 (15.5) 10/90(11.1)
Total 16/152(10.5) 18/146(12.3)
Table 2: The concordance rates for PD from twin studies.
The high concordance rates for the study by Vierrege et al53 reflects their biased method 
of twin ascertainment through relevant charities and colleagues. This method would be 
expected to over-ascertain concordant pairs. The study by Tanner et a l54 is of particular 
importance as not only is it the largest twins study yet conducted, but it is also based on 
a unique cohort of twins ascertained at recruitment to the US army during the second 
world war. Although twins who have survived long enough to take part in this study 
may be biased in certain respects, the initial sampling frame should have included 
almost all male twin pairs. Furthermore, this study was able to exam whether age of 
disease onset modified the concordance rates (see Table 3 taken from reference54). The 
results clearly indicate that overall there is no large increased risk for PD concordance 
associated with MZ status. However for twins with disease onset at 50 years or younger, 
there is a six fold increased risk with MZ status, although this estimate is fairly 
imprecise given the wide confidence intervals. This strongly suggests that at least early 
onset cases may have a greater genetic predisposition.
Concordance rate (%)
MZ twins DZ twins 
(no. pairs) (no. pairs)
Relative risk (95% Cl)
All twins 15.5(71) 11.1(90) 1.39 (0.6-3.1)
twins <= 50 years 100 (4) 16.7 (12) 6.0(1.7-21.3)
Table 3: Results from the World War II Twins Veterans’ study stratified by age of onset
Positron emission tomography (PET) scans of the unaffected twin in a PD twin pair 
have also interestingly highlighted that sub-clinical abnormalities in the substantia nigra 
(18F-dopa uptake reduced by more than 2 standard deviations) are more common in 
monozygotic (45%) than dizygotic twins (29%) although these differences failed to 
reach statistical significance55. These data are usually interpreted as supporting the 
importance of genetics but are also compatible with the idea that an environmental 
factor, which is more closely shared by MZ than DZ twins, accelerates cell death and 
hence clinical disease in one twin and not the other.
Family studies have produced more conflicting results, probably due to methodological 
differences such as the definition used to identify secondary cases e.g. whether isolated 
tremor or dystonia is included, and whether a positive family member was ascertained 
by reported history, questionnaire data from family members or personal interview and 
examination of all available family members.
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First author, date
Number of secondary cases of PD (%) in
PD family Control family
Martilla, 197650 16/429 (3.7) 11/443 (2.5)
Martin, 197657 16/488 (3.3) 7/450(1.6)
Roy, 198358 19/648 (2.9) 2/466 (0.4)
Duvoisin, 198647 4/146 (2.7) 3/145 (2.1)
Morano, 199459 12/74* (16.2) 7/148* (4.7)
Payami, 199460 94/586 (16) 21/522 (4)
Marder, 199661 19/1458(1.3) 38/7834 (0.5)
* Denominator is number of cases/controls rather than parents and siblings. 
Table 4: Prevalence of PD in family studies.
Interestingly, more recent studies are more likely to report positive findings than earlier 
reports. This might reflect better case ascertainment, publication bias or biased samples 
of cases. For example, the rate of secondary cases are remarkably high for more recent 
studies from Bonifati and colleagues (24% PD cases increasing to 43% if tremor is 
also included) and De Michele63 (35% PD cases). These high rates are almost 
unbelievable and presumably reflect the greater likelihood of sampling familial cases 
from specialist centres. The study by Marder61 however, which reported the lowest 
proportion of secondary familial cases, used community-based cases and used a 
questionnaire rather than reported history.
Another classical approach to disentangling the relative importance of genes and the 
environment is to study migrants or established communities that originated from 
another country and to compare their risk with that of their host and country of origin. 
There are surprisingly few migrant studies, which have examined PD. One study has 
compared the prevalence of idiopathic Parkinson's disease in a bi-racial community in 
Mississippi64 and Nigeria65, using standardised population-based case ascertainment 
methods screening all households. The results found no difference in the prevalence of
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white or black subjects in Mississippi, but far fewer cases in Nigeria than would have 
been expected from the black American rates. The authors concluded that black 
migration to the USA had resulted in an increased risk of idiopathic Parkinson's disease 
due to environmental factors65. Comparing prevalence rates, however, may be 
misleading as prevalence is a function of both disease incidence and case fatality. If 
survival of PD cases is far worse in Nigeria than the US, one would expect a lower 
prevalence rate even if the incidence rates were identical. For example, a study from 
New York found that Black men had a higher incidence but lower prevalence rate than 
white men due to their worse survival. 66 (see section 3.1 below for more details about 
geographical differences and incidental Lewy bodies in Africans as compared to 
Caucasians).
2.4.2 Genetic polymorphisms
Whilst the role of genetic factors in sporadic disease is unclear and may be of very 
limited importance, it is thought to follow an autosomal dominant pattern with reduced
fklpenetrance . However there are rare, but well documented cases of familial
/ o
aggregation , and early-onset cases (under the age of 40 years) appear to be more likely 
to have another affected family member69, analogous to the results from the US twin 
study
Though familial PD is rare, extensive study of the Contursi kindred was able to
nc\demonstrate linkage to chromosome 4q21 -23 and subsequently to a single base pair
71mutation in a  synuclein . This genetic abnormality does not account for either other 
cases of familial or sporadic PD, but it has enabled scientists to gain new insights into 
the potential pathophysiological mechanisms. Several other candidate genes (parkin,
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SNCA, UCHL1) have been identified and new possibilities are being regularly reported
77  71(see following references for current reviews of genetics of PD ’ .
2.4,3 Gene environment interactions
More recently there has been much interest in a possible interaction between genes and 
environment. Some studies have demonstrated that a mutant gene for debrisoquine 
hydroxylation (CYP2D6) 74-76 appears more common in cases of idiopathic Parkinson's 
disease than healthy controls. This is of particular interest as individuals with this gene 
are slower to metabolize debrisoquine and therefore may be more susceptible to any 
potentially harmful environmental “neurotoxin”. Other abnormalities have also been
7 7demonstrated such as the poor metabolism of paracetamol due to sulphoxidation . 
These observations are supportive of a “toxic” model of PD, which depends on both 
genetic or other effects on metabolism plus some neurotoxic exposure. Subsequent 
studies however have failed to reproduce these findings. A narrative review in 1998 
concluding that that there was little evidence that CYP2D6 polymorphisms conferred 
susceptibility for PD78 and a meta-analysis undertaken at the same period similarly 
found only weak evidence for a modest association (odds ratio 1.32, 95% Cl 0.98 to 
1.78, p=0.07)79. A recent large study examining the frequency of CYP2D6*4 allele for 
young (<50 years) and older onset (>=50 years) PD cases and controls noted 
paradoxically that the frequency of the poor metaboliser genotype was lower in early 
onset cases than older cases; this is the opposite of what one might predict if poor 
metaboliser status results in increased exposure to a neurotoxin and hence earlier 
disease onset. This pattern was also seen for the control groups suggesting that poor 
metaboliser status declines with age. The authors suggested that one possible 
explanation for the inconsistencies seen across studies is that not all studies match
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control groups by age and hence if cases are younger than controls there will be an 
increased association due to confounding by age.
However, even a modest genetic association for all subjects may mask much stronger 
associations for subjects with a susceptibility genotype, who have also experienced an 
adverse environmental exposure. Two publications 81,82 have suggested such possible 
gene environment interactions (see Table 5). Both studies had relatively small sample 
sizes and it is unclear how many tests of association were carried out. In both cases, 
there was no formal statistical test for interaction and this would clearly have been non­
significant given the extremely wide confidence intervals. It is likely that these initial 
results were type I errors and will fail to be replicated. They do however illustrate an 
important issue for epidemiological research. For example, the study by De Palma and 
colleagues 81 failed to find an increased risk associated with solvent exposure alone but 
did note a marked increased risk in the presence of the CYP2D6 polymorphism. This 
illustrates the theoretical possibility that PD may be a consequence of a fairly common, 
possibly universal exposure, but this only increases disease risk for a small sub-set of 
the population who are susceptible. Similarly, the GSTP1-1 polymorphism was only
associated with PD if subjects had been exposed to pesticides. Some caution is therefore 
required when interpreting “negative” genetic association studies.
Author (year) Exposure Gene Results
De Palma Solvents CYP2D6- Poor PM status if solvent
(1998)81 No association Metaboliser status not exposure
associated OR 14.5
(95% Cl 1.2-185)
Menegon Pesticides GSTP1-1 AB/BB genotype if
(1998)82 Increased risk No association pesticide exposure
OR 4.7
(95% Cl 1.3-17.1)
Table 5: Potential gene-environment interactions for Parkinson’s disease
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3. Descriptive epidemiology of Parkinson’s disease
3.1 Geographical patterns
International comparisons have in the past relied upon mortality rates adjusted for 
demographic differences between countries. Early findings demonstrated a 7 to 8 fold 
variation in mortality rates83,84 suggesting an important role for environmental factors as 
well as possible genetic differences. Mortality rates are susceptible to variations in 
diagnosis, survival and certification practice, which could produce large artefactual 
differences. This is best illustrated by the five-fold mortality differences observed 
between Scotland and Japan83. But, there is little difference in the prevalence rates for 
cases between 60-69 years of age, where underascertainment should be less problematic 
(Scotland 254 per 100,00015; Japan 245 per 100,00013). More sophisticated approaches 
differentiate between “multi-source” prevalence studies, which rely on the complete 
identification of patients with a pre-existing diagnosis, and “population-based” or 
“door-to-door” surveys which screen a total defined population identifying both pre­
existing and de novo cases85, using a two or three phase screening and validation 
process. A total population is initially screened to detect any potential cases and then 
any screen positive cases are examined by a specialist to confirm the diagnosis. Such 
population-based surveys provide the most valid comparisons between studies as the 
methods of ascertainment are more standardised than conventional multi-source studies 
and they overcome the problem of non-diagnosis. This method is particularly important 
for developing countries because of limited medical services or for communities where 
there may be differential access to health care. In the Copiah county study, more black 
cases (58%) than white cases (32%) were found to be undiagnosed64. Differential access 
to health care for ethnic minorities is well recognised in the USA86. This problem 
however is also seen for European studies. The EUROPARKINSON study compared
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prevalence rates from 5 studies, which all used a two phase door-to-door design. The 
proportion of subjects with PD who were newly diagnosed through the surveys varied 
from 11% in France and 13% in the Netherlands, to 26% in Girona, Spain, 31% in Italy 
and 52% in Pamplona, Spain. As might be expected, newly diagnosed cases were more 
likely to be older. Unfortunately, as the prevalence rates are usually based on relatively 
small numbers of cases, they are less precise with wide confidence intervals.
Age-adjusted prevalence rates from multi-source prevalence studies suggest that a three 
fold difference may exist between Libya (57 per 100,000) to Iceland (182 per 
100,000)85. Some variation in prevalence rates can be explained by differences in 
diagnosis and survival. A more informative comparison between countries can be made 
if one limits data to European countries with good health care systems, uses incidence 
rates as these are independent of differences in survival and compares rates for subjects 
under 70 years where underascertainment should not be as important88 (see Table 6). 
These results still suggest up to three fold variations in rates but this is reduced to less 
than two-fold (80%) if Iceland is excluded.
No obvious geographical pattern emerges; for example the rates for Denmark and 
Holland are more similar to Sardinia than rates from Ferrara, Italy.
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age-group relative rates*
(95% CIs)
Country 30-39 40-49 50-59 60-69 70-79 80-89 50-69
(period)
Iceland 1.4 5.6 32.9 97.2 136.2 69.2 61.3 2.75 (2.31-3.27)
(1954-1963)
S.W. Finland 0.7 2.6 19.8 62.3 92.6 47.9 40.1 1.80 (1.46-2.21)
(1968-1970)
Ferrara, 0.7 7.2 25.1 49.6 45.8 1.1 35.9 1.61 (1.40-1.86)
Italy
(1967-1987)
Aarhus, 0.0 1.0 15.8 39.8 58.5 28.1 26.8 1.20 (0.90-1.60)
Denmark
(1967-1970)
Netherlands 0.0 0.0 14.5 25.7 79.3 117.2 19.5 0.88 (0.54-1.42)
(1983-1985)
Sardinia, 1.3 7.1 26.4 18.0 4.3 0.0 22.3 1.00
Italy
(1961-1972)
♦Relative rates for 50-69 years compared with Sardinia, Italy
(original data taken from reference88).
Table 6: Age specific PD incidence rates per 100,000 from selected European studies
Prevalence studies using door-to-door ascertainment on the other hand fail to exclude 
the possibility that for both developed and developing countries there may be no 
marked differences in prevalence rates (see Figure 4), given overlapping confidence 
intervals. Some conflicting evidence exists for China and West Africa. The two 
Chinese studies show markedly different rates but it is note worthy that the 29 
province study covered a much larger population, hence the narrow confidence 
interval. In general, higher prevalence rates are seen for studies with a smaller study 
population as it is likely that case ascertainment is more complete. A recent pilot 
study from Taiwan (not shown in figure 4) found much higher rates than in China,
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even though it was carried out in a rural area89. The differences between the two 
studies from Nigeria may either reflect chance variation or methodological 
differences.
A recent report on the prevalence of post-mortem Lewy bodies in Nigeria has shown 
similar rates to those in Western populations90. Assuming that incidental Lewy 
bodies reflect pre-clinical disease, this finding supports the notion that the propensity 
to develop PD is seen equally across developing and developed countries. It does not 
exclude the potential role of environmental factor(s), as it is still necessary to explain 
why some African-Americans go on to develop clinical disease whilst their African 
counterparts remain asymptomatic91.
Similarly, the EUROPARKINSON collaboration found no differences in prevalence 
across the five European countries, except that rates were lower for France.
However the authors felt that this probably reflected underascertainment as the 
French screening phase was based solely on a questionnaire whilst the other four 
studies including a simple neurological examination.
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Age-adjusted prevalence rates per 100,000 
from door-to-door surveys
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Figure 4: International prevalence rates for PD
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It is clear that PD is found throughout the world, but it is uncertain whether it is less 
common in some countries such as China and Africa. In China there is some 
evidence to support the role of industrialisation as residing in a village residence was
O'}seen to be protective . There is a need for further migrant studies to elucidate the 
role of environmental factors and any possible critical period for age at migration. 
Across Europe there is relatively little variation, and these may be explained by 
methodological differences. The surprisingly high rates seen in Iceland may be 
idiosyncratic, reflect a higher degree of ascertainment found when surveying a 
relatively small population93 or are related to the marked genetic homogeneity seen 
in this population. Analysis of more recent drug utilization data for Iceland continue 
to support this observation94.
These geographical results pose a puzzle for both genetic and environmental 
hypotheses. Given the wide diversity of both factors across such different 
populations it is surprising to see such similar results. One possible explanation for 
this apparent paradox is that differences do actually exist but these are not large and 
are thus masked by the wide confidence intervals found in these studies. Secondly 
the use of prevalence rates may again mask significant differences in true incidence. 
Given the likelihood that case survival for PD is worse in less developed countries, 
then paradoxically the true incidence rates may actually be higher for such countries. 
Only larger studies across both developed and developing countries using 
standardised methods for determining incidence rates will enable us to be sure that 
geographical rates are uniform.
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3.2 Temporal patterns
3.2,1 Mortality rates
Descriptions of what might have been PD existed well before the nineteenth century. 
The ancient ayurvedic literature (4500-1000 B.C.) of India describe an illness 
“kampavata” consisting of tremor and akinesia95. Analysis of temporal trends have 
mostly relied on long-term patterns in mortality rates. Studies from several different 
countries have all demonstrated similar patterns of mortality over time: USA96'98, 
UK99'102, Ireland103, Italy104, Norway105, Denmark96, and Japan106.
Mortality rates for both men and women have shown increases for older age-groups 
(>75 years), and a decline for younger age-groups (< 65 years) (see Figure 5).
These patterns are remarkably consistent and predate the widespread introduction of 
levodopa in the 1970s. Interpreting these patterns is complex because of several 
possible explanations: (1) Awareness, diagnosis and certification of PD, particularly 
in the elderly, may have increased over time. This might explain some of the increase 
seen for older cases but is unlikely to explain the rise seen prior to the 1970s. It is 
also unlikely to explain the differential increase in mortality seen for men as
QO
compared to women, which could reflect occupational factors . White men over 80 
years showed a 100% greater increase than women when comparing mortality 
changes between 1962 to 1984. This is unlikely to reflect diagnosis or treatment98.
An almost identical pattern has also been seen using data from England and Wales 
(see Figure 6-unpublished personal observation). Whilst it is possible that women 
may be less likely to seek medical care than men, it is unlikely that this could explain 
such marked differences. (2) Levodopa treatment may have increased survival 
resulting in a shift of the age-specific mortality curve to the right by about 5 years96.
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Figure 5: Temporal trends for PD mortality in England and Wales by age group (adjusting for ICD coding changes)
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There is some evidence to suggest that the initial introduction of levodopa therapy 
may have delayed death107. However more recent survival cohorts108'110 suggest that 
PD mortality compared to the general population has not altered to a large degree 
from the pre-levodopa days10. Figure 7 illustrates this graphically by plotting either 
the standardised mortality ratio or hazard ratio for 24 published studies (between 
1967 to 1998), which have reported PD mortality compared to the general 
population. For each study the mid-point in time for case recruitment was taken as 
the date of the study rather than the publication date. There is no obvious trend so 
that contemporary studies continue to report a relative mortality risk of around 2 to 
2.5 not dissimilar to the Hoehn and Yahr classic paper10 and higher than the pre- 
levodopa era data from Rochester, Minnesota.111 The median life expectancy for a 
patient with PD has probably increased but this has occurred in parallel with a 
secular increase in life-expectancy for the whole population, so that the relative 
differences have not altered substantially.
(1) There may have been a genuine change in the incidence of disease: (a) The 
incidence of disease in the elderly may have increased because of a reduction in heart
i n
disease and stroke mortality and hence a decline for competing causes of death . 
This “competing cause” argument is only valid if the risk of PD is also associated 
with heart disease or stroke. Hence a reduction in heart disease deaths would 
selectively increase the pool of potential subjects who could develop PD. Only one 
study has shown such an association109 and this finding has not been confirmed110. If, 
however, these diseases are independent of each other, then whilst a reduction of 
heart disease will increase the absolute number of PD cases, it will not alter the age- 
specific rates, (b) There has been a decrease in the incidence of disease in young age-
q n
groups due to a decrease in environmental exposures . (c) The divergence of age-
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specific mortality rates reflects a cohort effect due to a self-limiting exposure, such 
as the encephalitis lethargica epidemic113,114. Such a hypothesis would predict an 
increase in mortality as “exposed” cohorts aged but a decline in the mortality of 
younger age-groups who would have been bom after the exposure. As these later 
unexposed cohorts reached old-age there would be a subsequent reduction in 
mortality for all ages.
There have been several attempts to examine the cohort hypothesis using mortality 
data100,101,103. Plotting mortality rates by birth cohort suggests excess mortality for 
cohorts bom between 1875-1895. Standardised mortality ratios for those aged 30-50 
in 1920 were elevated compared to those bom earlier or later in England and 
Wales100. More recent multivariable modelling methods have been developed to 
disentangle age, period and cohort effects115. These more sophisticated analyses 
suggest that after controlling for age and period, the maximal risk of PD mortality is 
for birth cohorts bom between 1898 to 1908.116 Surprisingly the shape of the 
mortality curves, though very similar for men and women showed a shift to the right 
for men, so that for men the peak rate was seen for men bom around 1910. This is 
rather late for exposure to encephalitis lethargica as the peak age of occurrence for 
the 1918-1920 epidemic was amongst 20 to 40 year olds 10°, who would have been 
bom between 1880 to 1900.
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Figure 7: Relative mortality for PD cases compared to general population from 24 studies published from the pre and post-levodopa era.
Despite these sophisticated methods, there is still an essential problem that cohorts 
bom after the epidemic from the mid 30s are still relatively young (< 65 years) and 
have not reached the age when mortality rates have been shown to be increasing. The 
cohort hypothesis is also unlikely to explain the differential mortality increase seen 
for men (see Figure 6) as there was little difference in encephalitis lethargica
117mortality rates for men and women . It is unfortunate that mortality data are
• 11 Runlikely to provide us with a true insight into changes of disease incidence.
3,2.2 Prevalence rates
Repeat prevalence studies can be useful in helping determine temporal trends, 
assuming they have been repeated in the same population using similar methods. 
Even then, it is likely that better case ascertainment on the second occasion may 
result in artefactually higher rates as has been observed for repeat surveys of multiple 
sclerosis in Scotland.119
In the United Kingdom, there have been 5 population based prevalence surveys of 
PD undertaken over almost a 40 year period. Table 7 highlights the main 
methodological differences between these studies. Despite this, the age adjusted rates 
are remarkably similar to each other (range 91 to 121 per 100,000). Further 
examination of the age specific rates (see Figure 8) show that in almost every case 
the 95% confidence interval for each age-specific point estimate overlaps the overall 
average rate for that age group (vertical dotted line). The only exception to this is the 
rate for 80 years and over from the Mutch survey15. This study specifically included 
old peoples’ and nursing homes and may therefore have ascertained a greater number 
of elderly cases.
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Table 7: Methodological aspects of previous UK prevalence studies
Author Year Size of 
of population 
__________ study__________
Sources of 
ascertainment
Diagnostic criteria Validation crude age adjusted' 
rate per rate per 
100,00 100,000
Brewis et al120 1961 71,101
Sutcliffe121 1982 208,000
GPs, consultants, Medical 
Officers of Health, interviews 
with householders 
GPs and consultants
Mutch eta l15 1984 151,616 GPs, consultants, drugs, PDS,
visits to homes
Sutcliffe et 1992 302,500 
al122
Schrag et al16 1997 121,608
GPs, consultants, drugs 
GP computerised database
Doctor diagnosis and 
occasional review
Examination only if 
clinical uncertainty
essential +/- tremor 
2+ of signs: tremor, 
rigidity, bradykinesia, 
postural reflexes 
PDS brain bank
PDS brain bank
examinations 
Personal examination
Personal examination 
and video
113
bradykinesia and rigidity Questionnaire plus some 108
164
Personal examination 121
128
109
91
120
98
121
PDS = Parkinson's disease society
* adjusted by direct standardisation to 1997 population of England
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Age groups
Brewis et al 1961
Sutcliffe 1982
Mutch et al 1984
Sutcliffe et al 1992
Schrag et al 1997
50-59
60-69
70-79
80+
50-59
60-69
70-79
80+
50-59
60-69
70-79
80+
50-59
60-69
70-79
80+
50-59
60-69
70-79
80+
10 100 1000 10000
Prevalence rate per 100,000 
(95% Cl)
Figure 8: Age specific rates (95% Cl) for UK prevalence studies
As the prevalence rate is dependent on incidence and case fatality, assuming a stable 
population, the simplest explanation for the stable prevalence rates is that the incidence 
and survival for IPD have both remained relatively constant over time. However this is 
unlikely given the marked changes in mortality rates for younger age groups over the same 
period (see figure 5). Mortality rates for both men and women have shown increases for 
older age-groups (> 80 years), and a decline for younger age-groups (< 70 years). If 
incidence had remained constant but disease duration increased then mortality rates would 
be expected to show a decline at younger ages with a corresponding increase in older 
groups. However this is still inconsistent as the age-specific prevalence rates for younger
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age groups should have increased over time. Assuming these results are methodologically 
sound, then the simplest explanation for these results is that incidence rates have declined 
in younger age groups whilst overall disease duration has increased resulting in higher 
mortality rates for older age groups.
3.2.3 Incidence rates
Incidence rates are far superior to both mortality and prevalence rates, but are still 
potentially biased as there may be temporal trends in the likelihood of case ascertainment 
either through consulting behaviour and/or doctor-diagnosis. Data from Rochester, 
Minnesota are unique in covering an extensive time period (1935-1979) 111’123>124< The 
annual incidence rate has increased from 11.4 per 100,000 in 1935-1944 to 18.2 per
100,000 between 1967-1979. The age-adjusted rates have however remained fairly 
constant over the last 30 years (see Figure 9).
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Figure 9: Average annual incidence of PD per 100,000 population, Rochester, Minnesota 
(data either standardised to 1960 or 1970 US population)
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Age-adjusted rates can mask heterogeneity in age-specific patterns as rates in older age 
groups could increase whilst those in younger groups decreased leaving the adjusted rate 
unchanged. The use of different age groupings in the two previous publications111,123 
makes it impossible to compare the age-specific rates over this entire period. Comparing 
1945-1954 with 1955-1966, there is a suggestion that the rate for cases aged between 40- 
69 has decreased whilst that for the over 70 years has increased125. Some indirect support 
for this observation comes from the UK National Morbidity surveys, which although not 
measuring incidence directly, have also found a consistent decline in new consultations for 
patients with PD under 75 years between 1971 and 1991 126'128.
A reanalysis of incidence data from Rochester data between 1976 to 1990 has provided
170further data to help us interpret the temporal trends. Overall rates have remained 
relatively stable but the age-specific patterns are consistent with a divergence by age 
group (see Figure 10) so that rates have been increasing for older subjects and decreasing 
for younger subjects. These differences may be due to chance and a Poisson regression 
model (undertaken by YBS) using these rates failed to show a significant interaction 
between age group and incidence period (p=0.23), however this may have been 
underpowered.
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Figure 10: Temporal trends for age specific incidence rates between 1976 to 1990 from 
Rochester, Minnesota.
3.3 Sociodemographic factors
3.3.1 Age
The risk of developing PD increases as an individual gets older. But, it is unclear whether 
the increase in risk is continuous or eventually declines for the oldest age-groups. The 
former pattern would favour the notion of “ageing-related” degeneration as has been 
argued for Alzheimer's dementia130. Multi-source incidence studies suggest that rates 
generally fall for the oldest age-groups (see table 6). But, older subjects are less likely to 
present to medical attention, are more difficult to diagnose and even when under 
residential care may be missed131. Door-to-door based studies consistently show that 
prevalence rates increase continuously in an exponential fashion64,132135. Because fairly 
broad age-groups are used to calculate the age-specific rates, it is possible that these 
studies could mask a flattening of the age curve. However, the study from Gironde, France 
calculated rates for five year age-groups between 65 and 90 years plus (see Figure 11) and 
also found an exponential rise135.
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Figure 11: Age-specific prevalence rates for PD in Gironde, France 
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3.3.2 Sex
The majority of studies support an excess of male to female cases. The average ratio of 
male to female standardised rates is 1.35 from prevalence studies and 1.31 from incidence
o C
studies, but the range of values is wide . This excess is seen for both multi-source and 
population-based studies. Hospital-based studies may be misleading, as there is evidence 
that the survival of women recruited from hospitals is worse than men and hence will bias 
the results in favour of increasing the prevalence o f men as compared to women109. The 
recent incidence data from Rochester, Minnesota 129 demonstrate that women have around 
half the risk of developing PD (calculated by YBS adjusting for age group and period, rate 
ratio of women versus men 0.48 0.35 to 0.67, p<0.001). Assuming this does not reflect 
gender differences in access to a specialist diagnosis, this may reflect either a protective 
effect of hormonal or other factors for women and/or a deleterious effect of occupational 
or other gender-related exposures in men. Unlike cardiovascular disease, the reduced risk
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in women was still seen and just as strong in the oldest (70-99 years) post-menopausal 
group, which rather weakens the case for a hormonal mechanism, although if PD has a 
long latency period (see earlier) this cannot be totally excluded.
3.3.3 Socioeconomic position and occupation
1 1AAdult social economic position is a variable often measured in epidemiological studies
117as it is so strongly related to many diseases , and is often used as a confounding variable 
when examining other exposures. American studies tend to use a classification based on 
years of education or income, whilst European studies are more likely to use an 
occupational-based classification138. As a variable it is non-specific, and acts as a proxy 
marker for many other exposures such as smoking, diet, obesity, occupational exposures, 
sanitary conditions, overcrowding, risk of infection, material and/or psychosocial 
deprivation and other factors. Many potential risk factors are distributed in a graded 
fashion by socioeconomic position. Demonstrating a disease gradient by socioeconomic 
position may not be aetiologically helpful as it does not help identify which one of these 
many potential exposures is of importance. However the lack of a gradient (or a reverse of 
that expected) is of relevance as it may challenge many conventional hypotheses. For 
example, if one speculates that PD is the result of a chemical exposure, it is likely such an 
exposure would be greater for manual rather than non-manual jobs, unless the chemical is 
commonly found in the domestic home environment. Similarly, risk of infection will be 
associated with crowding, sanitary conditions and hence socioeconomic position.
Mortality data from the United Kingdom show no social class gradient for deaths between
20-64 years. For older ages and based on proportional mortality ratios, there is a gradient
110with higher ratios in social class I and II than IV and IV . However proportional 
mortality ratios are influenced by the strong social class gradient for other more common
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causes of death, which would artefactually increase the proportion of PD mortality in 
higher social classes. More reliable data can be obtained from case-control studies. 
Unfortunately few studies have either examined or reported the results for adult social 
class or other proxy measures of socioeconomic position.
Most studies have failed to demonstrate any relationship with years of education 56,140"143. 
A large German case control study, using neighbourhood and regional controls, found that 
cases were more highly educated than controls for both control groups though no measure 
of association was reported and only p-values were presented (p=0.07 for neighbourhood, 
p=0.08 for regional controls).144 One study, which did show that cases were better 
educated,145 failed to adjust for age or gender, two important confounders as controls were 
both older and were more likely to be women. Similarly, a study of early onset PD 
demonstrated an initial two-fold elevated risk associated with having completed high 
school graduation, but this was almost completely attenuated after adjustment for smoking 
status and other variables146. In this case, as smoking is itself very socially patterned, one 
could argue that the authors over adjusted the association and hence masked a true 
association. A case-control study using discordant twin pairs suggested that cases were 
less likely to be manual workers but this was not significant (odds ratio 0.50 95% CIs 
0.10-2.23).147 In contrast, a nested case control study from the Sicilian door-to-door 
prevalence survey143, found that illiteracy was associated with an increased risk of PD 
(odds ratio 1.9, 95% Cl 0.9 to 4.4) but did not find a dose response effect with years of
tfieducation or any effect with being below 5 grade at school (odds ratio 1.1, 95% Cl 0.6 to 
2.2).
‘X'JOnly one study, a population based case control study from Hertfordshire, UK, , has 
examined both current and parental social class. It failed to find any statistically
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significant effects but in both cases, risks was elevated for lower social class, (odds ratio 
for social class IV and V versus I-IIINM: current social class 1.4, 95% confidence interval 
0.8 to 2.3; social class at birth 1.5, 95% confidence interval 0.9 to 2.5) Only one 
prospective study has reported social class and risk of PD and reported no significant risk 
associated with occupation but did not present any quantitative results148.
The lack of a social class or educational gradient is surprising as exposures to toxic, 
infectious and other exposures are likely to differ by social class. Adult social class is 
moderately correlated with parental social class but over the last 60 years there has been 
upward social mobility. Exposures acting in childhood may be more relevant than adult 
factors and more studies need to examine childhood circumstances by collecting data on 
parental social class as well as other childhood variables. Use of socioeconomic data from 
both periods of life may be helpful in identifying critical periods or phases in the life 
course where exposures are more relevant149. For example, data from the Collaborative 
cohort study provides useful empirical data to illustrate this point.150
Hazard ratio 
adjusted for age
p-value 
for trend*
Hazard ratio 
adjusted for 
adult SES and 
other variables
p-value 
for trend*
IHD 1.5 (1.2-1.9) 0.0001 1.3 (1.0-1.6) 0.04
Lung cancer 1.7 (1.1-2.4) 0.05 1.2 (0.8-1.9) 0.8
Respiratory
disease
2.0 (1.2-3.5) 0.008 1.6 (0.9-2.9) 0.12
Stroke 1.8 (1.1-2.9) 0.03 1.7 (1.1-2.9) 0.08
Stomach cancer 2.1 (0.9-4.6) 0.01 2.0 (0.9-4.8) 0.01
trend across 4 social class categories
Table 8: Association between childhood social class and cause specific mortality from the 
Collaborative study.
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As can be seen from table 8, the hazard ratio associated with manual versus non-manual
childhood socioeconomic status is positively associated with ischaemic heart disease, lung
cancer, respiratory disease, stroke and stomach cancer mortality; poorer individuals having
a greater risk of death from these causes. However adjustment for adult socioeconomic
status and other adult variables e.g. smoking, almost completely abolishes this association
with lung cancer. Poorer childhood circumstances are confounded by smoking behaviour.
For ischaemic heart disease and respiratory disease, these associations are attenuated
reflecting the importance of exposures acting in both early and later life in a cumulative
fashion. There is evidence that birth weight, childhood infections and patterns of
childhood development may increase the risk of both these diseases as well as adult life
style and socioeconomic factors.151,152 Interestingly for both stroke and stomach cancer,
the childhood associations remain hardly altered. These suggest that exposures acting in
early life that are socially patterned are important independent risk factors. For stomach
cancer there is growing evidence that infection with Helicobacter Pylori, which is usually
contracted in childhood may be an important determinant. The association with stroke is
less clear but may be linked to intra-uterine development or the development of arterial
1wall smooth muscle which continues to occur post-natally. If one could demonstrate 
that childhood social conditions were relatively more important than adult social 
conditions in the aetiology of PD, this may help identify an exposure window and would 
provide further evidence in favour of a long latency model.
Several different occupations have been reportedly linked to PD. For example, welding154 
and postal workers exposed to lead sulphate batteries155 to give two recent published 
examples. These reports are based on case series from specialist centres where a possible 
association with an occupation has been suggested often post-hoc. These observations may 
provide aetiological clues but are potentially misleading due to biased ascertainment or
56
inappropriate control data and require independent replication in large occupational 
datasets. A more rigorous approach is to examine specific occupational exposure within a 
case control or cohort design. Such an approach is usually statistically underpowered as 
most occupations are not sufficiently common. Farming or agricultural work has been 
examined as a specific occupation with a possible elevated risk. Some studies have noted 
an increased risk 142,156'158 but many studies have not 143,159'163. These inconsistencies may 
relate to differential confounding between farming and pesticide use across different 
populations and birth cohorts, (see below for more details concerning pesticides as 
exposure).
A few studies have examined broad occupational or industrial groups, such as mining, 
retail trade or manufacturing. One such study examined a case series of patients from a 
specialist movement disorder’s clinic with occupational data from a random sample of 
individuals taken from the census.161 The results showed significantly elevated odds ratios 
for the following occupations; social sciences, law, library (2.49, 95% Cl 1.27 to 4.88), 
teaching (2.50, 95% Cl 1.67 to 3.74), medicine, health (2.07, 95% Cl 1.34 to 3.2), 
forestry, logging, mining, oil/gas (3.79, 95% 1.72 to 8.37). Certain occupations also had 
significantly reduced odds ratios; management, administration (0.48, 95% Cl 0.32 to 
0.72), clerical (0.58, 95% Cl 0.40 to 0.85), construction (0.31, 95% Cl 0.15 to 0.63), 
housewives, not applicable (0.16, 95% Cl 0.10 to 0.26). The authors suggest that these 
occupational patterns are consistent with a viral respiratory infective hypothesis so that 
occupations with little person contact such as construction workers have less risk whilst 
others such as medical staff or workers who may share sleeping accommodation are at 
greater risk. Alternatively these patterns may also reflect a mixture of selection bias (more 
educated and medical staff being more likely to be seen at a specialist unit), smoking
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behaviour (occupations with less smoking at greater risk) and chance due to multiple 
significance testing.
Another study, using death certification164, also noted similar findings using proportionate 
mortality ratios. Excess mortality was observed for teachers, medical personnel, 
machinists and machine operators, scientists, writers/designers/entertainers, support and 
clerical workers and occupations involving pesticides, solvents, and electromagnetic fields 
and in legal, library, social, and religious work. This study again failed to control for 
confounding factors such as smoking. In addition as it is based on the proportion of deaths 
from PD relative to death from any other cause, it has the additional problem that it is 
confounded by other causes of death. Thus medical staff may have proportionally more 
PD deaths if they have proportionally less death from heart disease compared to the 
general population.
One case control study noted that a history of working in a service occupation (domestic 
service, food and beverage preparation, protective service, building and related service) 
was associated with reduced risk (odds ratio 0.69, 95% Cl 0.47 to 1.00) I58. This 
association was slightly strengthened after adjustment for age, sex and smoking status 
(odds ratio 0.57, p=0.02) and there was an association with duration of time in service 
occupation (cases versus control, 13.1 versus 8.7 years, p=0.003). However, professional, 
technical and managerial group hardly showed any elevated risk (odds ratio 1.09, 95% Cl 
0.75 to 1.58). The authors could not explain their findings and suggested they needed 
replication before assuming any causal relevance. Another small case control study from 
Israel165 noted an elevated risk for work in the construction industry (odds ratio 2.94, 95% 
Cl 1.08 to 7.99) in contrast to the study cited earlier161.
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3.3.4 Ethnicity
Relatively little high quality data exist on the prevalence and incidence of PD amongst 
blacks either in Africa or in populations of mixed ethnic populations. A review of PD in 
populations of African origin highlighted 15 studies that have examined this issue.166 Most 
of the cited studies were methodologically poor with inadequate data on denominator 
populations, failure to adjust for age, and incomplete case ascertainment due to difficulties 
accessing health services. More recently, studies both in the United Kingdom and from 
Guadaloupe, French West Indies 168 have suggested that African Carribeans and Indians 
may have a more atypical phenotype of PD compared to Caucasian subjects. The study 
from Guadaloupe also suggested a link with ingestion of benzyl-tetra-hydroisoquinilines 
(BTHQ) alkaloid, contained in fruits and herbal teas. Although this is an unusual 
exposure, it supports the possible role of neurotoxic agent in this case of dietary origin.
The UK based study reported a greater proportion of “atypical” levodopa hyporesponsive 
patients amongst both African Carribeans and South Asians residing in South East
1A7London. These results were from a hospital-based patient cohort, rather than a 
population-based prevalence study. Case ascertainment was likely to over represent cases 
which poses diagnostic and/or therapeutic problems, such as a poor response to levodopa 
therapy. It is less clear, however, whether this over ascertainment would have been 
differential depending on patients’ ethnicity, as all cases were recruited from the same 
centres. Hospital referral for specialist opinion is influenced by both patient and doctor 
related factors.169 Almost no data exist on these factors for African Caribbeans, but some 
evidence exists for South Asians, particularly with reference to ischaemic heart disease. 
South Asians living in London are more likely to report consulting a doctor when 
presented with a standardised history of chest pain than Caucasians.170 However, they are 
less likely to be referred for stress testing, and have to wait much longer than Europeans to
be seen by a cardiologist.171,172 Assuming the observations for heart disease apply to 
movement disorders, then this differential pattern of referral may partially explain the over 
representation of atypical South Asian and African Carribean patients as doctors may be 
less likely to refer ethnic minority patients to a movement disorder clinic unless they are 
more difficult to diagnose or manage. The non-specificity of the observation, affecting two 
very distinct ethnic sub-groups, further supports the notion that this may reflect 
ascertainment bias. Future population based studies will be required to confirm or refute 
these observations.
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4. Analytical epidemiology of Parkinson's disease
A large number of potential exposures have been cited as possible risk factors for PD. 
These have been divided into several groupings for coherence: (a) type of neighbourhood; 
rural residence and well water consumption (b) neurotoxins, (c) infectious agents, (d) 
trauma (e) life style exposures and (f) miscellaneous exposures. The theoretical and 
empirical evidence for each one of these areas will be examined in detail with comments 
on the validity and methodological limitations.
4.1 Type of neighbourhood
4.1.1 Rural versus urban residence
Rural residence, like socioeconomic position, is a rather non-specific variable as it could 
simply act as a proxy marker for various other exposures, such as well water consumption, 
farming, pesticide exposure, diet, contact with farm animals, age at infection, differences 
in life style or risk of head trauma. As such, this risk factor is compatible with a wide 
range of different hypotheses. Whilst rurality can be considered as a descriptive variable, 
like age and sex, few descriptive studies have reported urban - rural differences in either 
prevalence or incidence. A study from Ferrara, Italy did observe a greater risk of 
developing PD in rural areas, but this was restricted to cases under 50 years and was not 
seen among housewives and must therefore be treated with caution as a post-hoc sub­
group analysis173.
Many analytical studies have however included some measure of rurality as either a risk
factor or potential confounder for other exposures. It is paradoxical that industrialisation
has been proposed to explain the differences in geographical prevalence rates between
countries, yet within countries residing in a rural area has been noted to increase
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risk146,156,159,160,174'176. One of the first reports of such an association came from a Canadian
| nn
case series of 21 cases whose disease started under 41 years of age . This noted an 
excess of cases bom in a rural area (19 out of 21), which was highly significant given the 
population distribution between urban and rural areas. This urban-rural difference was 
supported by an early ecological study from Canada, which noted higher rates of PD 
mortality, cases and dmg utilisation in rural areas. It also observed, not surprisingly, that
178these areas also had high rates of pesticide consumption However this was not
17Qreplicated by a later study from Georgia, USA. A study from the Republic of Ireland 
also noted a 50% elevation in hospital admission rates for PD cases from rural areas 
compared to urban areas with a significant trend compared across semi-rural and urban 
areas.103 As the authors point out, these patterns may be due to ascertainment bias as cases 
living further away may be more likely to be admitted as compared to urban cases.
Some studies have suggested that living in a rural area in early life is more important159, 
whilst others suggest that it is the total number of years of rural residence 156. This finding
Q7is not consistent with some studies showing a decreased risk or no significant 
risk141,146,157,180'182. It is important to determine whether any increased risk for rurality is 
seen only in early life or increases with greater years of exposure. The former suggests a 
critical or sensitive period model, whilst the latter suggest an “accumulation” model149
There is marked heterogeneity in the risk estimates associated with rurality (see Table 9). 
Other than chance variation, it is likely that such variation may be partially explained by 
methodological variations in design. Demographic variables, such as rural residence are
18Tparticularly sensitive to the method of recruiting controls and the possibility of selection 
bias.
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Most studies recruit cases from neurology or movement disorder clinics based in urban 
centres. These specialist centres will often have a wide catchment area and see patients 
from both urban and rural areas. For elderly cases, it is likely that rural patients might be 
managed locally and not get referred on because of transport and access difficulties184. 
This is less likely for atypical, severe and young cases and specialist clinics will have an 
over-representation of such cases .
Studies showing an increased risk for rural exposure, (see Table 9) have generally selected 
controls from the relevant hospital, which recruited the cases. Controls were usually 
subjects with more common medical conditions such as heart or respiratory disease and 
would therefore be more likely to include local urban residents. Such a bias would 
artefactually increase the proportion of PD cases from rural areas. The only exception174 
used spouse controls. It is likely that spouses are more likely to come from the same area 
as the case and would obviously share the same current area of residence. Studies which 
failed to demonstrate any increased risk used a variety of methods: buddy controls141, 
neurological clinic controls181, stratified sampling157, rheumatoid arthritis controls146 and 
population-based control selection180. The use of buddy controls is not to be 
recommended as it may well result in overmatching and again such controls are likely to 
share the same area of residence as cases.186 Selecting patients from a specialist clinic 
may diminish selection bias but is also problematic especially if a single disease entity is 
chosen. Three studies that attempted to ensure non-biased ascertainment of both cases and
'\* y  |  |  o a
controls, using population controls, ’ ’ failed to show any real association between 
rural residence and risk of PD.
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Table 9: Summary of studies reporting association between rural residence and PD.
Author Year study design sample size cases controls results comments
cases controls
Studies with increased risk
Rajput177 1986 case series 21 0 disease onset <41 
years
Nil 19/21 grew up in rural areas
(p=0.02)
weak evidence
Wong159 1991 C-C study 19 38, 19 cases with at least 
one sibling with 
PD
Clinic controls & 
sib pairs with 
essential tremor
OR 4.3 (p=0.01) with clinic 
controls. No association 
with tremor controls
Univariate analyses only. Potential case 
selection bias
Ho156 1989 C-C study 35 105 hospital or old age hospital or old age 
homes homes
OR 4.9 (1.4 to 18.2) for >40 
years in rural areas
Univariate analyses only. No details on 
mix of cases and controls from different 
sources. Study carried out in Hong Kong
Golbe187 1988 C-C study 106 106 MD clinic spouses OR 2.0 (1.0 to 3.9) for at 
least 2/12 per year until 
marriage
Univariate analysis. 2:1 ratio of men to 
women. Problem as spouse controls.
Roller160 1990 C-C study 150 150 MD clinic Neuro & Medical 
clinics
OR 1.9 (1.1 to 3.1). 
Association strongest in 1st 
decade of life
Multivariate analysis showed only no. of 
years of rural residence significant 
(p=0.03). (Data not shown)
Stem141 1991 C-C study 149 149 Neuro clinic "buddy" controls OR 1.7 (0.9 to 3.1) adjusted 
for smoking & head injury
No dose-response effect. Greater for 10 
years residence than >10 years. Stronger 
association with old onset cases.
McCann188 1998 C-C study 224 310 hospitals, 
residential homes, 
community 
groups
hospitals, 
residential homes, 
community 
groups
OR 1.7 (1.17 to 2.57) 
adjusted for age and sex
Australian study. Mode of control 
selection unclear.
Smargiassi189 1998 C-C study 86 86 Neuro clinic OPD clinics OR 2,48 (1.28 to 4.83) for 
rural versus urban
Study from Parma, Italy. No adjustment
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Author Year study design sample size 
cases controls
cases controls results comments
No or decreased risk
Jimenez-
Jimenez176
1992 C-C study 128 256 MD clinic A&E attendees OR 1.1 (0.7 to 1.7) for rural 
residence. OR 1.6 (1.0 to 
2.6) for migration to city 
after 30 years
Univariate analysis. Choice of age at 
migration post-hoc. Population mainly 
from immigrants from rural areas.
Semchuck190 1991 C-C study 130 260 PD register community 
control (RDD)
OR 0.9 (0.6 to 1.4) first 15 
years; OR 0.8 (0.5 to 1.2) 
first 45 years
Univariate analysis. Community controls 
from same population.
Tanner92 1989 C-C study 100 200 Neuro clinic Neuro clinic OR 0.6 (0.3 to 1.0) Univariate analysis. Study carried out in 
China
Wang191 1993 C-C study 93 186 Neuro clinic Neuro clinic OR 0.76 (0.49 to 1.18) for 
rural versus urban
Matched study from Tianjin China. No 
adjustment for confounders
Martyn32 1995 C-C study 172 343 Primary care 
database
Primary care 
database
OR 1.4 (0.82 to 2.49) for 
village versus large town
population based study, Hertfordshire, K
Gorell163 1998 C-C study 144 464 Primary care 
database
Primary care 
database
OR 1.19 (0.73 to 1.93) 
adjusted for race, age, sex 
and smoking status
Study from Detroit with good case and 
control selection.
Chan162 1998 C-C study 215 313 Hospitals Hospitals OR 1.00 (95% Cl 0.995 to 
1.01) for percentage stay in 
rural area
Study from Hong Kong. Multivariate 
analysis adjusting for smoking, pesticide 
exposure, farming, and dietary variables
Marder192 1998 C-C study 89 188 community
survey
community 
volunteer controls
OR0.80 (0,27 to 2.10) for 
rural living
Unadjusted OR. Study from multi-ethnic 
New York.
Behari193 2001 C-C study 377 377 MD clinic neuro controls OR 0.94 (95% Cl 0.70 to 
1.25) for >10 years rural 
versus no years
Study from Delhi, India. Results 
unadjusted.
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4.1.2 Well water
Well water has been extensively examined as a potential risk factor for PD. It was first 
noted to be associated as part of the same case series report that highlighted rural 
residence with very early onset PD .177 Well water is also a rather non-specific exposure 
as it could act as a carrier of a potential neurotoxin (pesticides or heavy metals) or as a 
vector for an infective agent. Only one study has directly tested the composition of well 
water consumed by cases and controls and this failed to find any difference in either 
pesticides or heavy metal composition of the water supply.194’195. Alternatively, well 
water, like rural residence, may simply be a proxy marker for another exposure, which 
is more common in rural environments.
Well water, like rural residence has been seen to be associated with PD (see Table 10). 
This is not surprising as the two exposures are closely correlated. Hence studies that 
demonstrate a relationship between rural residence also tend to show a relationship with 
well water and vice versa. The strong correlation between these two variables can be 
demonstrated by the results from a Kansas case-control study. Well water had a 
significantly raised odds ratio of 1.7 with PD, but after adjusting for rural residence this 
was almost totally attenuated to 1.116°. The authors concluded therefore that well water 
was not a risk factor for PD but this may be misleading as their analysis may have been 
inappropriate due to over adjustment. One study specifically used factor analysis in an
1 ^ 7attempt to overcome the problems of excessive collinearity . This is only a partial 
solution and does not overcome the problems of determining “independent” effects 
when measurement error is taken into account196. Designing studies that specifically 
break the confounding between two closely correlated exposures is better than using 
complex statistical methods, but is not always possible in reality.
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Studies that show an increased risk again tend to have selected cases from a specialist
clinic whilst controls are usually recruited from a more local population, except for the 
1study from India . In contrast, studies that fail to show an association have a more 
diverse source of both cases and controls.
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Table 10: Summary of studies reporting association between well water consumption and PD.
Author Year study design sample size cases controls results comments
cases controls
Increased risk
Rajput177 1986 case series 21 0 disease onset <41 
years
Nil 20/21 drank well water for 
first 15 years of life
weak evidence
Wong159 1991 C-C study 19 38, 19 cases with at least 
one sibling with 
PD
Clinic controls & 
sib pairs with 
essential tremor
OR 2.8 (p=0.07) with clinic 
controls. No association 
with tremor controls
Univariate analyses only. 
Potential case selection bias
Jimenez-
Jimenez176
1992 C-C study 128 256 OP MD clinic A&E attendees OR 1.8 (1.1 to 2.9) for well 
water > 30 years. No 
association for any
Univariate analysis. Choice of 
years of consumption post-hoc.
Roller160
Smargiassi189
1990
1998
C-C study 
C-C study
150
86
150
86
MD clinic 
Neuro clinic
Neuro & Medical 
clinics
OPD clinics
exposure 
OR 1.7 (1.0 to 2.8). 
Association strongest in 
first 40 years of life
OR 2.78 (1.46 to 5.28) for 
well water versus none
Multivariate analysis showed 
only no. of years of rural 
residence significant (p=0.03). 
(Data not shown)
Study from Parma, Italy. No 
adjustment
Behari193 2001 C-C study 377 377 MD clinic neuro controls OR 1.94 (95% Cl 1.33 to 
2.80) for >10 years well 
water versus no years
Study from Delhi, India. Results 
strengthened after adjustment for 
a variety of other risk factors.
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Author Year study design sample size 
cases controls
cases controls results comments
No association 
Golbe197 1990 C-C study 106 106 MD clinic spouses OR 1.1 (0.5 to 2.5) for at Univariate analysis. 2:1 ratio of
Semchuck190 1991 C-C study 130 260 PD register community control
least 2/12 per year until men to women. Less of a
marriage problem as probably not biased 
by sex
OR 0.9 (0.6 to 1.5) first 15 Univariate analysis. Community
Tanner92 1989 C-C study 100 200 Neuro clinic
(RDD) 
Neuro clinic
years; OR 1.1 (0.6 to 2.0) controls from same population, 
first 45 years
OR 0.7 (0.4 to 1.3) Univariate analysis. Study
Stem141 1991 C-C study 149 149 Neuro clinic "buddy" controls
carried out in China 
OR 0.8 (0.4 to 1.6) adjusted No dose-response effect. No
Gorell163 1998 C-C study 144 464 Primary care Primary care
for smoking, rural residence difference in association for 
& head injury young cases versus old cases.
OR 0.97 (0.65 to 1.40) Study from Detroit with good
McCann188 1998 C-C study 224 310
database
hospitals,
database
hospitals,
adjusted for race, age, sex case and control selection, 
and smoking status
OR 0.6 (0.4 to 1.0) adjusted Australian study. Mode of
Chan162 1998 C-C study 215 313
residential homes, residential homes, 
community groups community groups
Hospitals Hospitals
for age, sex, rural residence control selection unclear. 
OR 1.04 (95% Cl 0.70 to Study from Hong Kong.
Kuopio198 1999 C-C study 123 246 prevalent cases random controls
1.54) for drinking well Multivariate analysis adjusting 
water for smoking, pesticide exposure, 
farming, and dietary variables 
OR 1.01 (95% Cl 0.65 to Well designed study from
1.61) for unpurified water < Finland 
20 years
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4.2 Neurotoxins
The report that l-methyl-4-phenyl-l,2,5,6-tetrahydropyridine (MPTP) has neurotoxic 
effects in humans199 led to the hunt for a more commonly occurring environmental 
toxin. It is generally thought to be reasonable to use the MPTP model for trying to 
elucidate the pathophysiology of idiopathic PD.200 PD is not the only 
neurodegenerative disorder which could be possibly linked to a neurotoxic factor. 
Alzheimer’s disease, Pick’s disease, and the ALS-parkinsonism-dementia complex 
have all been linked to possible toxic exposures.
The neurotoxin hypothesis has been given indirect support by the observation that
H A  m  AAA AAA
PD cases may have relatively less effective detoxification systems ’ * * ’ . This
enhances the plausibility that PD arises because of variations in metabolism, either 
due to genetic (see above) or other factors, and an environmental toxin. If 
susceptibility is relatively rare, for example the proportion of the general population 
with poor metabolizer status for debrisoquine is thought to be between 5-10% , the 
exposure may be common as the majority of exposed subjects will not experience 
any adverse results. From an epidemiological perspective, a common exposure 
experienced by 80% or more of the general population will be much harder to detect 
and require far larger sample sizes. Studies will either need to be restricted to 
subjects with the susceptibility genes or be able to test for interactions between 
genetic and exposure status. Such studies require far larger sample sizes (around 
2,000-10,000) 204 than are usually undertaken.
A variety of different neurotoxic exposures have been examined. Most interest has 
focussed on herbicides and pesticides but metals, solvents, proximity to industrial
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areas, general anaesthetics and well water have all been considered as potential 
neurotoxic exposures.
4.2.1 Herbicides & Pesticides
Because of the structural similarity between MPTP and paraquat205, researchers were 
quick to consider the possible role of herbicides and pesticides on PD risk. An early 
ecological study from Canada showed a positive relationship between rural areas 
with the greatest pesticide usage and both PD mortality and drug utilization levels178.
4.2.1.1 Case control studies
Case control studies are inconsistent but the majority of studies suggest an elevated 
risk associated with exposure association h i , i 42.i46, i56,157,159.160,162.i63, i65. i74.i76,189,193,206-
209. A recent meta-analysis has been published that summarised and included data 
from 19 published studies. 210 The authors noted marked heterogeneity between 
studies (P<0.0001) but presented a pooled estimate from a random effects model of 
1.94, (95% Cl 1.49 to 2.53). Using the data they present in table 2 of their manuscript 
one can summarise the results graphically (see Figure 12).
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Figure 12: Forest plot of observational studies reporting association between 
herbicide or pesticide and risk of Parkinson’s disease.
The solid line represents the null hypothesis and the diamond shows the combined 
estimate with its 95% confidence interval. This graph shows that most small studies 
tend to report a positive effect for herbicides and pesticides, with an absence of 
negative studies, which would be expected by chance under the null hypothesis. This 
suggests publication bias and the potential for misleading pooled estimates211,212. 
Interestingly, the four bigger studies show marked heterogeneity, particularly the 
paper by Golbe, which was relatively small. Rechecking the original paper identified 
that the 95% confidence interval used by the authors was incorrect as it was far too 
precise and hence placed undue weight on this estimate. All the studies were 
therefore checked and several more errors were identified, usually when the authors 
had to calculate the 95% confidence intervals from the raw data. The revised and 
updated analysis, including a further 3 studies, (see Figure 13) still shows a
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significant association (odds ratio 1.67, 95% Cl 1.32 to 2.10, p<0.001). As the 
largest study 207 has a strong positive effect on the pooled estimate, a sensitivity 
analysis was undertaken by repeating the analysis removing this study and testing for 
publication bias.
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Figure 13: Revised forest plot of observational studies reporting association between 
herbicide or pesticide and risk of Parkinson’s disease using corrected and updated 
data.
The following graph (Figure 14) plots the standardized effect for the exposure (larger 
value - greater risk) against a measure of precision (larger studies generally more 
precise). In addition it has plotted a regression line showing a negative slope with the 
estimated intercept or measure of bias as 1.85, 95% Cl 0.25to 3.46, p=0.03). These 
data suggest that bigger studies would show a smaller, if  any, effect and that the 
pooled estimate is exaggerated due to publication bias.
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Figure 14: Egger plot of standardised effect against precision to detect publication 
bias
In contrast if one removes the large null study by Stem213, then the regression line 
from the Egger plot shows a positive regression slope suggesting that even bigger 
studies would find a larger effect associated with herbicides and pesticides; this 
seems less scientifically plausible.
It is important to consider several possibilities to explain the marked heterogeneity of 
results across studies; (a) sample size: most of the studies, which show an 
association, suggest a two to three fold increased risk associated with pesticide use.
A weak study may have insufficient power to detect such a risk and would lead to a 
spurious negative finding (type II error). However the major negative studies were 
generally bigger and would have been sufficiently large to have significantly 
detected such an elevated risk160,176. For example the Kansas study was sufficiently 
powerful to detect a two-fold increased risk160, (b) type o f exposure: Some of the
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studies have measured occupational pesticide exposures142,160 and some have 
included domestic exposure141,156. Clearly the types of chemicals, dose and duration 
of exposure will differ markedly in these two different contexts, (c) biased exposure 
measurement: There is always concern about recall bias in case control studies. 
However it is hard to imagine why this should operate for cases in some but not all 
studies given the similarity of their populations. More likely, is that recall of these 
exposures by controls may differ given the marked differences in how these are 
selected, (d) confounding factors: Studies that show an increased risk with pesticides 
also tend to be the same studies with an increased risk for rural residence. This is 
unsurprising as occupational pesticide use is likely to be more common in rural 
areas. However in some studies the association with pesticide use was present142 
despite no association with rural residence180 and vice versa160. The study from 
Calgary, Canada by Semchuck and colleagues142,180 is particularly impressive as its 
design should have minimised any selection bias and it also obtained detailed 
occupational histories, (e) selection bias: An artefactual association between 
pesticides and PD could exist if “selection bias” resulted in an over-representation 
of rural cases compared to rural controls (see section on rural residence for detailed 
discussion). This could explain the elevated results seen with the study from Taiwan 
where cases came from a specialist movement disorders clinic and controls were 
recruited from out patient clinics with more minor problems e.g. headaches, back 
pain, cervical spondylosis etc. However the large German case control study used 
two sources of controls, local and regional and found similarly elevated risks for both
707groups . This excludes the likelihood of selection bias in this study.
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One possibility is that there is true heterogeneity of effect as pesticides differ 
between studies and only some types show an association with PD. Alternatively, 
there may be gene environment interactions so that populations that show an 
association with pesticide have a greater frequency of susceptibility genes compared 
to those that do not. However, this explanation is unlikely as most of these studies 
cover a similar time period and examine similar populations in North America and 
Europe. However, two other features of the association suggest a non-causal 
relationship. Firstly, most studies fail to find an association with any specific type of 
pesticide but rather see this with pesticides in general. This could reflect the 
difficulty in subjects recalling the actual makes or brands but weakens the case for a 
specific pathophysiological mechanism. Secondly, only some of the studies which 
show significant associations show any evidence of a dose response effect. Many 
studies which show an association with exposure dichotomised as a simple yes/no 
variable then fail to find any suggestion of increased risk with either greater years of 
exposure or acreage. For example, herbicide use in the German case control study 
showed the following odds ratios with dose years; never -1, 1-40 years - 1.7,41-80 
years -1.4, >80 years - 2.2. 207
4.2.L2 Cohort studies
Only limited data are available on occupational cohorts and such studies are difficult 
given the relatively low incidence and the need for a long follow-up period. The 
“Iowa 65+ rural health study” demonstrated that farmers, either still working or 
retired, were less likely to have PD compared to other rural controls214. No 
information was provided however as regards their pesticide exposure and smoking 
status was not taken into account. Another occupational cohort study examined a
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group of workers known to be exposed to pesticides (mainly orchardists) with a 
control group of non-exposed subjects undertaking similar physical activities e.g. 
lorry drivers, roofers etc. 215 All subjects were examined by a trained nurse using the 
UPDRS rating scale. Parkinsonism was defined as two or more of the cardinal four 
signs. The response rate was moderate with only 37.5% (323/871) participants 
agreeing to be examined. Only one case (0.3%) of pre-existing PD was identified but 
65 (21%) subjects had parkinsonism, which is remarkably high. This figure questions 
the validity of their case definition. No association was found with ever exposure of 
pesticides but the prevalence ratio for the highest tertile of exposure was 2.0, (95%
1.0 to 4.2). No significant dose-response trends were observed and there was no 
significant associations between parkinsonism and acre-years of pesticide exposure 
or any specific pesticide.
The public health importance of pesticide use as a cause of PD is limited. Assuming 
a causal relationship, the population attributable risk, that is the percent of all PD 
cases that might be related to occupational pesticide use, is only around 10%, using 
the data from the Canadian study, though this could vary between 2-25% (95% 
confidence intervals)142. This estimate excludes non-occupational exposure, which is 
far more common although less intense. If some individuals are particularly 
susceptible to even low level exposure, then pesticides could pose a far more serious 
public health risk.
4,2.2 Metals and solvents
Heavy metal exposure has been considered as a possible neurotoxin that could cause 
movements disorders. 216*218. Possible mechanisms include binding of metal ions to 
neuromelanin inducing oxidative cytotoxicity.219 The results of studies examining
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metal exposure have been inconsistent (see reference for review) Two of the 
largest and best conducted studies are described below in more detail. A population 
based case control study from Detroit recruited 144 cases with idiopathic PD and 
464 controls. An industrial hygienist, blinded to the case-control status of 
subjects, rated occupational exposure to each of the metals of interest. After 
adjustment sex, race, age, and smoking status, an increased association with PD was 
seen for more than 20 years’ exposure with copper (OR 2.49, 95% Cl 1.06, 5.89) 
and manganese (OR 10.61, 95% Cl 1.06,105.83). Various other combinations of 
metals were also found to show significant associations for greater than 20 years’ 
exposure (e.g. lead-copper OR 5.24, 95% Cl 1.59,17.2, lead-iron OR 2.83, 95% Cl 
1.07, 7.50, and iron-copper OR 3.69, 95% Cl 1.40, 9.71). The authors concluded 
that “chronic exposure to these metals is associated with PD, and that they may act 
alone or together over time to help produce the disease.” 221
In contrast a larger case control study from Germany found less supportive evidence.
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for a true association. It recruited 380 cases of PD with two control groups; 379 
neighbourhood controls and 376 regional controls. The risk associated with exposure 
to occupational lead, mercury, zinc, copper, cadmium, chrome, nickel and arsenic 
exposure was examined. Only lead showed a statistically significant association with 
regional controls (odds ratio 1.9, 95% Cl 1.1 to 3.1) although this was not found with 
the neighbourhood control group (odds ratio 1.2, 95% Cl 0.7 to 2.0) Interestingly, 
cases reported more exposure to a wide variety of other potential toxic exposures 
(gases and vapours, glues, paints, lacquers, exhaust fumes etc.). This study however 
also obtained more objective data by using a job exposure matrix (JEM) to allocate 
occupational exposure. This approach may misclassify individual exposure and 
ignores non-occupational exposure. However, it avoids the likelihood of recall bias
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as exposure classification is irrespective of case status. Reanalysis using the JEM 
classification failed to find any significant associations. This highlights the danger of 
relying solely on self-reported exposure data.
The same German study also found that solvents showed a significant elevated risk 
with both control groups (odds ratio 2.6, 95% Cl 1.2 to 5.4, odds ratio 3.4, 95% Cl 
1.5 to 7.5) This has also been reported from a small Italian case control study (odds 
ratio 2.78, 95% Cl 1.23 to 6.26) for exposure to organic solvents for at least 10 years 
but no adjustments were made for confounding factors.189
4.2.3 Residence near industrial areas
Whilst occupational exposure to neurotoxins has been considered, studies have not 
examined residential proximity to industrial areas as an exposure. Such an approach 
has been used to examine risk of cancers near sites that may be releasing potential 
carcinogens into the local environment.222 Often, close residence will imply that such 
individuals also work at the industrial plant, in which case direct exposure will be a 
far greater hazard than passive exposure secondary to close residential exposure. 
Again, such an exposure will be confounded by socioeconomic position and smoking 
status as poorer individuals are likely to live closer to any large industrial plants.
4.2.4 General Anaesthesia
Several studies have examined an association between surgical operations, 
particularly under a general anaesthetic and risk of PD. There are two possible 
reasons why this might be a plausible hypothesis. Firstly, the drug agents used for an 
anaesthetic cross the blood-brain barrier and may have a neurotoxic effect among 
susceptible individuals. Secondly, there is a growing awareness that despite major
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advances in anaesthesia, patients can suffer cerebral ischaemic events. Studies of 
patients undergoing major procedures such as coronary by-pass grafts have 
demonstrated deficits in cognitive function compared to the pre-operative status.
This finding, however, may be limited to this procedure as the complexity of by-pass 
may introduce additional hazards of micro-emboli which are not normally 
encountered in less complex procedures.
Few studies have reported on this risk factor. De Michele and colleagues found no 
association (odds ratio 1.1, 95% Cl 0.8 to 2.8) based on a simple crude dichotomous 
classification and without controlling for potential risk factors63. Similarly, a study of 
monozygotic twins discordant for disease failed to find any excess risk (odds ratio 
1.0, 95% Cl 0.3 to 3.3)147. The wide confidence interval means one cannot exclude a 
substantial risk. A more sophisticated and larger case control study from Germany 
did note a slightly increased risk with anaesthesia (odds ratio local controls 1.4, 95% 
Cl 1.0 to 2.0, regional controls 1.3, 95% Cl 0.9 to 1.9), but did not observe any dose 
response relationship.
4.3 Infectious exposures
The notion that PD could be related to an infectious agent has existed since the 
recognition of post-encephalitic parkinsonism. Other neurological diseases, such as 
subacute sclerosing panencephalitis, also provide an analogous model of disease 
related to latent infection. Whilst a toxic hypothesis has risen in popularity, an 
infectious hypothesis has declined and work examining infections is generally 
older30,94,147,224'226. Some authorities feel “the disease is not of viral origin..”34 and 
hence there is no further need test this hypothesis. This rejection of a potential
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infective mechanism is possibly too nihilistic and this hypothesis is still worthy of 
further investigation.
4.3.1 Seroepidemiology
99 7  ') ')0The inconsistent seroepidemiological results ’ and failure to detect specific viral
99Qparticles, inclusions or antigens in brain autopsy material has been taken as 
evidence refuting an infectious hypothesis. However several intriguing observations 
remain which require an answer. Serological analysis, if anything, suggest that serum 
antibody titres for PD cases are often no different or lower than for controls. In a 
relatively small study of 51 PD cases and 42 medical patient controls, Elizan noted 
that serum antibody titre levels were statistically significantly reduced for measles, 
rubella and herpes simplex 1 in cases compared to controls.227 Whilst serological 
data are objective, they cannot differentiate between age at infection which might be 
a more important predictor than infection per se94,230.
4.3.2 Self-reported history o f infection
Few studies have examined childhood infections and this is prone to bias either due 
to differential recall, cases reporting more infections than controls, or more likely 
non-differential misclassification as both cases and controls have difficulty 
accurately recalling a past history of infection. The summary of results for a wide 
range of infections across for studies that have reported the risk of PD associated 
with childhood infections is shown in the table below.
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Kessler Martyn Sasco Morano
OR 95% Cl* OR** 95% Cl OR 95% Cl OR 95% Cl*
Chicken pox 1.05 0.72 to 1.55 0.97 0.59 to 1.62 0.83 0.52 to 1.30 0.73 0.22 to 2.09
Measles 0.92 0.61 to 1.39 0.7 0.38 to 1.34 0.47 0.26 to 0.86 2.32 0.71 to 9.88
German
measles 1.17 0.69 to 2.01 1.4 0.25 to 7.3
Mumps 0.92 0.62 to 1.35 0.82 0.54 to 1.3 0.66 0.26 to 1.58
Encephalitis 2.55 1.52 to 4.34
Shingles 1.24 0.67 to 2.31
Scarlet fever 0.57 0.30 to 1.08 0.84 0.49 to 1.4
Diphtheria 2.3 1.17 to 4.65 1.0 0.48 to 2.1
Bronchitis 1.3 0.72 to 2.38
Croup 4.1 1.07 to 16.1
Whooping
cough 1.12 0.69 to 1.81 0.88 0.60 to 1.3
Rheumatic
fever 1.0 0.18 to 5.44 2.5 1.0 to 6.07 1.8 0.56 to 5.7
Herpes simplex 0.67 0.34 to 1.31
viral hepatitis 1.51 0.22 to 9.17
Brucellosis 1.45 0.35 to 5.52
Influenza 1.1 0.69 to 1.8
* 95% Cl calculated from raw data in paper 
** OR recalculated for ever at any age
Table 11: Association between self-reported childhood infection and risk of PD
There are no really consistent patterns; for example 3 of the 4 studies show a reduced 
risk associated with measles infection but the fourth shows a greater than doubling 
risk. The confidence intervals are wide for most of the estimates, though significant 
associations were seen for encephalitis (increased risk)225, diphtheria, croup and 
rheumatic fever (increased risk)32, measles (decreased risk) 226. A Finnish community 
based case control study noted a reduced risk for rubella infection (odds ratio 0.37, 
95% Cl 0.16 to 0.90, p=0.03) and a reduced risk of tuberculosis infection < 20 years 
(odds ratio 0.14, 95% Cl 0.00 to 0.89,p=0.04).198 One other study examined measles, 
mumps, rubella and Spanish flu and noted that there were no significant associations
' I ' l  1
but did not present any empirical data. Of particular note is the study based on the 
Harvard and Pennsylvania alumni cohort as this was a nested case control study from 
a cohort of 50,002 college men. Exposure history on childhood infections is unique
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as it was collected at college entrance, many years before disease onset and so cannot 
be biased by differential recall. Data are also likely to be far more valid as the time 
gap between recall and disease onset will be much shorter compared to other studies 
with elderly subjects. In addition, as this cohort is likely to be much more socially 
homogenous, it is likely that differences in infection are less likely to be crude 
markers of socioeconomic position and hence merely confounding. The authors 
provide several possible interpretations for their results226; (a) measles infection may 
be genuinely protective, (b) failure to report measles may indicate early or atypical 
measles infection which is harmful, (c) failure to report measles may indicate lack of 
immunity and hence infection with measles in adult life, which is harmful or a higher 
risk of influenza infection in the 1918 influenza epidemic. In the last case, the 
protective effects of measles may only be seen in specific birth cohorts and not 
replicated elsewhere. Interestingly, pertussis, chicken pox, and mumps infection also 
appeared to be less common in this sample though to a less marked effect , 
consistent with the serological results.
A reduced frequency of childhood infections could be a chance phenomenon, but 
might relate to other factors, such as infection in very early life. One study suggested 
the possibility of "in utero" infection but this was based on ecological data and 
failed to be replicated224. Alternatively, it may reflect variations in immune function 
or the possibility of confounding by another factor such as socioeconomic position or 
family size. The non-specificity of the results favours the role of a confounding 
factor, but this remains unresolved.
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4.3.3 Contact with animals
Few studies have measured exposure with farm animals as a possible mediator of an 
infective zoonosis. Observed associations with rural exposure, pesticides and farming 
could all be explained if an infective agent was transmitted by a common farm 
animal. Such a hypothesis is consistent with the failure to see any marked secular 
increase of PD over time. Unlike pesticides, which have increased in exposure, 
contact levels with livestock have probably remained fairly uniform. Three previous 
studies (see Table 12) have either failed to find any association or if anything found a 
protective effect. The study by Golbe and colleagues 174 used spouse controls which 
may have resulted in “overmatching” for exposure so that the effect estimate is an 
underestimate of the true risk. The other study by Tanner and colleagues was based 
in China and found that contact with pigs and chickens was protective for PD. 
Similarly a study from Delhi, India found a positive dose-response effect for 
exposure to pets so that exposure of greater than 10 years was associated with half 
the risk of PD (odds ratio 0.50, 95% Cl 0.34 to 0.74) 193. A Finnish study noted a 
generalised phenomenon that cases had fewer household pets and less contact with a 
wide range of domestic animals such as cows, horses, sheep, pigs, and chickens.198 
This study was well designed in terms of case and control selection and there was no 
overall association with rural residence.
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Author Year Study
design
sample size cases controls results comments
cases controls
Golbe197 1990 C-C
study
106 106 MD clinic spouses OR 1.3 (0.7 to 
2.7) for at least 
2/12 per year 
until marriage
Univariate analysis. 
2:1 ratio of men to 
women. Problem as 
spouse controls.
Tanner92 1989 C-C
study
100 200 Neuro
clinic
Neuro
clinic
OR 0.2 (0.1 to 
0.3) for pig 
raising; OR 0.5 
(0.3 to 0.9) for 
chicken raising
Univariate analysis. 
Study carried out in 
China
Kuopio198 1999 C-C
study
123 246 prevalent
cases
Random
controls
OR 0.59 (0.38 
to 0.94) 
Having dogs 
>=20 years
Generally less 
contact with pets and 
farm animals
Behari193 2001 C-C
study
377 377 MD clinic Neuro
clinic
OR <=10 years 
0.89 (0.41 to 
1.93), >10 
years 0.71 
(0.51 to 0.98) 
for pet 
exposure
Adjustment for 
covariates increased 
association (OR 0.50, 
0.34 to 0.74)
Table 12: Studies examining association with farm animals and pets
4,3.4 Travel within and outside the country
Migration both within and between countries may lead to new infectious exposures. 
This is obviously true when travelling from a developed to developing world country 
but may also be true for migration between urban and rural areas. The role of 
infection in early life, as a protective factor, has been argued to explain the apparent 
low rates of multiple sclerosis amongst South African whites compared to their 
European peers232,233 as well as Ashkenazi Jews who migrated to Israel in childhood 
as compared to adulthood.234 Similarly studies of leukaemia have found evidence 
that both migration from rural to urban areas as well as general short distance 
migrations associated with increased population mixing are associated with an 
increased risk. Migration as an exposure is clearly not specific to an infectious 
hypothesis and may be a confounder for other exposures such a diet or other toxic 
environmental exposures. Few if any studies of PD have examined this issue directly.
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A small case control study from Beer-Sheva, Israel165 noted that Israelis who had 
migrated more than 25 years ago in the past had an elevated risk of PD compared to 
those who had migrated in the last 25 years (odds ratio 2.10, 95% Cl 1.17 to 3.78, 
p=0.02). This suggests that exposures acting in earlier life may be of importance but 
the authors did not adjust for other covariates so this association could be secondary 
to other confounding variables.
4.3.5 Proxy measures o f infection
Because of the problems with accurate retrospective recall of childhood infections, 
some researchers have used surrogate markers of infectious risk. These measures 
whilst crude are usually reported with greater validity and may therefore 
paradoxically be more powerful predictors of disease risk.
4.3.5.1 Childhood sanitation
The risk of contacting an infectious agent transmitted through the oral-fecal route are 
associated with levels of sanitation. Conventionally, these are measured by recording 
access to hot water and toilet facilities e.g. indoor versus outdoor. Only one study32 
for Hertfordshire, UK has reported the association of childhood sanitation with PD. 
No increased risk was noted with either presence of a bathroom (odds ratio 1.1, 95% 
Cl 0.71 to 1.71), or indoor WC (odds ratio 1.0, 95% CI0.55 to 1.70). Assuming early 
exposure was protective, one would have expected to see an increased risk with 
better measures of sanitation such as a bathroom or indoor WC.
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4.3.5.2 Family size, crowding and birth order
Another important predictor of infectious hazard related to family size and in 
particular over crowding. Historically, it was common for many children to share 
rooms and the same bed enabling easy cross-infection of air-borne infections. Some 
studies have measured whether children attended a boarding school as a surrogate 
exposure for extreme overcrowding and increased risk of exposure to infectious risk. 
For example a case control of childhood leukaemia noted an odds ratio of 0.28 (95% 
Cl 0.09 to 0.88, p=0.03) associated with attendance at creche in infancy. More 
interestingly, research in the field of asthma and atopy has specifically examined the 
hypothesis that age at infection maybe more important than infection per se. This has 
been indirectly assessed by birth order. Thus a first bom child is likely to be 
exposed to an infectious agent at an older age than their younger sibling, as the latter 
is at greater risk of contact from their brother or sister.
The case control study from Hertfordshire32 has reported the risk associated with 
overcrowding and PD, defined as >1.5 persons per bedroom. Just as for sanitation, 
there was no apparent association (odds ratio 1.1, 95% Cl 0.68 to 1.69), although 
cases were more likely to have had father’s with social class IV and V (odds ratio 
1.5, 95% Cl 0.85 to 2.53).
4.3.5.3 Vaccinations
Vaccinations have sometimes been measured as an exposure either because it is 
postulated that the vaccine itself may result in some damage through an autoimmune 
process or, as is more likely, vaccination may actually be protective due to immune 
cross-reactivity between the specific vaccine and other potential pathogens. In the 
former scenario vaccination would be associated with an increased risk whilst in the
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latter it would have a reduced risk. It is important to note that socioeconomic 
variables may confound any association with vaccination status as parents of lower 
socioeconomic status are generally less likely to have their children vaccinated.
There is no existing literature on any association between childhood vaccinations and 
risk of PD.
4.4 Trauma 
4,4A Head trauma
The concept that trauma might be a cause of Parkinson’s disease was originally 
suggested by James Parkinson. For most of the nineteenth century, it was believed 
that “peripheral” trauma might result in PD due to an ascending neuritis (see 
reference by Factor and colleagues for more details ). By the twentieth century, the 
role of peripheral trauma had been rejected but interest now focussed on central 
trauma especially if associated with concussion. The “punch drunk” syndrome 
associated with parkinsonism was first described by Martland in 1928. This 
syndrome is characterised by loss of pigmented neurons in the substantia nigra but 
absence of Lewy bodies. However, failure to detect pathological evidence of trauma 
to substantiate this association has resulted in much scepticism of such an 
association. Stem has suggested that absence of gross macroscopic evidence of 
trauma should not exclude the hypothesis as trauma may produce more subtle effects 
such as alterations in the permeability of the blood-brain barrier. 4 Similarly, even 
small degrees of traumatic brain injury may be deleterious as the brain has a high 
content of iron and any release of extracellular iron will stimulate free radical 
reactions resulting in further oxidative tissue damage. 240
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Some , but not all studies have noted an excess risk of head trauma amongst PD 
cases than controls 32-59’141-146’231’241’242 207. (see Table 13). Estimates for the 
association are variable from a halving of risk to a four-fold increased risk. The twin 
study by Bharucha is interesting as exposure was measured relative to the unaffected 
co-twin 241. This study failed to find any association but only head injuries in 
childhood were examined.
The usual explanation for a positive association is the likelihood of recall bias. This 
is the phenomenon that an exposure is differentially recalled (either positively or 
negatively) by cases than controls. For PD, it is likely that cases will try harder to 
report an event, such as a head injury, which might explain why they have developed 
this disease. One method to reduce this possible bias is to only measure severe head 
injuries, such as those resulting in loss of consciousness, which should be recalled 
equally well by both cases and controls. The results in the table provide some 
empirical support for this approach as in general the associations are either 
attenuated or absent when severe head injury is reported rather than any head injury. 
Despite this, several studies show a doubling of risk even with this approach. 
Another method is to use disease rather than “healthy” controls. For example, one 
study selected controls from patients with rheumatoid arthritis146. This is to be 
avoided as firstly the use of a single disease control group makes interpretation of 
associations problematic. Is a positive association with a risk factor due to increased 
exposure in PD or reduced exposure in the other disease group? Secondly, it is 
unlikely that head injury is such a salient exposure for patients with a peripheral 
disease such as rheumatoid arthritis. Other disease controls, such as stroke patients, 
may be better suited but still do not avoid the problem altogether. Another strategy is
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to try and control for recall bias by asking cases about their “lay beliefs” concerning 
the cause of their disease243. Subjects who report trauma as a possible cause can then 
be removed from the analysis to determine the degree of potential bias, although this 
might underestimate the true risk244. This approach has not been used in previous 
studies in this area.
Methodologically, cohort studies avoid the problem of recall bias as exposure is 
measured prior to disease status. Only one study245has examined a cohort of subjects 
with recorded head injuries and followed them up for subsequent risk of PD. This 
study identified 821 individuals with medically recorded head injury resident in 
Olmsted county. Record linkage was used to identify all deaths recorded as due to 
PD. Standardised mortality ratios were calculated using age and sex specific rates for 
Rochester county. No increased risk for parkinsonism was observed (SMR 1.04, 95% 
confidence interval 0.48 to 1.98). However, the study had limited power; it had a 
30% probability of detecting a two-fold relative risk if the alternative hypothesis was 
true245. Susceptibility to trauma, rather than severity per se may be more important. If 
head injury triggers a cascade of biological events that lead to cell death in only a 
few susceptible individuals, then a head injury cohort may be less able to detect an 
increased risk than case-control studies.
90
Author Year study design sample size 
cases controls
cases controls results comments
Bharucha147 1986 C-C study 31 31 nationwide
search
monozygotic
twin
OR 0.8 (0.3 to 2.3) more head 
injuries than twin
Wide confidence interval so 
cannot exclude moderate 
elevated risk
Stem141 1991 C-C study 149; 69 
young onset, 
80 old onset
149 Neuro clinic "buddy" controls OR 2.9 (1.5 to 5.8) adjusted for 
smoking & rural residence
Slightly stronger association 
for young cases versus old 
cases. No dose-response 
effect.
Factor246 1991 C-C study 97 64 MD clinic spouses OR 2.3 (1.1 to 4.9) for any 
head injury, OR 2.1 (0.9 to 5.2) 
for injury with altered 
consciousness
Data incorrectly analysed as 
unmatched. When adjusted 
for imbalance in gender, 
more men as cases, results 
no longer significant
Butterfield146 1993 C-C study 63; disease 
onset<51 
years
68 source not 
stated
Rheumatoid 
arthritis controls
OR 1.7 (p=0.17) for ever been 
knocked out?
Univariate analysis only. 
Single disease control 
group. Response rate for 
cases 69% versus 41% in 
controls
Semchuck190 1993 C-C study 130 260 PD register community 
control (RDD)
OR 3.9 (1.3 to 7.9) head 
trauma adjusted for family 
history PD & herbicide use. 
OR 2.2 (1.1 to 4.6) if head 
injury for which medical 
attention is sought
Community controls from 
same population. 
Attenuation if limited to 
more serious injury.
Morano247 1994 C-C study 74 148 Neuro clinic A&E controls OR 0.6 (0.3 to 1.3) for cranial 
trauma
Univariate analyses only. 
Exposure classified as 
Yes/No
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Author Year study design sample size 
cases controls
cases controls results comments
Martyn32 1995 C-C study 172 343 GP registers GP registers OR 0.6 (0.3 to 1.3) for head 
injury severe enough to result 
in loss of consciousness or 
admission to hospital
Univariate analysis. 
Population sources of cases 
and controls.
De
Michele63
1996 C-C study 116 232; two 
control 
groups
Neuro clinic spouses & other 
neuro clinic 
controls
OR 2.3 (1.0 to 5.6) for head 
injury with loss of 
consciousness
Univariate analysis. Crude 
measure-no indication of 
frequency
Seidler144 1996 C-C study 380 755; two 
control 
groups (376 
and 379)
Nine neuro 
clinics
random 
neighbourhood or 
regional control
OR 1.4 (0.9 to 2.3) for 
neighbourhood or OR 1.5 (1.0 
to 2.4) for regional control for 
trauma with dizziness, blurred 
vision and/or memory loss
The test for trend with 
number of episodes was 
borderline non-significant 
(p=0.07 and 0.11 
respectively).
Smargiassi
189
1998 C-C study 86 86 Neuro clinic OPD clinics OR 2.88 (0.98 to 8.49) for 
cranial trauma (undefined)
Study from Parma, Italy. No 
adjustment
Table 13: Summary of studies reporting an association between head injury and PD
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4.4.2 Intra-uterine or birth trauma
The possibility that PD is a developmental disorder whose origins stem from the 
intrauterine period has hardly been considered. Such a hypothesis would 
conceptualise intrauterine events resulting in either a greater susceptibility to future 
age-related degeneration or simply that individuals are bom with less dopaminergic 
capacity within the substantia nigra, (see section 2.2 above) Eldridge and Ince were 
perplexed by the low concordance rate observed in MZ twins and the observation 
that there may be lifelong personality differences between the twin who goes on to 
develop PD as compared to their sibling.31 Their unifying hypothesis was that there 
was some PD protecting factor which influenced the total number or ultimate 
survival of dopaminergic and related neurones of the substantia nigra. This factor 
must be distributed unevenly, possibly through a circulatory imbalance distributed by 
the placenta. They supported this notion by analogy with other traits that are also 
discordant in MZ twins e.g. birth weight or the “prune belly” syndrome.
Another measure of intra-uterine trauma or growth retardation is birth weight. This 
measure has been used to support the possible role of intrauterine influences or 
“programming” for a variety of important chronic diseases of adulthood, such as 
heart disease, hypertension, and diabetes. 248 Such a hypothesis is not easy to test 
with rarer disorders as one requires a very large cohort with birth weight details. The 
best empirical evidence so far has been provided by a case control study, which 
uniquely had recorded birth weights and weight at 1 year in a sub sample of cases 
and controls. This failed to find any evidence that birth weight had any real 
association with PD, but as it was limited to 65 subjects in total, it had rather limited 
power and relatively imprecise estimates of risk. For example, the relative risk of PD 
associated with a one pound increase in birth weight in the unmatched analysis was
1.1 (95% confidence interval 0.76 to 1.60). A study of monozygotic twins discordant 
for PD found that cases were lighter, as one would have hypothesised, than their co­
twins (odds ratio for being heavier at birth 0.8, 95% Cl 0.2 to 2.5)147. Although no 
specific birth weight data were available, it is likely that mothers would correctly 
recall which of a twin pair was heavier. A large case control study from Germany 
noted an elevated risk associated with premature delivery, and hence presumably 
lighter birth weight, with both neighbourhood (odds ratio 2.2, 95% Cl 0.9 to 5.7) and 
regional controls (odds ratio 1.6, 95% Cl 0.7 to 3.9) although in both cases the results 
failed to reach conventional levels of statistical significance.207 It is also possible that 
intrauterine events may effect cerebral development and dominance thereby 
determining handedness. Thus handedness could be used as a proxy marker of such 
an influence. 249 Although a highly speculative hypothesis, the possible role of intra­
uterine factors on cerebral development remains unresolved.
4.5 Life style exposures
4.5.1 Smoking
The inverse relationship between smoking and PD is one of the most consistent 
observation in the epidemiology of PD and has been seen for both case control and 
cohort studies. Kahn, in one of the earliest cohort study of smoking and mortality250, 
was so surprised by the association that he sought and received confirmation from 
both Doll and Hill251 and Hammond252.
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Author Year Follow-
up
period
(yrs)
Sample size Results Comments
Khan23U 1966 8.5 248,046 SMR
0.23
first cohort study
RogotOJ 1980 16 SMR
0.46
Male US veterans
Hammond232 1966 4 1,003,229 SMR
0.81
Males between 65 
and 79 years
Doll231 1994 40 34,439 men 
& 6194 
women
SMR
0.80
ever versus never 
male and female 
doctors
Grandinetti145 1994 26 8006 RR 0.39 Japanese men 
residing in 
Honolulu
Heman234 2001 20
(NHS) 
and 10 
(HPFS)
121,700 
women 
(NHS), 
51,529 male 
health
professionals
RR 0.4 
(NHS) 
RR 0.3 
(HPFS)
Current smoker 
versus never 
smoker in male 
and female nurses 
and health 
professionals.
SMR = standardised mortali ty ratio, RR = risk ratio
Table 14: Association between smoking status and risk of PD from prospective 
cohort studies
Some publications have failed to show a statistically significant association but 
usually the results have been in the same direction. The consistency of this finding in 
different populations and using different methods makes it reasonable to exclude 
chance as an explanation for this association. Other possible explanations are: (1) 
Bias - Individuals may biologically age at different rates due to genetic differences in 
the ability to repair cellular damage. Smoking may adversely affect DNA repair 
mechanisms and therefore smokers with less efficient mechanisms would be 
selectively eliminated by death (selective mortality). Older surviving cigarette 
smokers would have relatively more effective DNA repair mechanisms and would 
therefore be protected from developing either PD or Alzheimer’s disease29,255. This 
argument is flawed for several reasons reasons . Monozygotic twin pairs, where
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both twins are alive still show the inverse association with smoking. 241,257 Case 
control studies using early onset cases are also consistent with the findings even 
though selective mortality is unlikely to be of any importance for populations at this 
young age.146 In fact, the pooled analysis of data from the EUROPARKINSON case
' J C Q
control study found a strong interaction between age, sex and smoking status . 
Whilst overall it found no association between ever smoking and PD (odds ratio 1.1, 
95% Cl 0.7 to 1.8), they found a markedly protective effect for cases with onset 
under 75 years (odds ratio 0.4, 95% Cl 0.1 to 0.9). This is the exact opposite of what 
one might have predicted from the selective mortality hypothesis. (2) Causality - 
There are several biologically plausible reasons why smoking may protect or retard 
the development of PD. Carbon monoxide or other factors in cigarette smoke may 
scavenge free radicals . Smoking may have an effect on mitochondrial activity and
OfkCioxidative damage . Polyaromatic hydrocarbons in tobacco smoke may induce
0(\\cytochrome P-450 enzymes and lead to increased metabolism of xenobiotics . If 
smoking did in fact alter the rate of nigral cell death one would predict that smokers 
who developed PD would both be older in age than non-smokers and have a slower 
rate of disease progression. Both of these predictions are refuted by empirical 
evidence145,262'265. (3) Reverse causality - PD makes people give up smoking as a 
secondary phenomenon. But the inverse association is still found if smoking habits 
are examined for a period before onset of clinical disease146,266. It is possible 
however that subtle changes in personality occur well before overt clinical disease as 
part of a more insidious onset. Such changes might effect smoking behaviour. 
Personality may therefore either act as a proxy marker of disease, or is a confounding 
variable unrelated to the disease process). (4) Confounding - There are premorbid 
personality differences associated with both the likelihood of becoming a smoker and
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continuing to smoke and other exposures/genes that are directly related to the risk of 
developing PD (see figure 15). Smokers appear to differ in personality traits from 
non-smokers and are more likely to be extrovert or exhibit type A behaviour267. Non- 
smokers have higher levels of shyness and defensiveness268. Similar personality 
differences may also determine alcohol consumption. Most studies do demonstrate 
that PD cases either are no different or have reduced alcohol consumption (see 
below)181,263. PD cases are reported to show personality changes (see section 4.6.1), 
such as introvertism, that would make them less likely to be smokers ’ ' . We do 
not however know to what degree personality, such as being the more dominant 
twin50could influence other risk factors, such as migration from rural to urban areas, 
or reducing the risk of exposure to pesticides. Alternatively certain genes may 
influence both the tendency to smoke and the risk of developing PD. This argument 
has been suggested to explain the similar association found with Alzheimer's 
disease272.
Environmental
exposures
clinical disease
Intrinsic personalitygenes
Socio-cultural
influences
smoking behaviour
Figure 15: Theoretical links between smoking behaviour and other determinants of 
disease.
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4.5.2 Alcohol\ tea and coffee
Far less evidence exists for the association between alcohol, tea and coffee 
consumption. Alcohol is clearly neurotoxic and heavy consumption results in a 
variety of neurological complications such as Wernicke’s encephalopathy. Tea and 
coffee contain caffeine, a central nervous stimulant. Caffeine is an adenosine A(2A) 
receptor antagonist that enhances locomotor activity in animal models of 
parkinsonism and may be neuroprotective in MPTP models of parkinsonism.
Fewer studies have reported associations with tea, coffee and alcohol than for 
smoking behaviour. These studies have been generally consistent in demonstrating 
that cases are less likely than controls to drink either tea, coffee or alcohol 
148,156,181,241,263,274 145 59,275193 ^  gome stuciies, these inverse associations fail to reach
conventional levels of statistical significance. However the effect size is consistent or 
slightly weaker than that seen for smoking behaviour. However, it is important to 
recall that it is easier to accurately assess smoking behaviour particularly over a life 
time. Whilst smoking behaviour remains relatively consistent until a person gives up, 
alcohol consumption is much more variable both on a weekly as well as seasonal 
basis. Binge drinking at weekends is often not adequately measured by conventional 
methods and yearly fluctuations are harder to summarise.
Godwin-Austen266 reported that PD cases were less likely to drink alcohol but did 
not present any data. Butterfield and colleagues146 merely reported that there were no 
significant differences (P<0.05) between coffee, black tea and alcohol consumption 
but failed to present any data to quantify this association. Similarly Kondo
97Areported that cases (n=46) were less likely intake alcohol between 20 to 39 years 
(odds ratio 2.9) although this was not statistically significant. No further data to
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enable the calculation of a confidence interval were presented. A study by Lang and 
colleagues 277 compared the distribution of alcohol consumption for 125 PD patients 
with pre-existing data from a community survey from residents of Camberwell. They 
did not carry out any formal statistical test though commented that “fewer patients 
with PD than controls fell into the moderate or heavy alcohol intake categories.” No 
adjustment was made for other confounders. A Spanish case control study reported 
non significant differences for both coffee and tea consumption so that cases were 
less likely to be exposed.59 A large case control study from Rochester, Minnesota278 
showed significant inverse associations with alcoholism (odds ratio 0.41, 95% Cl 
0.19 to 0.89) and coffee drinking (odds ratio 0.35, 95% Cl 0.16 to 0.78); there was a 
significant dose response effect with coffee drinking. Similarly, the large German 
case control study275 of 342 cases and 342 community control subjects also noted 
that cases consumed less beer (OR 0.26, 95% Cl 0.14 to 0.49) and spirits (OR 0.56, 
95% Cl 0.36 to 0.86), but not wine, and they consumed less coffee (OR 0.27, 95% 
Cl 0.14 to 0.52, highest versus lowest quartile), but not tea, than controls. Whilst a 
study from Washington State found no association with coffee drinking (odds ratio 
1.0, 95% CO 0.5 to 2.0) for >6 cups per day versus never but did a reduced risk with 
tea consumption (odds ratio 0.4, 95% Cl 0.2 to 0.9). 279
The most impressive data come from the Honolulu Heart Program follow-up as this 
is the only prospective data. Diet was assessed using a 24 hour dietary recall
AQA
questionnaire which had been validated against a week dietary record. Incidence 
rates were calculated over a 30 year follow-up period and case identification as based 
on death certification review, hospital records and records from local neurologists. 
The adjusted relative hazard ratio for non coffee drinkers compared to those
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consuming > 28 oz/d was 5.1 (95% Cl 1.8 to 14.4), with a marked dose response 
effect (adjusted for age and pack-years of smoking). Interestingly the same, though 
weaker, protective effect was seen for caffeine from non-coffee sources. The same 
study had also previously reported an inverse association with alcohol consumption 
though this failed to reach statistical significance (crude risk ratio 0.41, 95% Cl 0.40 
to 1.12, adjusted risk ratio 0.76 95% Cl 0.45 to 1.28)148
Alcohol, tea and coffee may contain substances that are possibly protective for PD. 
However, it seems difficult to imagine that such diverse exposures could each 
provide similar protective effects. One possible explanation for this inverse 
association is that these behaviours merely confound smoking patterns; smokers are 
more likely to drink more tea, coffee and alcohol. However, the data from Honolulu 
show similar protective effects for coffee drinking across never, past and current 
smoking strata. In fact the largest gradient is observed for never smokers, so residual 
confounding by smoking is unlikely to be an explanation. An alternative explanation 
is that PD cases are simply less likely to indulge in any addictive prone behaviours, 
be it smoking, alcohol or coffee and/or tea drinking. This could reflect either intrinsic 
(genetic, personality, central nervous system) or extrinsic (socio-cultural) influences 
(see figure 15). This pattern of diminished utilisation of common addictive 
substances may provide some clue as to either early pre-morbid manifestations of the 
disease or a common aetiological factor. For example, in the study by Mayeux and 
colleagues 145, it was the combination of both smoking and alcohol consumption 
which showed the strongest effect.
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4.5.3 Dietary factors
Diet could play a role in the aetiology of PD. The rare disease of ALS/Parkinsonism- 
dementia, seen on the Islands of Guam and Rota, is thought to be probably due to a 
dietary toxin from the cycad plant281, which is not found in Western diets. Diet is a 
complex and difficult to quantify exposure . Usually all individuals are exposed to 
the hypothesized causal factors and thus continuous variables need to be measured, 
often with a limited range of variation. Retrospective data are especially prone to 
inaccuracy and recall bias . Recall of past diet in each case is seen to be strongly 
influenced by current dietary intake . This influence may be especially important 
in the context of case-control studies, where the possibility that cases but not controls 
may alter their diets subsequent to the diagnosis of their disease.
Several studies have found a relationship between specific food stuffs and PD. These 
results are however still rather tentative and inconsistent. For example one study 
showed that the protective effect of foods such as peanuts was only seen for females, 
whilst a protective effect of salad with dressing was only found in men174. Nuts and 
seeds were seen to be harmful in yet another study146. Several studies that have 
examined diet are shown in Table 15. Some studies have found no associations with
  Ofi.4 'lQAvitamin E " whilst another has found a protective association with high intake
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Authors Year Design Main findings
Golbe197 1990 C-C study 
with spouse 
controls
Female PD associated with less 
peanut consumption, Male PD 
associated with less salad dressing 
(both sources of Vitamin E)
Butterfield146 1993 C-C study 
with
Rheumatoid
arthritis
Consumption of nuts 10 years 
before diagnosis (OR 1.5, p=0.035)
Morens286 1996 Healthy
Japanese
men
PD associated with less legumes 
consumption (OR 0.27 95% CIs 
0.09 to 0.78), Vit E not 
significantly associated
Hellenbrand284 1996 C-C study
General
population
Reduced PD intake of beta-carotene 
(OR 0.67 95% CIs 0.37 to 1.19, p 
for trend =0.06) and ascorbic acid 
(OR 0.60 95% CIs 0.33-1.09, p for 
trend =0.04) Vitamin E not 
associated
Logroscino288 1996 C-C study
Medicare
recipients
No associations with vitamin E and 
vitamin C
de Rijk289 1997 XS study 
Elderly 
general 
population
Reduced intake of vitamin E (OR 
0.5 95% CIs 0.2 to 0.9). No 
significant association with vitamin 
C
Johnson290 1999 C-C study 
primary care 
database
No association with anti-oxidants; 
increased risk with fat (OR 1.94, 
95% Cl 1.05 to 3.58), cholesterol 
(OR 2.11, 95% Cl 1.14 to 3.90), 
iron (OR 1.88, 95% Cl 1.05 to 
3.38)
Table 15: Studies examining dietary consumption and risk of PD
One case control study found an increased risk of PD with dietary cholesterol and 
fat290, however serum cholesterol levels measured prospectively were not associated 
at all with risk of PD (OR 0.99, 0.99 to 1.00 per mg)148.
A large prospective cohort study o f41,836 women, which had been followed up for 
6 years, found no association between vitamin E and PD but a significant protective 
effect was seen for both vitamin C and manganese consumption, whilst vitamin A
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was associated with an increased risk291. The report of this study has never been 
published in anything more than abstract form. YBS contacted the senior author 
(Prof. Aron Folsom) on this report to see if further analysis had altered the results. 
Prof. Folsom reported that the lead author had left and no one had time to write up 
the paper but the results had not changed.
The failure of the DATATOP trial to show any benefit with a-tocopherol292 should 
not be interpreted as excluding the potential role of dietary antioxidants. Firstly it is 
possible that the wrong intervention was chosen and secondly dietary factors may 
protect disease onset (induction) and yet have little effect on prognosis once disease 
is established (promotion). For example stopping smoking after the diagnosis of 
lung cancer has little effect on survival.
The role of dietary factors is still unclear as current evidence is weak. It is important 
to consider both adult and childhood diet, in view of the potential long latency period 
for PD. More sophisticated methods of dietary measurement, such as 7-day weighed 
diaries and biomarkers, using prospective cohorts would establish whether these 
results are artefactual.
4.6 Miscellaneous risk factors
4.6.1 Personality
There have been few studies that have examined personality of patients with PD.
270,271,276,293-296 some exposures this is particularly problematic with
retrospective data from a case control study. Various differences have been
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described, such as more caution and less flexibility271,297, pedantic, rigid and loners,
onn, introspective, over-controlled, anhedonic with suppressed aggressivity. .
These personality characteristics are associated with less “novelty-seeking 
behaviour”, which may be dopamine dependent, and may explain differences in 
smoking behaviour as well as other addictive-prone habits. Studies of the D4R knock 
out mouse also demonstrate less novelty seeking behaviour,299 but whether this 
model is of any relevance to PD is less certain.
A cross-sectional survey of 783 college students noted that the sub-group who scored 
highest on shyness and defensiveness reported the least smoking behaviour and also 
reported the highest frequency of illness associated with pesticides as well as other 
xenobiotic odours. However, the latter finding may simply reflect a lower 
threshold for reporting any complaint.
Given the methodological problems with such retrospective assessment, as well as 
the frequency of co-morbid depression in patients with PD300,301, it is hard to evaluate 
the importance of these findings. A larger case control study of 122 patients and an 
equal number of controls failed to find any differences in novelty seeking behaviour 
but found that the higher rate of depression in cases explained differences in “harm 
avoidance” behaviour.302
More recently PET scan studies have begun to address this issue. A pilot study of 9 
PD cases noted that uptake of 18 F-dopa was lower in left caudate, but not in other 
areas and correlated with novelty seeking.303 In contrast, another study304 failed to
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find any relationship between 18 F-dopa uptake in any of the brain regions, though 
the novelty seeking score was lower amongst cases.
Perhaps more convincing are reports comparing discordant MZ twins. 50,305 In two 
independent studies, the affected twin with PD was reported as “less often the 
leader”. However, due to small sample sizes these differences could have occurred 
by chance. In the absence of any prospective data on personality type and risk of PD, 
this interesting issue remains unresolved.
4.6.2 Comorbidity
The association between PD and other diseases can be a useful clue as to shared 
common aetiological factors be they genetic or environmental. (1) Cardiovascular 
disease, hypertension and diabetes: Heart disease and stroke have been reported to 
be less common in male cases of PD or to be no different from the general 
population306. Most studies which have reported causes of death for PD subjects have
1 f t  1 A 7  7 A 0used proportional mortality ’ ’ and have therefore potentially underestimated the 
relevance of heart disease as compared to the general population 309.
One cohort study reported a two to three fold increased risk for both heart disease 
and stroke mortality rates for PD patients compared to a general population control 
group.109. This is particularly surprising considering the consistent observation that 
PD cases are less likely to be smokers. This observation has not been replicated in 
another population based study 110. It is possible that the misdiagnosis of 
parkinsonism secondary to cerebral atherosclerosis resulted in this artefactual 
association.
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Hypertension amongst PD patients has either been reported as being less 
common264,306 or no different from control groups148,156,225. This might relate to 
abnormalities in autonomic control mechanisms. No increased risk has been seen for 
diabetes148,156. (2) Malignancy: Several studies have demonstrated that PD patients 
experience about half the number of cancers than would be expected from general 
population rates109,308,310-312. When this is examined in more detail, this deficit is 
specifically related to smoking related cancers109,310 and may be simply explained by 
the larger proportion of never smokers in the PD population.
4.6.3 Family history o f other diseases
The rationale for examining the co-occurrence of other diseases, apart from PD, in 
family members is to examine for either shared genetic and/or environmental co­
factors that may be linked to a common aetiological pathway. For example, the 
observation that in Sardinia both individuals with multiple sclerosis and their healthy 
siblings are more likely to also suffer from type 1 diabetes suggests a possible 
common genetic mechanism linked to the DR3 haplotype.313
4.6.3.1 Risk o f diseases in other family members
Many studies have reported an increased risk of PD in other family members. 
58,61,67,314-320 couu  reflect either genetic or shared environmental influences on 
disease risk. If there is an underlying common pathway between PD and other 
neurodegenerative disorders then one would predict that other family members 
would have a greater than expected risk of other neurodegenerative disorders e.g. 
Alzheimer’s disease, motor neurone disease. One study of 151 newly diagnosed
cases of motor neurone disease calculated the hazard ratio for PD and dementia in 
grandparent, parents and siblings compared to a control group.320 It noted both an
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increased risk of dementia (odds ratio 1.9, 95% Cl 1.1 to 3.1) and PD (odds ratio 5.6, 
95% Cl 0.6 to 50.3), though the latter could have been due to chance and was based 
on small numbers.
One must also consider the possibility of recall and/or ascertainment bias in such 
studies as cases are either more likely to report such events or family members are 
more likely to seek early medical diagnosis knowing that their relative has developed 
a neurological disorder.
One way to differentiate if the reduced frequency of cancers amongst cases of PD 
(see above) is due to their own smoking behaviour or a reduced susceptibility to 
cancers is to examine whether other family members also appear protected for this 
disease compared to general population.
4.6.3,2 Aging genes-parental longevity
Parkinson’s disease is clearly a disease associated with ageing. However, it has also 
been suggested by Riggs ’ that Alzheimer’s and Parkinson’s disease may be 
related to the “ageing genes” so that susceptible individuals have genes associated 
with more rapid biological ageing and this in turn may interact with environmental 
risk factors such as smoking. One way to test such a hypothesis is to examine 
whether parental longevity is linked to risk of offspring PD. In other words, one 
would hypothesise that parents of PD cases would die at a younger age than control 
parents. Only one paper has previously examined this hypothesis This study did 
not find any difference in parental longevity for cases of PD compared to a control 
group.
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5. Rationale for current study
5.1 Limitations of previous work
The review above highlights the limitations of much of the existing data on 
Parkinson’s disease. From this review it is clear that many, though not all studies, 
have the following methodological limitations to varying degrees, (a) sample size: 
Many studies recruit less than 150 cases and 150 controls. They are essentially 
underpowered, unless they recruit multiple controls, to detect an odds ratio of 2.0 at 
conventional levels of significance and power, (b) Case and control selection: Many 
studies recruit cases from specialist movement disorder centres. This sample of cases 
are likely to be biased and not representative of all cases. In particular, more atypical 
or harder to diagnose cases will be included and the catchment population is likely to 
be wider for such cases. Controls are selected from a wide variety of sources; 
neurology clinic, other medical admissions, outpatient clinics, spouse controls, buddy 
controls etc. Few studies use population based sampling or primary care databases 
where cases and controls have equal chance of being ascertained, (c) Exposure 
measurement: This is variable and will depend on the exposure and study. Most 
studies use simple dichotomous classifications i.e. ever exposed to well water 
(yes/no) and do not collect detailed life history data. More recent occupational 
studies have used blinded classification of toxic exposures as assessed by an 
occupational hygienist or a job exposure matrix. This is far superior but is still 
problematic as classification is essentially ecological based on group exposure 
measurements. The issue of “recall bias” is either ignored or simply discussed and no 
method to adjust for recall bias, other than selecting another disease control group is 
used, (d) Design: The vast majority of studies are case control in design for obvious 
reasons of statistical efficiency and ease of obtaining controls. Few prospective 
studies have yet reported data on risk of PD yet these are clearly important results as
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evidenced from the Honolulu Heart Program follow-up data, (e) Confounding: 
Because several of the potential risk factors are highly correlated i.e. rurality, well 
water consumption, pesticide exposure, conventional multivariable techniques are 
problematic and can produce misleading risk estimates. In such cases statistical 
adjustment is less effective than attempting to reduce the degree of confounding in 
the design of the study. When this study was designed (circa 1993) there were few if 
any large well conducted case control studies. A review of the evidence at that time 
highlighted the potential interest of a possible toxic exposure transmitted through
1 'JQingestion of well water. The largest and best study at that time was from
Chicago.160 This study noted an elevated risk for well water consumption OR 1.7 
(1.0 to 2.8) but after adjustment for rurality, which was highly correlated, this risk 
was markedly attenuated suggesting no association. It was unclear whether the well 
water hypothesis was an important aetiological clue or simply the result of biased 
case selection or due to confounding by other rural exposures. This hypothesis, and 
the problems in testing it, largely motivated the location and design characteristics of 
this current study. Some of the methodological issues mentioned above are discussed 
again in section 7 in explaining the rationale for the design of this study.
5.2 Aims of current study
The objectives of this study were (a) to test the hypothesis that consumption of 
well-water during childhood and/or later life is associated with an increased risk of 
early-onset Parkinson's disease independently of rural residence or other potential 
confounders (b) to examine the relationship between other potential exposures across 
the life course - such as childhood infections, exposure to domestic or farm animals, 
pesticides, head injury, smoking behaviour and socioeconomic position- which may 
have an aetiological role for PD.
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6. Design and methodological issues
6.1 Study designs
Most analytical studies of PD aetiology use a case control approach. This is because 
PD is a relatively rare disease. Any prospective study needs to have a large sample 
size to generate sufficient cases for analysis. The combined alumni cohorts of 
Harvard and Pennsylvania colleges consisted of 50,000 individuals and only 
generated 160 cases . Older cohorts will be more efficient in terms of statistical 
power. Case control studies, whilst far more practical, are more prone to biases. 
Particularly problematic, is the recruitment of control subjects and the retrospective 
measurement of putative exposures. Associations must be treated with some caution 
and where possible verified using either historical data or by using a cohort design.
Most exposures are measured by subjective recall. This has two problems: low 
impact exposures, such as past diet, are likely to be poorly recalled by both cases and 
controls (non-differential misclassification). This will dilute any true relationship and 
lead to erroneously concluding that there is no relationship. High impact exposures 
might be differentially recalled by cases and not controls, particularly if there is pre­
existing knowledge of a possible link between the exposure and disease. For 
example, a previous head injury might be more salient in the minds of cases than 
controls, as they may link the trauma with their neurological disease (“recall bias”).
6.2 Choice of study population
Most of the previous studies in this area have been carried out in North America, 
Western Europe and the Far East. Only one previous study has been done in the 
United Kingdom and no study has been undertaken in the Republic of Ireland. It is
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useful to examine the well-water hypothesis in a different geographical areas to 
determine the generalisability of any findings. The Republic of Ireland was chosen 
for the following reasons: (a) The prevalence of well water consumption in the 1940s 
was around 50% (see appendix 1). The statistical power of any study is partially 
dependent on the prevalence of exposure, with a prevalence of 50% being the 
optimum level for maximisation of this power.324 (b) There were only nine consultant 
neurologists in the Republic of Ireland at the start of the study. As it is essential to 
obtain the cooperation of all the neurologists, a small number is both practically 
more convenient and reduces diagnostic variability, (c) The population of Ireland is 
sufficiently large to provide a reasonable number of cases of early-onset PD (see 
sample size calculation below). Further, there has been much internal migration over 
the last 50 years from rural to urban areas.325 This facilitates a dose-response 
analysis by both number of years in a rural environment and well water consumption 
and allows for some breaking of the confounding between early life exposures and 
later environments, (d) Though health care is not free in Ireland, drugs for certain 
diseases are provided free regardless of income under the “long term illness scheme” 
(LTIS). Parkinson’s disease is one of those diseases so that all parkinsonian patients 
should be registered on a computerised database held at each Area Health Board, 
assuming they register for the scheme. It is possible that affluent patients who are not 
concerned about their drug costs are unwilling to complete the necessary form and so 
are omitted. This provides potentially a very useful database to cross-check cases 
ascertained through other sources and ensure cases are not missing.
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6.3 Case definition
The diagnostic criteria used in this study are similar to those in other studies: the 
presence of two or more of the cardinal features of the disease (tremor, rigidity, 
bradykinesia and postural instability) in the absence of a secondary cause or features 
of atypical parkinsonism (e.g. multiple system atrophy, progressive supranuclear 
palsy, multi-infarct dementia). Head trauma is not an exclusion criterion, unless 
symptoms followed within a six month period, as the role of this exposure is to be 
examined. A poor levodopa response is also not an explicit exclusion criteria.
Studies often have a consultant neurologist or movement disorders specialist review 
the diagnosis as well as using the above entry criteria. As only early-onset cases were 
recruited, it was presumed that most of our cases would have been seen by a 
consultant neurologist. The results from the preliminary case identification study 
supported this assumption. Only 17 cases of the 223 cases (8%) did not have a 
consultant neurologist diagnosis. However because nine different neurologists are 
involved, and the possible development of atypical features since a case was last 
seen , it was felt important that all cases be examined by a clinician with sufficient 
competence to determine any atypical features.
6.4 Early onset cases
The initial observation of an association between well-water and PD was made in a 
study of early-onset cases (<40 years). Whilst other studies have also found this 
association for older cases, the selection of younger onset cases has several
87advantages, (a) Up to 40-50% of PD cases may remain undiagnosed, however 
people who develop symptoms whilst still economically active are likely to seek
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medical attention. Furthermore general practitioners are more likely to refer such 
cases for a consultant neurological opinion, because of the relatively early-age of 
onset. A historical cohort study of all PD cases diagnosed by a non-neurologist 
showed that the most important determinants of referral to a neurologist was age 
(onset under 70 years), gender (males more likely to be referred), private health
IOC
insurance, and frequent attendance, presumably a proxy for disease severity.
The distribution of the neurologists in all major cities means that relatively good 
access is available for the whole population and the Irish Health care system, whilst 
partially insurance based, does provide free health-care for low income residents 
(approximately 30% of the general population), (b) The prevalence of dementia is 
lower in younger cases of PD and therefore fewer cases are likely to be excluded 
because they cannot provide a history, (c) Younger cases are more likely to be able 
to provide an accurate history of early life exposures. They are also more likely to 
have either a parent or an older sibling still alive who could provide corroborative 
information on early life exposures, (d) If age of onset relates to the dose of exposure 
(i.e. higher exposure leading to earlier onset) then it will be easier to detect an 
increased risk for early, as opposed to late-onset, cases. This argument applies to the 
prevalence of genetic mutations, which increase the susceptibility to environmental 
exposures.
The definition of early onset disease is to some degree arbitrary. Quinn and 
colleagues argued that cases of apparent idiopathic PD beginning between the ages 
of 21-40 years should be called “young onset Parkinson’s disease” whilst those under 
21 years should be labelled “juvenile Parkinsonism”. The latter group all had
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familial disease whilst the former group only had slightly more familial cases than 
would be expected. More recent follow-up of this case series of patients shows that 
the natural history in terms of relative mortality is not very different from older cases 
of PD.327 It is generally felt that younger cases of PD are not a distinct clinico- 
pathological entity but reflect the lower end of the age of onset distribution of
p £ j  69,326,328,329
We decided to choose a pragmatic definition for early onset based on the number of 
potential cases that could be ascertained and the sample size requirements. All cases 
had to have had symptom onset at 55 years or younger and be 66 years or younger at 
the time of case identification (not necessarily at the time of interview due to the time 
lag between identification and interview). The second criteria was established to help 
case selection from existing databases were age is recorded but not age of disease 
onset. This was operationalised by only examining records of potential cases with a 
date of birth 1.1.1926 or later. All older cases were automatically excluded. Where 
the date of birth was valid, case notes, GP records or occasionally the patients 
themselves were used to determine if the subject met the age criteria for entry into 
the study.
This definition of “early onset” uses an older upper age cut-off than one would 
normally find in the literature but is still relatively young compared to the average 
age of onset from population based studies. For example, a recent prevalence survey 
of PD cases noted a mean age of 72 years with an onset at 66 years330. This group 
therefore has developed PD around 11 years younger than a typical sample of PD 
cases.
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6.5 Case ascertainment
Cases were ascertained using a multi-source approach, (a) Each consultant 
neurologist was visited and asked for permission to access past clinic letters to 
identify potential cases. This was possible for 6 (2 of the 3 Cork consultants, the sole 
Galway neurologist and 2 of the Dublin neurologists) of the 9 consultants, (b) The 
Health Research Board, Dublin was asked to provide details of any hospital in 
patient episodes (HIPE) in the whole of the Republic of Ireland with a diagnosis of 
PD and date of birth 1.1.1926 or later. The respective consultants, if not one of the 
neurologists, were then contacted by letter and asked to check whether their patients 
met the entry criteria. If they were eligible the consultants were asked to contact their 
patients on our behalf with the respective information sheet, (c) The Area Health 
Boards were asked to provide us details of patients on the long term illness scheme 
with a diagnosis of PD and whose date of birth was 1.1.1926 or later. For one area 
health board, there was no diagnostic information so this could not be used. In this 
area, a list of all general practitioners was compiled and a mailshot was sent 
describing the purpose of the study and asking for details about potential 
participants.(d) There were two Parkinson’s disease patient support groups in Ireland 
(Dublin and Cork). These were both approached and a talk was given about the 
study. Both organisations kindly sent out a mailshot about the study to their 
members, (e) Some additional cases were supplied directly by personal 
communication after the study had obtained publicity through the Irish consultants’ 
news magazine and word of mouth.
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6.6 Control ascertainment
Control selection is one of the most problematic issues in the design of case control 
studies.183 A standard approach to control selection is to randomly select population 
controls from the same broad area (e.g. health board), matched by sex and age- 
frequency matched in three or five year age bands. Controls are selected from the 
same population as cases and have the same chance of being selected as cases if they 
were to develop the disease.186 An association between well water and PD, if one 
exists, will be demonstrated by this method, but the odds ratio for rural exposure, 
which is strongly correlated with well water, will also be elevated. In this situation 
use of multivariable methods to control for rural area as a confounder, as has been 
done in some previous studies, may be seriously misleading, since rural exposure and 
well-water consumption are strongly associated and have different measurement 
properties.196,331
6.7 Control of confounding
A conventional design approach to control for confounding is to undertake a matched 
case control study so that controls are matched to cases on the confounding variable. 
In this case, rurality is perceived as a confounder and well water is the key exposure. 
Then if differences exist in well water consumption between cases and controls 
matched by rurality, it cannot be due to confounding by rurality. This approach is 
frequently used for matching by exact age and sex and many of the earlier studies use 
a matched design.
In this situation one could match controls on an urban/rural residence variable by 
selecting neighbourhood controls, or local buddy controls. There are both pros and
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1 8 A  1 1 9  1 1 1cons of using a matched as compared to unmatched design. ’ ’ However, the 
main concern is that this would result in “over-matching”, with controls being so 
similar to cases that there is no heterogeneity of exposure and therefore any true 
association may be masked.
Controls should, therefore, be selected from similar areas to cases in terms of 
rurality, but from a wide enough geographical area to ensure that childhood 
well-water exposure is not identical. Examining historical data from the 1946,1961 
and 1971 censuses, it is possible to verify that such heterogeneity actually exists (see 
appendix 1). As can be seen, the proportion of households supplied with mains water 
varies both for urban and rural aggregates. Therefore, cases were stratified into sex (2 
strata - males/females), year of birth (7 x 5-year bands e.g. 1926-1930, 1931-1935, 
etc.) and rurality (2 strata - urban/rural) groups. For each of the 28 strata, an equal 
number of controls was recruited so that the design is “frequency matched”, enabling 
an unmatched analysis but balancing cases and controls across strata. In this way an 
urban case from Dublin city, where 98.8% of the population had access to mains 
water in 1946 could be frequency matched to an urban control from Limerick county 
where only 45% of individuals had access to mains water in 1946. In this way, the 
balance of urban and rural cases and controls will be fairly similar but there will still 
be an opportunity to demonstrate differences in well water consumption over the 
person’s life course.
The method for selecting controls utilised the RANSAM computerised electoral 
database.334 This validated database registers 98% of the Irish population. To 
classify rurality, we used a geographical unit known as the district electoral division
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(DED). This covers around 1000-4000 residents and has been classified by the 
Central Statistics Office (CSO) as urban or rural, depending on the proportion of 
residents living in towns or cities. For each case, around 30 controls were selected 
from a randomly selected DED stratified by an urban/rural indicator. Over-sampling 
is necessary as RANSAM contains no data on age. To find a control within the 
appropriate 5 year date of birth period, and hence age, more potential controls than 
necessary are generated. Each potential control was visited by an interviewer from 
the Economic and Social Research Institute (ESRI) by door-knocking and was 
invited to take part if they met the entry criteria. This method was successfully 
piloted and the pilot study suggested that around 10 controls may need to be visited 
to identify 1 eligible and willing control per case of the appropriate sex and age 
range.
Each potential control must meet the same entry criteria as cases, except, of course, 
for the presence of PD. It was decided to exclude any control who reported tremor, 
in case they may have PD. This may exclude some subjects with benign essential 
tremor but the number of excluded subjects is likely to be very small. It is unlikely 
that from a random sample of 250 population controls aged less than 67 years, there 
would be more than one if any cases of undiagnosed parkinsonism.
6.8 General inclusion and exclusion criteria
Other than the clinical case definition criteria, all subjects (cases and controls) had to 
fulfil the following inclusion and exclusion criteria; (i) have a date of birth of 
1.1.1926 or later (ii) have been bom in the Republic of Ireland (iii) be able to 
complete the interview (iv) have no major psychiatric or cognitive disorder.
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6.9 Ethical approval
There was no LREC or MREC structure within Ireland at the onset of the study. 
Surprisingly, the Area Health Boards did not have any responsibility in this matter. 
As we were usually accessing hospital records, we approached every Trust (around 
40) for permission to examine their notes if necessary and interview their patients. In 
some cases, Trusts did not have an ethical committee and were forced to put together 
a panel to adjudicate our request. However, technically, they only covered their 
patients and not the population controls we had recruited. In the absence of an 
appropriate body to seek approval and at the advice of Prof. James McCormack 
(Emeritus Prof. of Primary Care, TCD) we wrote to the Royal College of General 
Practitioners, Ireland describing the study and asking for their approval. Although 
this body is not formally constituted as an ethical committee they were happy to 
approve, in principal, the study.
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7. Data collection
7.1 Questionnaire development-reliability and validity
During the pilot year a questionnaire was developed covering the following areas: 
full residential history, history of types of water consumption, occupational history, 
exposure to pesticides (adapted from Koller160) and other toxic compounds, history 
of viral infection, travel history, sanitary conditions in early life, smoking history, 
head trauma, family history etc.
The questionnaire was administered face-to-face and lasted around 1 hour, although 
in some cases this took up to 1.5 hours. The questionnaire was found to be 
acceptable with all our pilot subjects, however the wording of certain questions was 
changed based on this experience. Some of the interviews were recorded and 
playback of the tapes was used to ensure standardization of interview technique. The 
reliability of certain items was tested by reinterviewing pilot subjects by phone. The 
results show a concordance rate of 92% (11/12) for water consumption (Kappa coeff. 
82%) and 83% for pesticides, herbicides and other chemicals (10/12) (Kappa coeff. 
63%). The concordance for the following childhood infections was also examined: 
measles, whooping cough, chicken pox, polio, mumps, glandular fever and influenza. 
The overall concordance rate for all these infections was 85% (67/79) (Kappa coeff. 
66%). The concordance rate varied from 50% (whooping cough) to 100% (mumps).
1 ft(\ \ R7These results are very similar to that found in other studies. ’ In addition, we 
examined the concordance rates between cases and older siblings or parents. Cases 
were asked not to discuss any of the questions with their respective relative. These 
rates were reasonable e.g. water supply (concordance 89%), infections (concordance 
84%).
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Validation of self-reported exposures is often difficult or impossible. For our key 
exposure, that of well-water consumption, it was initially hoped that individual 
records from the census could be examined to validate these data. However, the 1922 
Census Act does not permit any individual data from the census to be released for 
reasons of confidentiality. The CSO were willing to report aggregate data for us but 
unfortunately the state of the records in the archive meant it would have been very 
time consuming to identify individual records, so this option was not possible.
7.2 Interviewer and recall bias
All the cases and controls were interviewed by the researcher (YBS) and a research 
assistant (Finola Finnan), on a random basis since the large number of subjects and 
geographical distribution makes interview by a single person unachievable in one 
year. This method does introduce the problem of “interviewer” bias as members of 
the research team were aware of the hypothesis that was being tested. As 
Schlesselman points out, keeping interviewers ignorant of the study hypothesis “is 
usually an unobtainable ideal”186. An alternative approach would have been to hire a 
group of interviewers from the ESRI (at least 8-10 would be necessary to cover such 
a large area). These interviewers could be trained without reference to the specific 
hypothesis, although could not be blinded to disease status. However the use of so 
many interviewers introduces the problem of additional costs and much greater 
variability in the quality of data collection.
We attempted to minimise the problem of interviewer bias by the following 
techniques:
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(1) both interviewers were trained by Ms. Shane Allwright (Senior Lecturer in 
Epidemiology, TCD), who has past experience of training interviewers for several 
large scale epidemiological surveys. In the pilot phase, each interviewer sat in and 
listened to how the other interview undertook the questioning so that they could try 
to make the process as similar as possible. Second, a standardised questionnaire was 
used with specific prompts taken from the OPCS handbook for interviewers. 
Wherever appropriate, such as when subjects had to choose one of a specific list of 
options, the interviewers asked the subjects to choose their response from a card that 
was shown to them. In this way the interviewer could not prompt or put more 
emphasis on one option over another. The question for water consumption 
specifically asks subjects to choose from (a) mains piped water, (b) private pump, (c) 
public pump, (d) well, (e) stream or river. These categories were selected to directly 
correspond with the classification used in the 1946 census. For some exposures 
(farm animals, high risk occupation, domestic chemicals, metals, travel abroad, 
symptoms of associated with head injury, childhood infections, family history of 
diseases) subjects had to either choose a single response or could report as many 
items as appropriate from the presented list. For other exposures (contact with farm 
animals, dietary exposures, tea and coffee consumption, alcohol consumption) they 
were asked to choose a label or category that best described the frequency of 
exposure. Thirdly, all interviews were recorded with the subjects’ permission. This 
meant that the interviewers knew that all the interviews could be re-examined at a 
later date if necessary to determine whether the questioning was in any way biased.
Recall bias in relation to the main study hypothesis, well water consumption, is 
unlikely to be a major problem as this hypothesis is generally not well publicised. All
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contacts with organisations such as the Parkinson's Association avoided stating the 
hypothesis, and only general environmental factors were mentioned in the covering 
letter to all participants. However, this was likely to be more of a problem in relation 
to head trauma. Two strategies were used to try and control for this bias. Firstly, 
serious head injuries were differentiated from any head injury on the assumption that 
whilst cases are more likely to over-report trivial head injuries, there will be less 
difference between cases and controls for more serious injuries. In addition, an 
approach suggested by Raphael was used. At the end of the interview, all cases 
were asked if they had any lay beliefs about the cause of their disease. This was 
unprompted but a categorical coding system was included which enabled the 
interviewers to code trauma as a possible aetiology. More than one cause could be 
reported. In this way, one could repeat the analysis excluding cases who have a 
strong a priori belief that head injury caused their disease and see if an association 
still exists for subjects who do not appear to have as much reason to be biased in 
their exposure classification.
7.3 Clinical data on PD patients
All patients were examined neurologically by YBS for specific signs relevant to the 
diagnosis of PD or possible other conditions associated with Parkinsonism. Using
I o
these data, the Parkinson’s Disease Brain Bank criteria were applied to all cases to 
decide with they should be included or excluded in the analysis. Data were collected 
on disease onset and severity. Disability was assessed by using the Hoehn and Yahr 
and Northwestern University Disability scales10,335 Cognitive function was assessed 
using the mini-mental state examination336, however this was slightly modified by 
excluding the first five questions on orientation. As in most cases, patients had
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provided us with their address to visit them it seemed slightly inappropriate to ask 
them this again. This means that the normal maximal score of 30 is changed to 25.
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8. Statistical issues
8.1 Statistical methods
Standard statistical methods have been used. Differences between continuous 
variables were tested using the unpaired t-test for independent samples and analysis 
of variance. Where necessary, skewed variables were transformed using standard 
statistical approaches. For example, number of siblings in family was log 
transformed after adding a constant (1.1) to remove zero values. Specific details 
concerning classifying certain variables is provided in the relevant results section.
Differences in means and 95% confidence intervals were calculated using standard
‘X‘X'7formulae and the p-values obtained from the Z-score. Comparison of proportions 
was tested using either the Chi-squared test or differences in proportions and 95% 
confidence intervals calculated using standard formulae.337. Categorical or ordinal 
variables were regrouped if the number of observations in a particular strata was 
small or based on conventional cut-offs.
The crude association between exposure and case control status was expressed as an 
odds ratio and 95% confidence interval. Initial simple associations were examined 
using the “tabodds” function in Stata, allowing adjustment for the stratification 
variables (sex, age group (five year band) and an urban-rural indicator of current 
residence). Tabodds produces the Mantel-Haenszel adjusted odds ratio and produces 
test statistics and confidence intervals based on the score statistics. A % test of 
homogeneity of odds was calculated as well as a test for trend for ordinal variables. 
Unconditional logistic regression analysis was used for multivariable analysis and 
again the stratification variables were included in all models to avoid any biased
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estimates of effect size 186. The choice of potential confounders in these models was 
made after examining the simpler associations and on the basis of past research as 
well as biological plausibility rather than any arbitrary level of statistical significance 
as in a step-wise modelling procedure.
8.2 Sample size issues
The study was designed to be able to detect an odds ratio of 2.0 or more. Assuming 
an a  level of 0.05 (type I error) and a p level of 0.2 (power 80%) and a 1:1 ratio of 
cases and controls, the following samples sizes would be required dependent on the
frequency of exposure in the control group.
Frequency Number of total number of
of exposure (%) cases/controls subjects
10 307 614
20 186 372
30 153 306
40 144 288
50 148 296
60 165 330
70 201 402
80 282 564
90 533 1066
Table 16: Sample size requirements for an odds ratio of 2.0 
We anticipated recruiting around 200 cases and controls (total 400 subjects) which 
would provide adequate power for a broad range of exposures with a frequency of 
between 20 to 70% in the control population.
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9. Results
9.1 Recruitment and interview
9.1.1 Response rate for cases
The response rate for cases is shown in the flow chart below. From 627 potential 
cases, 322 were excluded as they did not meet the entry criteria leaving 305 cases.
- not bom in 
Ireland
21 - atypical 
PD
32 - drug 
induced
40 - died prior 
to interview
91 - losses
207 - onset 
> 5 5  vears
44 - unable to 
contact
47 - refused
14 - unable to 
give history
214 cases 
interviewed
627 - potential 
cases
322 - excluded 
by criteria
305 - cases 
fulfilling entry
Figure 16: Flow chart showing recruitment, exclusion and losses of potential cases
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From these remaining potential cases, it was not possible to invite 44 cases as the 
details concerning address were inadequate and we failed to make contact with them. 
214 cases out of 261 invited cases agreed to take part in the study (82% response 
rate). This sample was 70% of all the cases fulfilling the potential entry criteria.
9.1.2 Response rate for controls
The response rate for controls is illustrated in the table below. In all 7810 potential 
control subjects were randomly sampled from the electoral register from 264 
geographical areas. These comprised 319 (7.7%) District Electoral Divisions from a 
total of 3438 in the whole country. In total, 4780 potential controls were contacted by 
the ESRI interviewers and from this sample 501 eligible and willing controls were 
ascertained (ratio of 9.5 contacts per control) from 240 geographical areas. From this 
sample of 501 potential controls we randomly sampled and interviewed 212 controls 
on the basis of the sex, age group and urban/rural stratification variables. Urban 
controls were ascertained first as the ESRI interviewers undertook the control 
ascertainment in the urban areas first before door-knocking in the rural areas.
The vast majority of contacted subjects were simply ineligible due to the age range 
required (38.5%). Some subjects had to be excluded as they had died, moved away 
permanently, were ill or senile or could not be located (7.8%). One cannot be certain 
as to the exact response rate as some subjects were either never contacted though 
could have been eligible e.g. never at home, temporarily absent, or refused to provide 
any information on their eligibility.
Amongst those subjects known to be eligible the overall response rate was 74.2% 
and it was almost identical for urban and rural controls. However, this over-estimates
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the true response rate as some of the non-contactable controls are likely to also be 
eligible. To provide a sensitivity analysis, the response rate has been recalculated 
assuming the percent of ineligibles in this group is the same as that found amongst all 
subjects who were contacted. By applying the urban and rural specific percentages 
one can recalculate a revised response rate of 65.5%. It is likely that this is a worst 
case scenario as subjects who are never present are more likely to be male and young 
e.g. travelling salesman, builders away on jobs, so it is probably likely that the 
ineligibility rate for this sub-group would be higher than for the rest of the sample 
and hence the “true” response rate lies somewhere between 65% to 75%
Urban
areas
(%) Rural
areas
(%) Total (%)
No. of areas 173 91 264
Total target persons 5080 100 2730 100 7810 100
Contacted but
ineligible 2011 39.6 993 36.4 3004 38.5
Moved permanently 291 5.7 70 2.6 361 4.6
Deceased 46 0.9 50 1.8 96 1.2
Could not locate 93 1.8 24 0.9 117 1.5
Ill/senile 23 0.5 14 0.5 37 0.5
Temporarily absent 145 2.9 27 1.0 172 2.2
Never at home 156 3.1 65 2.4 221 2.8
Refused all information 81 1.6 16 0.6 97 1.2
Eligible but unwilling 102 2.0 72 2.6 174 2.2
Eligible and willing 290 5.7 211 7.7 501 6.4
Total contacts 3238 63.7 1542 56.5 4780 61.2
Percent eligible for all 16.3 22.2 18.3
contacts
Response rate for all
potential controls 63.8 68.7 65.5
Response rate for
eligible 74.0 74.6 74.2
Table 17: Number of contacts, eligible participants and response rate for control 
subjects
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9.1.3 Clinical characteristics o f cases
Four cases that initially appeared to be eligible for the study were excluded. One case 
had benign essential tremor, one case reported a history of parkinsonism immediately 
following a head injury and the remaining two cases did not fulfil the PDS Brain 
Bank criteria. Five cases did not undergo formal neurological examination by the 
researcher, but the remaining 205 cases fulfilled the PDS Brain Bank criteria. 55 
cases (26.8%) had all four cardinal features of PD, 114 (55.6%) had 3 features and 
36 cases (17.6%) had only two features. The mean age of onset was 45.7 years 
(standard deviation 7.6 years). The median duration of the disease since diagnosis 
was 7 years (range 1 to 25 years). The mean Hoehn and Yahr score was 2.44 
(standard deviation 0.97) and the mean mini-mental state was 21.6 out of 25 total 
score, (standard deviation 2.6). All subsequent analyses are therefore based on data 
from 210 cases and 212 controls unless there is missing data for some subjects.
9.1.4 Descriptive data on interviewing process
From Table 18, it is clear that cases took considerably longer to complete the 
interviews. This is partially due to the additional clinical questions about symptom 
onset, disease duration, drug responsiveness and atypical features. However, it also 
reflects in some cases difficulties related to speech and cognition. Cases were far 
more likely to have another person present at the interview, usually their spouse. On 
some occasions, spouses may have responded on behalf of the cases, although 
requested not to do so. This could result in some differences in the quality of the data 
provided by cases and controls.
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interview cases controls adjusted
odds
ratio
95% Cl
interviewer YBS
FF
98
112
104
108 1.21 (0.81-1.80)
present at subject only 92 182 1.00
interview plus spouse 94 25 8.27 (4.49-5.24)
plus another 24 5 8.84 (3.25-24.04)
mean time 
for
interview (mins) 60.8 37.5
Difference in 
means
23.2 (19.6 to 27.0)
(SD) (24.3) (11.6) 
p-value*
* based on log transformed values
YBS = Yoav Ben-Shlomo, FF = Finola Finnan
<0.0001
Table 18: Characteristics of interview process by case control status 
9.2 Age and sex
More men were recruited into the study than women. Due to age and sex frequency 
stratification, the proportion of women was similar for both cases (36%) and controls 
(39%). Similarly, the mean of the subjects was almost identical, with less than one 
year difference.
Age and sex cases controls adjusted 
odds ratio 95% Cl
sex men 134 130
women 76 82 0.88 (0.59-1.32)
Difference in
means
mean age
(years) 57.0 57.8 0.76 (-0.56 to 2.09)
(SD) (6.9) (7.0)
p-value* 0.23
Table 19: Demographic details of cases and controls
131
A wide variety of exposures were measured and analysed. These exposures have 
been presented in a life course perspective, so that exposures, which potentially act in 
early life are presented first. This provides a logical structure to the order of 
exposures and enables the reader to appreciate the temporal relationship between 
exposures. It also provides some impression of any differences between the life 
courses’ of cases and controls.
9.3 Perinatal characteristics
Cases reported a similar frequency of antenatal or perinatal events as compared to 
controls (see Table 20). The frequency of hospital births, a possible indicator of 
antenatal problems in urban areas, was almost identical for cases and controls. Cases 
did report a greater frequency of problems with delivery but this was based on a 
small percentage and could have been due to chance.
There was no real difference in the distribution of birth weight into three crude 
categories (average weight, less than average, more than average). These data 
suggested that cases were if anything heavier than controls, although this may have 
been due to chance (p value for trend=0.17). Only 81 subjects (34 cases, 47 controls) 
were actually able to recall their birth weight. Analysis of this subset using birth 
weight as a continuous variable supported the results from the crude categorisation 
that PD cases were heavier: mean weight (lbs) cases 8.71 versus controls 7.19,
(p=0.01).
Handedness, as a measure of cerebral dominance, was used as a crude proxy measure 
of an intrauterine problem with cerebral development. There was no evidence that 
cases were more likely to be left handed than controls. Analysis of maternal age at 
the time of pregnancy as a continuous variable produced identical results as the 
categorical data. There was no difference in mean maternal age in years (cases 31.8 
versus controls 31.6, p=0.92).
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Perinatal cases controls adjusted* 
odds ratio
95% Cl
Mother ill yes 7 7 1.01
*
(0.33 to 3.08)
during no 144 174
pregnancy
p-value 0.98
Born premature yes 2 8 0.28 (0.06 to 1.32)
no 151 157
p-value 0.09
Born hospital hospital 62 58 1.04 (0.64 to 1.69)
versus home home 127 142
p-value 0.87
Problems with yes 12 8 1.95 (0.75 to 5.05)
delivery no 144 174
p-value 0.16
birth weight below average 11 12 1.40 (0.51 to 3.79)
average 62 87 1.00
above average 31 21 1.91 (0.98 to 3.73)
p-value for trend 0.17
handedness left/ambidextrous 30 25 1.20 (0.69 to 2.11)
right 180 187
p-value 0.52
handedness score 3 175 189 1.00
2 24 15 1.71 (0.85 to 3.42)
1 or 0 11 8 1.35 (0.53 to 3.40)
p-value for trend 0.18
Twin birth Yes 5 5 1.08 (0.29 to 4.01)
No 196 203
p-value 0.90
* adjusted for age group, sex and current residence urban or rural
Table 20: Association of perinatal exposures with PD
9.4 Exposures during childhood and school years
9.4.1 Familial socioeconomic status
Cases appeared to come from slightly more affluent homes than controls (see Table 21). 
This was seen consistently across all measures of socioeconomic status (father’s social 
class, housing tenure, higher qualifications and employment of other workers) although
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it was strongest for social class. This showed a significant trend of diminishing odds 
ratio for lower social class categorization.
Familial
SES
cases controls adjusted*
odds
ratio
95% Cl
Father's social class
I to III 68 51 1.00
NM
HIM 76 71 0.83 (0.50 to 1.36)
IV& V 63 86 0.55 (0.33 to 0.94)
p-value for trend 0.03
Father's housing
tenure
owned 111 111
rented 98 98 0.90 (0.59 to 1.36)
p-value 0.61
Father's education
school qualification 157 163
higher qualification 47 38 1.26 (0.77 to 2.07)
p-value 0.84
Employ other
workers
yes 106 104
no 102 105 0.89 (0.61 to 1.30)
p-value 0.34
* adjusted for age group, sex and current residence urban or rural
Table 21: Association of familial socioeconomic status with PD 
9.4.2 Contact with domestic and farm animals
Cases were in general less likely to have pets in childhood. For specific contact with 
dogs, cats, and birds, there was moderate evidence that this was unlikely to be due to 
chance. This suggests that even if one of these animals was present in the household, 
the case had little if any contact with it and presumably the animal was cared for by 
another member of the household.
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domestic
animals
cases controls adjusted* 
odds ratio
95% CIs
No pets yes 23 17 1.31 (0.67 to 2.56)
no 186 195
p-value 0.62
dog yes 155 172 0.65 (0.40 to 1.06)
no 54 40
p-value 0.08
dog contact yes 140 167 0.52 (0.32 to 0.83)
no 69 45
p-value 0.005
cat yes 124 143 0.78 (0.51 to 1.17)
no 85 69
p-value 0.23
cat contact yes 96 122 0.66 (0.45 to 0.98)
no 113 90
p-value 0.04
birds yes 43 53 0.72 (0.45 to 1.16)
no 166 159
p-value 0.18
bird contact yes 25 39 0.55 (0.31 to 0.97)
no 184 173
p-value 0.04
rabbit yes 35 28 1.43 (0.80 to 2.54)
no 174 184
p-value 0.22
rabbit contact yes 31 27 1.28 (0.71 to 2.33)
no 178 185
p-value 0.41
other pet yes 19 15 1.22 (0.57 to 2.62)
no 190 197
p-value 0.61
other pet yes 17 10 1.63 (0.69 to 3.89)
contact no 192 202
p-value 0.26
* adjusted for age group, sex and current residence (urban/rural) 
Table 22: Contact with domestic pets and PD
Similarly, cases appeared to have less contact with farm animals although no clear trend 
existed except for reduced contact with chickens.
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Exposure cases controls adjusted* 
odds ratio
95% CIs
farm yes 149 174 0.54 (0.32 to 0.89)
animal
contact no 60 38
p-value 0.02
horses weekly 86 92 0.73 (0.46 to 1.15)
monthly 25 42 0.41 (0.22 to 0.77)
< once a year 98 78 1.00
p-value for trend 0.25
cows weekly 90 105 0.62 (0.39 to 1.01)
monthly 23 37 0.41 (0.21 to 7.9)
< once a year 96 70 1.00
p-value for trend 0.05
pigs weekly 68 74 0.83 (0.51 to 1.36)
monthly 38 36 0.68 (0.37 to 1.24)
< once a year 113 102 1.00
p-value for trend 0.49
sheep weekly 31 30 1.12 (0.62 to 2.05)
monthly 24 29 0.83 (0.46 to 1.48)
< once a year 154 153 1.00
p-value for trend 0.99
chickens weekly 87 128 0.49 (0.30 to 0.80)
monthly 34 23 0.91 (0.49 to 1.69)
< once a year 88 61 1.00
p-value for trend 0.001
other farm weekly 9 11 0.83 (0.34 to 2.03)
animal monthly 3 5 0.45 (0.11 to 1.82)
< once a year 194 191 1.00
p-value for trend 0.47
* adjusted for age group, sex and current residence 
(urban/rural)
Table 23: Farm animal contact with PD
9.4.3 Childhood infections
Subjects were asked about whether they could recall having any of these childhood 
infections (measles, whooping cough, chicken pox, polio, mumps, glandular fever, or 
other infections). Very few respondents mentioned any other infection so this has not 
been presented. If a subject answered “yes”, they were then asked to state either how 
old they were when they were ill or if they could not recall this, whether this was before 
they went to school, during their school years, after leaving school or don’t know.
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For subjects who responded negatively to an infection, a follow-on question asked 
whether they recalled ever coming into contact with someone who had had one of the 
above infections. Again the broad age period at contact was recorded.
In general, cases reported less illness or contact with any of the childhood infections 
however, the wide confidence intervals indicate that this could have been due to chance. 
Interestingly, if the baseline group was altered to only include subjects who reported no 
past infection or contact with infection the differences between cases and controls was 
more marked. The largest effect was observed for chicken pox followed by glandular 
fever and whooping cough. If infection was dichotomised (ill or contact versus none) 
then the odds ratios for chicken pox (0.51, 95% Cl 0.33 to 0.81, p=0.004) and whooping 
cough (0.56, 95% Cl 0.37 to 0.81, p=0.006) were both stronger and there was moderate 
evidence against the null hypothesis. This reduced frequency of infection is consistent 
with the higher family socioeconomic status, and may reflect fewer brothers and sisters 
and/or less overcrowding. A different possibility is that infection rates may not differ 
but cases may be more likely to be exposed at a younger age so that they are less likely 
to actually remember being ill and hence under report the frequency of infection. 
However there did not appear to be any real systematic differences for the age period of 
either illness or contact. Whilst cases were more likely to report getting whooping 
cough during the pre-school period, there was little evidence against the null hypothesis 
and not replicated for the other illnesses.
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childhood
infections
cases controls adjusted
*
odds
ratio
95% CIs adjusted* 
odds ratio
95% CIs
measles ill 182 189 0.86* (0.48 to 1.55) 0.63Y (0.27 to 1.46)
contact 13 15 0.24 (0.03 to 1.73)
no 13 8 1.00 1.00
p-value 0.61 0.42
whooping ill 76 91 0.83 (0.55 to 1.26) 0.64 (0.40 to 1.02)
cough contact 38 56 0.43 (0.24 to 0.75)
no 94 65 1.00 1.00
p-value 0.38 0.04
chicken ill 69 95 0.57 (0.37 to 0.86) 0.40 (0.23 to 0.68)
pox contact 62 64 0.68 (0.40 to 1.16)
no 77 53 1.00 0.007 1.00
p-value 0.001
polio ill 4 5 0.79 (0.22 to 2.78) 0.86 (0.27 to 2.75)
contact 16 24 0.59 (0.29 to 1.20)
no 189 183 1.00 0.71 1.00
p-value 0.17
mumps ill 106 118 0.79 (0.53 to 1.17) 0.69 (0.43 to 1.10)
contact 35 40 0.65 (0.40 to 1.16)
no 67 54 1.00 0.24 1.00
p-value 0.11
glandular ill 5 9 0.44 (0.13 to 1.43) 0.45 (0.14 to 1.38)
fever contact 21 27 0.71 (0.38 to 1.31)
no 177 170 1.00
p-value 0.16 0.08
* adjusted for age group, sex and current residence (urban/rural)
* Baseline group is no reported infection;Y Baseline group is no reported infection and 
no contact with infection
Table 24: Childhood infections and PD
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age period 
of infection
cases controls adjusted*
odds
ratio
95% CIs
measles pre-school 42 48 1.00
school 127 129 1.08 (0.67 to 1.72)
post-school 20 23 1.01 (0.49 to 2.07)
p-value 0.79
whooping pre-school 23 28 1.00
cough school 62 87 0.94 (0.47 to 1.87)
post-school 22 30 0.67 (0.27 to 1.63)
p-value 0.82
chicken pre-school 9 16 1.00
pox school 68 80 1.90 (0.68 to 5.30)
post-school 51 55 1.23 (0.47 to 3.24)
p-value 0.300
polio pre-school 1 1 ** **
school 15 18
post-school 4 10
p-value
mumps pre-school 8 10 1.00
school 94 102 1.25 (0.45 to 3.44)
post-school 31 39 0.88 (0.28 to 2.74)
p-value 0.88
glandular pre-school 0 0
fever school 5 9 1.00
post-school 18 25 2.78 (0.34 to 22.9)
p-value 0.32
* adjusted for age group, sex and current residence (urban/rural)
** unable to calculate adjusted odds ratios because of small numbers 
Table 25: Age-period of infection and PD
9.4.4 Family size, crowding and sanitation in childhood
Childhood was defined arbitrarily as the first fifteen years of life. For 263 subjects this 
was spent in a single household. However, for the remainder, subjects resided in up to 
four different households. In these cases, the main childhood residence was used for 
analytical purposes. This was defined as the household for which the subject spent the
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longest period in their first fifteen years of life. Where two households had exactly the 
same duration, the earlier household was selected in preference. Overcrowding was 
defined as the ratio of siblings to bedrooms. Where a subject had both indoor and 
outdoor toilets, the indoor toilet was recorded as the main one. If a subjects spent their 
childhood at boarding school this was recorded.
In view of the reduced reporting of some childhood infections, one might have predicted 
that cases would be more likely to be lower in the birth order than controls. This would 
mean that exposure to common childhood infections would have occurred at an earlier 
age due to sibling transmission and may have resulted in a less severe or sub clinical 
illness. However, the results show no obvious birth order effect and cases were as likely 
as controls to be first bums.
There was some weak evidence that cases came from slightly smaller households (mean 
number of siblings 4.73 versus 5.14, difference 0.40, 95% Cl -0.13 to 0.94, p-value for 
transformed data 0.38). Cases also lived in slightly less crowded households (mean 
overcrowding ratio 2.17 versus 2.42, difference 0.25, 95% Cl -0.07 to 0.57, p-value for 
transformed data 0.10). Though the number of exposed subjects was small, cases were 
more likely to report residing in boarding schools than controls (p=0.04). This may 
reflect more intensive exposure to an infectious agent in childhood or confounding by 
socioeconomic position. Adjusting for father’s social class attenuated the association 
(odds ratio 2.11, 95% Cl 0.86 to 5.20, p=0.10)
There was no obvious difference in the type of toilet facilities available to either cases 
or controls but cases were significantly less likely to have an outside toilet (p=0.005) 
consistent with earlier data suggesting that they originated from more affluent 
households and therefore more likely to have better sanitary conditions.
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Childhood
sanitation
cases controls adjusted*
odds
ratio
95% Cl
Birth order
first 53 51 1.00
second 47 49 0.95 (0.55 to 1.65)
third 28 24 1.29 (0.63 to 2.66)
fourth 34 27 1.29 (0.67 to 2.48)
fifth 14 22 0.52 (0.24 to 1.14)
sixth or lower 34 39 0.93 (0.51 to 1.70)
p-value for 0.69
trend
main toilet
flush 101 97 1.00
closet/privy 30 33 1.03 (0.54 to 1.95)
no facilities 73 76 0.99 (0.58 to 1.71)
p-value 0.83
Toilet location
inside 83 63 1.00
outside 60 100 0.48 (0.29 to 0.81)
p-value 0.005
Boarding school
Yes 18 8 2.66 (1.01 to 7.02)
No 190 200
0.04
* adjusted for age group, sex and current residence urban or rural 
Table 26: Childhood sanitary conditions and PD
9.4.5 Childhood diet
There were few differences in reported childhood vegetable consumption. This may 
partially reflect the relatively homogenous diets consumed in both urban and rural 
areas in Ireland during the 1930s to 1950s as well as the poor ability to genuinely 
distinguish dietary differences retrospectively. Three vegetables showed significant 
trends, with cases consuming less than controls. These were cauliflower (p=0.05), 
onions (p=0.006) and peas (p=0.02). It should be noted that both cauliflower and 
onions were only just significant and a large number of food stuffs were tested. 
These findings must be treated with some caution as they were not selected a priori 
and may simply reflect a type I error.
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Childhood
vegetables
cases controls adjusted* 
odds ratio
95% Cl
broccoli
< 1/month 186 196
lx month or more 20 16 1.47 (0.73 to 2.95)
p-value 0.28
brussel sprouts
<1 /month 137 131 1.00
lx/month 34 41 0.78 (0.45 to 1.34)
lx/week or more 34 40 0.89 (0.52 to 1.52)
p-value 0.42
beans
<1/month 141 135 1.00
lx/month 26 33 0.74 (0.40 to 1.36)
lx/week or more 37 43 0.87 (0.52 to 1.44)
p-value 0.48
cabbage
<1 or lx/month 22 17 1.42 (0.69 to 2.91)
lx/week 152 161 1.00
lx/day 30 34 1.05 (0.58 to 1.88)
p-value 0.56
carrots 27 27
<1 /month 14 15 1.04 (0.57 to 1.90)
lx/month 164 170 1.02 (0.46 to 2.23)
lx/week or more 1.00
p-value 0.86
cauliflower
<1/month 114 101 1.00
lx/month 47 46 0.83 (0.49 to 1.40)
lx/week or more 44 64 0.59 (0.36 to 0.96)
p-value 0.05
leeks
<1/month 173 163 1.00
lx/month 12 23 0.51 (0.24 to 1.10)
lx/week or more 20 26 0.76 (0.40 to 1.43)
p-value 0.22
lettuce
<1/month 49 38 1.61 (0.95 to 2.74)
lx/month 31 26 1.39 (0.76 to 2.54)
lx/week 99 125 1.00
lx/day 26 23 1.62 (0.85 to 3.08)
p-value 0.19
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Childhood
vegetables
cases controls adjusted* 
odds ratio
95% Cl
marrow
< 1/month 185 195
lx month or more 20 16 1.4 (0.69 to 2.85)
p-value 0.36
mushroom
<1/month 104 96 1.00
lx/month 28 27 1.00 (0.54 to 1.88)
lx/week 49 60 0.84 (0.54 to 1.31)
lx/day 24 29 0.85 (0.44 to 1.61)
p-value 0.45
onions
<1 or lx/month 42 23 1.98 (1.08 to 3.61)
lx/week 143 156 1.00
lx/day 20 33 0.66 (0.36 to 1.22)
p-value 0.006
peas
<1 /month 45 33 1.77 (1.03 to 3.05)
lx/month 26 22 1.51 (0.79 to 2.88)
lx/week or more 134 157 1.00
p-value 0.02
potatoes
at least 1 x week 10 9 1.08 (0.41 to 2.81)
lx/day 197 203
p-value 0.88
spinach
<1/month 191 199
lx/month or more 15 13 1.21 (0.57 to 2.57)
p-value 0.62
tomatoes
<1/month 46 47 1.24 (0.75 to 2.04)
lx/month 37 24 1.74 (0.95 to 3.20)
lx/week or more 123 141 1.00
p-value 0.32
turnips
<1 or lx/month 37 25
lx/week or more 167 187 0.65 (0.37 to 1.14)
p-value 0.13
* adjusted for age group, sex and current residence urban or rural
Table 27: Childhood vegetable consumption and PD
Cases reported either similar or less fruit consumption than controls. Only weak 
evidence against the null hypothesis was seen for plums (p=0.02), oranges (p=0.03), 
and raspberries (p=0.03), although the latter did not show a consistent trend.
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Childhood
fruit
cases controls adjusted* 
odds ratio
95% Cl
apple
<1 or lx/month 19 15 1.46 (0.66 to 3.21)
lx/week 96 92 1.15 (0.76 to 1.74)
lx/day 90 105 1.00
banana
<1/month 107 95
1.00
0.52
0.34 
(0.30 to 0.92)
lx/month 30 50 0.80 (0.51 to 1.25)
lx/week or more 68 67 0.28
grapefruit
<1/month 180 186 1.00
lx/month 15 14 0.95 (0.46 to 1.96)
lx/week or more 11 12 1.03 (0.43 to 2.46)
oranges
<1/month 61 49 1.68
0.96 
(1.02 to 2.76)
lx/month 52 45 1.45 (0.89 to 2.36)
lx/week or more 93 118 1.00
peaches
<1/month 167 172 1.00
0.03
lx/month 20 18 0.98 (0.51 to 1.91)
lx/week or more 19 21 0.92 (0.47 to 1.81)
plums
<1/month 110 97 1.00
0.79
lx/month 41 35 0.99 (0.59 to 1.65)
lx/week 37 53 0.64 (0.37 to 1.10)
lx/day 15 27 0.56 (0.27 to 1.18)
raspberry
<1/month 140 125 1.00
0.02
lx/month 23 21 1.04 (0.52 to 2.08)
lx/week or more 40 65 0.56 (0.35 to 0.92)
0.03
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Childhood
fruit
cases controls adjusted* 
odds ratio
95% Cl
strawberry
<1/month 117 108 1.00
lx/month 28 22 1.04 (0.55 to 1.97)
lx/week or more 60 82 0.68 (0.44 to 1.04)
0.09
* adjusted for age group, sex and current residence urban or rural
Table 28: Childhood fruit consumption and PD 
9.5 Adult exposures
9.5.1 Adult socioeconomic and marital status
There were no significant differences for marital status or adult socioeconomic 
position whether based on years of education, further qualifications, main adult 
social class, housing tenure or car ownership. Cases had a tendency to leave school 
earlier and were slightly less likely to obtain further formal education. Despite this, 
they had slightly higher adult socioeconomic status as measured by occupation, but 
were slightly less likely to own their own house and car.
Cases were almost half as likely to have joined the armed forces professionally but 
there was only weak evidence against the null hypothesis (p=0.15).
Adult SES cases controls adjusted* 
odds ratio
95% Cl
Education (years) 
<=14 75 75 1.00
15-16 73 74 0.95 (0.59 to 1.54)
17+ 61 61 0.88 (0.51 to 1.53)
p-value
Qualifications
None 129 111 1.00
0.81
further training 49 73 0.50 (0.31 to 0.80)
University 30 28 0.81 (0.44 to 1.52)
p-value 
social class 
I & II 66 58 1.00
0.10
III 84 77 0.98 (0.60 to 1.60)
IV& V 42 46 0.81 (0.45 to 1.43)
p-value 0.53
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Adult SES cases controls adjusted* 
odds ratio
95% Cl
Armed forces
No 192 181 1.00
Yes 17 29 0.58 (0.27 to 1.23)
p-value 0.15
Housing tenure
Owner occupier 183 190 1.00
other 24 22 1.13 (0.60 to 2.16)
p-value 0.70
Car ownership
Yes 165 177 1.00
No 42 35 1.36 (0.81 to 2.29)
p-value 0.25
marital status
ever married 177 186
never married 31 26 1.32 (0.73 to 2.39)
p-value 0.35
* adjusted for age group, sex and current residence urban or rural 
Table 29: Adult socioeconomic status and PD
9.5.2 High risk occupations
Based on past publications, a list of “high risk” occupations was generated that might 
a priori increase the risk of PD. For almost every occupation, other than farming and 
saw mill worker, cases were less likely to report ever having worked in one of these 
jobs in the past. Farming showed a 51% increased risk but this was not significant. 
An aggregate category comprising any of these jobs showed no real difference 
between cases and controls.
It should be noted that most of these jobs are relatively rare, other than farming, so 
that the study was underpowered to detect anything but large odds ratios. Amongst 
positive respondents, the years in that occupation was noted. Again there was no 
evidence that cases spent longer in that occupation (data not shown). For farming, the 
mean number of years were almost identical for both groups (cases 28.1 versus 
controls 28.6, difference 0.5, 95% Cl -5.6 to 6.5 yrs, p=0.88).
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Specific
occupations
cases controls adjusted* 
odds ratio
95% Cl
farmer or 
labourer
No 144 153 1.00
Yes 65 59 1.51 (0.89 to 2.55)
p-value
gardner
No 205 203 1.00
0.13
Yes 4 8 0.49 (0.15 to 1.63)
p-value 
road worker
No 200 199 1.00
0.24
Yes 9 12 0.72 (0.29 to 1.79)
p-value
chemical worker
No 203 204 1.00
0.48
Yes 5 7 0.66 (0.23 to 1.91)
p-value
saw millworker
No 196 203 1.00
0.44
Yes 12 8 1.65 (0.65 to 4.20)
p-value
paperworker
No 205 205 1.00
0.29
Yes 3 6 0.50 (0.14 to 1.80)
p-value
builder/ decorator
No 187 184 1.00
0.28
Yes 21 27 0.73 (0.37 to 1.43)
p-value 
metal worker
No 201 197 1.00
0.35
Yes 7 14 0.44 (0.17 to 1.12)
p-value 
high risk job
No 114 118 1.00
0.08
Yes 98 92 0.90 (0.57 to 1.43)
p-value 0.67
* adjusted for age group, sex and current residence urban or rural 
Table 30: Occupational exposure and PD
Apart from specific high risk occupations, there was no real evidence that within any 
of these jobs, cases were more likely to have greater exposure than controls, in terms
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of mixing, applying or using spraying techniques that would increase inhalation of 
either herbicides or pesticides.
Specific
occupational exposures
cases controls adjusted* 
odds ratio
95% Cl
chemical exposure
No 193 189
Yes 17 23 1.45 0.73 to 2.86
p-value 0.29
herbicides
No 164 171
Yes 46 41 0.78 0.45 to 1.34
p-value 0.36
mix 34 33 1.30 0.71 to 2.39
yourself
someone else 12 8 1.49 0.61 to 3.68
N/A 164 171 1.00
p-value for trend 0.48
apply yourself 35 34 1.20 0.65 to 2.21
someone else 11 7 1.76 0.67 to 4.60
N/A 164 171 1.00
p-value 0.47
back-pack 27 23 1.20 0.63 to 2.26
tractor mounted 14 18 0.90 0.39 to 2.12
N/A 169 171 1.00
p-value 0.65
pesticides
No 193 194
Yes 16 19 1.16 0.56 to 2.39
p-value 0.68
mix 9 10 0.95 0.37 to 2.47
yourself
someone else 7 9 0.76 0.27 to 2.11
N/A 194 193 1.00
p-value 0.79
apply yourself 13 17 0.80 0.36 to 1.74
someone else 4 2 1.75 0.32 to 9.51
N/A 193 193 1.00
p-value 0.71
back-pack 4 4 1.12 0.26 to 4.87
tractor mounted 5 3 1.78 0.39 to 8.10
N/A 201 205 1.00
p-value 0.64
* adjusted for age group, sex and current residence urban or rural 
Table 31: Specific occupational exposures and PD
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9.5.3 Non-occupational exposure to toxic substances 
Regardless of whether subjects had ever worked in a “high risk” occupation, all 
subjects were asked about general exposures to a standardised list of ten substances, 
which was shown by the interviewer. If subjects responded YES to any of the 
substances shown on the list, exposure was categorised into frequency.
In general cases were less likely to report any exposure. This was non-specific and 
seen for all substances except for printing materials. In many cases the p-value for 
trend was small but in fact there was no real evidence of a dose response effects as 
the reduced risk observed for 1-2 times per month compared to less than 2 times per 
year was much as the same as that seen with 2 times per year. There was no evidence 
against the null hypothesis that there was a significant difference in the mean number 
of exposure years between cases and controls (data not shown).
toxic
exposures
cases controls adjusted* 
odds ratio
95% Cl
herbicides
< 2 x year 123 104 1.00
2 x /year 32 60 0.41 0.24 to 0.69
1-2 times per month 53 48 1.14 0.66 to 1.99
p-value 0.31
pesticides
< 2 x year 165 142 1.00
2 x /year 20 32 0.54 0.29 to 0.99
1-2 times per month 23 38 0.52 0.30 to 0.92
p-value 0.006
fertilisers
< 2 x year 148 121 1.00
2 x /year 44 67 0.47 0.28 to 0.79
1-2 times per month 16 24 0.50 0.24 to 1.05
p-value 0.003
wood preservatives
< 2 x year 191 175 1.00
2 x /year 14 28 0.41 0.20 to 0.84
1-2 times per month 3 9 0.30 0.08 to 1.16
p-value 0.002
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toxic
exposures
cases controls adjusted* 
odds ratio
95% Cl
glues
< 2 x year 171 148 1.00
2 x /year 14 36 0.31 0.16 to 0.61
1 -2 times per month 23 28 0.56 0.30 to 1.08
p-value 0.008
paints
< 2 x year 122 75 1.00
2 x /year 65 115 0.33 0.21 to 0.52
1-2 times per month 21 22 0.46 0.22 to 0.96
p-value 0.001
solvents
< 2 x year 193 187 1.00
2 x /year 4 10 0.39 0.13 to 1.20
1 -2 times per month 11 15 0.57 0.24 to 1.39
p-value 0.08
printing materials
No 197 204
Yes 11 8 1.34 0.52 to 3.40
p-value 0.54
petroleum
No 199 194
Yes 9 18 0.43 0.19 to 0.97
p-value 0.04
dry cleaning
materials
No 206 208
Yes 2 4 0.41 0.08 to 2.05
p-value 0.26
* adjusted for age group, sex and current residence urban or rural 
Table 32: Non-occupational toxic exposures and PD
It is possible that cases are less likely to engage in activities, such as gardening, DIY, 
or manual jobs that involve exposure with such substances. An alternative possibility 
is that these results are artefactual and merely reflect the possibility that cases are 
less likely to spontaneously state they have been exposed. If, because of disease 
severity, cases have more difficulty in responding, one would predict that cases 
would respond positively to fewer items.
Indeed there is evidence for such an effect. Classifying cases into three disease 
severity groups based on their Northwest University Disability score, there is
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evidence of heterogeneity across these groups, with a decrease in the number of 
items with worsening disability (p-value for trend 0.01). Similarly there is marked 
difference between cases and controls.
subjects (no. of subjects) Mean number 
of items
P-value for
heterogeneity
(ANOVA)
NUDS < 34 (28) 1.18
NUDS 35-44 (88) 1.70
NUDS 45+ (89) 1.99 0.04*
Controls (212) 2.65 <0.0001**
*p-value across disability categories 
** p-value for cases versus controls.
Table 33: Association between disability level and number of toxic exposures
However, repeating the analysis including only cases with NUDS >=45 produced 
qualitatively similar results (not shown). This suggests that the reduced frequency 
cannot simply reflect the impact of disease severity in reducing willingness to report 
items.
There was no obvious association overall between reported exposure to metals and 
case control status. Some metals showed slight excess whilst others we reported less 
often. None of these odds ratios reached conventional levels of statistical 
significance.
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exposure 
to metals
cases controls adjusted* 
odds ratio
95% Cl
Any metal
No 158 159
Yes 52 50 1.12 0.69 to 1.83
p-value 0.65
Lead
No 188 182
Yes 28 24 1.15 0.61 to 2.14
p-value 0.67
Mercury
No 204 204
Yes 6 8 0.66 0.21 to 2.08
p-value 0.47
Zinc
No 192 198
Yes 18 14 1.28 0.62 to 2.67
p-value 0.5
Manganese
No 205 205
Yes 5 7 0.70 0.21 to 2.31
p-value 0.56
Copper
No 184 179
Yes 26 33 0.75 0.42 to 1.34
p-value 0.33
Aluminium
No 195 191
Yes 15 21 0.64 0.31 to 1.32
p-value 0.22
* adjusted for age group, sex and current residence urban or rural
Table 34: Exposure to metals and PD
Cases were less likely to report residing within a 5 mile radius of a large industrial 
area or factory (odds ratio 0.73, 95% Cl 0.49 to 1.08, p-value 0.12) but this may have 
been due to chance. This is consistent with reduced reporting of toxic exposures, 
assuming that some residents close to such sites will also work at these premises.
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9.5.4 Smoking behaviour and role o f external influences 
Cases showed a marked dose response relationship with smoking pack years across 
both ex and current smoking status. This association is if anything stronger than that 
reported by other studies. This is important as, given the relatively young age of 
cases and controls, any effect of selective mortality due to smoking-related deaths is 
likely to be minimal. This hypothesis would argue that smoking should appear less 
“protective” at younger ages.
It was postulated that this behaviour may either reflect greater external pressure to be 
a non-smoker, through family, friends and partners, or operate regardless of such 
external pressures due to an intrinsic mechanism. The latter could reflect specific 
personality traits which are less likely to take up or maintain smoking behaviour (e.g. 
novelty seeking behaviour) or may reflect genetic and/or metabolic pathways which 
makes nicotine addiction less likely.
The patterns of smoking seen amongst other key external influences show little 
difference between cases and controls, however there was a progressive trend that 
more contemporaneous influences, e.g. marital partner, were also more likely to be 
non-smokers for cases as compared to controls. This presumably reflects increasing 
selection of friends or partners who share the same smoking status as the subject. 
Summating the total number of external pressures (excluding spouse as it was not 
clear what their smoking status was before or after disease onset) there was little 
difference in the number of such influences between cases and controls (mean 
difference between cases and controls 0.07, 95% Cl -0.09 to 0.24, p-value =0.39)
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smoking patterns cases controls adjusted*
odds
ratio
95% CIs
smoking
(packyears)
never 103 78 1.00
ex-smoker
1 to 10 27 26 0.81 0.42 to 1.55
10 or more 56 60 0.67 0.40 to 1.10
current smoker
1 to 30 16 19 0.56 0.25 to 1.25
30 or more 6 27 0.15 0.05 to 0.44
p-value 0.0003
Social influences
Parental smoking
No 38 37
Yes 170 173 0.91 0.54 to 1.53
p-value 0.72
Adolescent
friends’ smoking
No 142 147
Yes 62 67 0.83 0.53 to 1.29
p-value 0.4
Adult peers’
smoking
No 80 71
Yes 129 138 0.78 0.52 to 1.19
p-value 0.25
Spouse’s smoking
No 123 89
Yes 29 35 0.61 0.35 to 1.07
p-value 0.08
* adjusted for age-groups, sex and urban-rural indicator 
Table 35: Smoking behaviour and PD
There was no association between smoking, age of disease onset, NUDS disability, 
mini mental state score, and disease prognosis . If anything, current smokers 
appeared to have a younger age of disease onset and slightly worse prognosis. This 
does not support any protective effect of smoking on the natural history of the 
disease.
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non-smokers ex--smokers current smoker p-value for
heterogeneity
p-value for 
trend**
Adjusted means*
age at disease onset 42.6 43.2 42.4 0.73 0.79
Hoehn and Yahr 
(HY) score (1-5)
2.19 2.13 2.19 0.92 0.86
NUDS (0-50) 43.6 42.4 44.7 0.36 0.92
MMSE (0-25) 22.3 21.9 21.5 0.31 0.10
good prognosis (%) 30.7 28.7 24.4 0.85 0.7
NUDS = Northwestern University Disability Scale 
MMSE = Mini Mental State Examination
* Mean values adjusted for urban men aged between 51 to 55 years 
** p-values based on transformed data
Table 36: Association between smoking status and Parkinson’s disease severity
9.5.5 Alcoholf tea and coffee
Because of the problems in quantifying past consumption of alcohol, tea and coffee, 
it was decided to measure current consumption but also ask about possible changes 
in consumption compared to intake at the age of 25 years. In addition, analyses were 
rerun for cases with less than average disease duration (<10 years) to see if the 
associations differed. It is reasonable to hypothesize that increasing disease severity 
will be associated with reduced consumption of alcohol though it is less clear 
whether this would increase or decrease tea and coffee consumption as cases are 
likely to be more housebound.
Cases were less likely to consume moderate amounts of alcohol and there was a 
significant trend. There was an increased risk to be an ex-drinker although this was 
not statistically significant. Amongst those subjects who reported some consumption 
of alcohol, cases were more likely to have reduced their consumption and less likely 
to report drinking more now compared to how much they used to drink when they 
were 25 years old. Repeating the analysis just for subjects who either reported being 
never drinkers or not having altered their consumption if anything increased the
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strength of the inverse association although the test for trend was no longer 
significant due to the reduced sample size. On the other hand, restricting the analysis 
to cases with mild disability somewhat attenuated the association for the highest 
alcohol category but still suggested an inverse pattern. In this analysis, cases were 
less likely to report being ex-drinkers, suggesting that mild disease onset does not 
stop consumption per se.
Alcohol consumption cases controls adjusted* 
odds ratio 95% CIs
Alcohol
(units per week) 
Never drinker 51 46 1.00
Ex-drinker 19 15 1.21 0.51 to 2.89
>0 and <10 units 101 91 0.91 0.54 to 1.53
>=10 39 60 0.51 0.26 to 1.00
p-value
For current alcohol drinkers
drinking less now 67 55 1.32
0.02 
0.69 to 2.53
about same 28 31 1.00
drinking more now 45 70 0.57 0.27 to 1.22
p-value
Alcohol (if no change)
(units per week)
Never drinker 50 41 1.00
0.04
>0 and <10 units 22 20 0.79 0.32 to 1.97
>=10 5 11 0.35 0.10 to 1.24
p-value
Alcohol (if HY score 1 or 2)
(units per week)
Never drinker 28 46 1.00
0.14
Ex-drinker 7 15 0.64 0.19 to 2.22
>0 and <10 units 60 91 0.91 0.49 to 1.67
>=10 33 60 0.73 0.33 to 1.66
p-value 0.24
Table 37: Alcohol consumption and PD
For tea consumption, there was little evidence of any association between cases and 
controls. Amongst subjects reporting no change in consumption, there was if 
anything an increased risk with the highest category of consumption. However, when 
restricting the analysis to the less disabled cases, this association was inverse. This
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apparent contradiction may be due to either mild cases, who are more likely to be 
still in employment, cutting down intake to avoid the embarrassment of spilling tea 
due to their tremor or because cases with longer disease duration have increased 
consumption, though this contradicts their reported change in tea consumption.
Tea consumption cases controls adjusted*
odds
ratio
95% CIs
Tea (cups/day)
<1 cup/day 16 14 1.00
1 and < 4 cups per 76 60 1.19 0.51 to 2.77
day
>=4 cups per day 112 137 0.87 0.39 to 1.92
For current tea 
drinkers
drinking less now 28 17 1.29
0.16 
0.64 to 2.35
about same 153 111 1.00
drinking more now 17 75 0.16 0.09 to 0.31
tea (if no change)
(cups per day)
<1 cup/day 10 7 1.00
<0.001
1 and < 4 cups per 52 41 0.90 0.29 to 2.85
day
>=4 cups per day 94 64 1.49 0.51 to 4.36
tea (if HY score 1 
or 2)
<1 cup/day 12 14 1.00
0.32
1 and < 4 cups per 48 60 1.34 0.53 to 3.35
day
>=4 cups per day 66 137 0.60 0.23 to 1.52
0,16
* adjusted for age-groups (6 categories), sex and urban-rural indicator 
Table 38: Tea consumption and PD
Similar results were observed for coffee consumption as compared to tea. There was 
no real evidence of any association with any of the analyses. In this case mild cases 
were no less likely to drink more cups per day, but the cut-off was at a lower level 
than tea. However, it is worth noting that coffee consumption is far lower than tea 
consumption in Ireland. The relatively low prevalence of moderate/heavy
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consumption and lack of variation in exposure may have limited the ability to detect 
any real differences.
Coffee consumption cases controls adjusted*
odds
ratio
95% CIs
Coffee (cups/day)
<=1 cup/day 165 159 1.00
> 1 and < 2.5 cups 18 23 0.74 0.38 to 1.42
>=2.5 cups per day 27 30 0.93 0.50 to 1.70 
0.44
For current coffee drinkers
drinking less now 30 19 1.23 0.58 to 2.58
about same 70 43 1.00
drinking more now 22 74 0.21 0.11 to 0.41 
<0.0001
coffee (if no change)
(cups per day)
<=1 cup/day 111 94 1.00
> 1 and < 2.5 cups 9 4 1.81 0.52 to 6.34
>=2.5 cups per day 14 8 1.28 0.49 to 3.35 
0.45
coffee (if HY score 1 or 2)
<=1 cup/day 96 159 1.00
> 1 and < 2.5 cups 11 23 0.70 0.32 to 1.53
>=2.5 cups per day 21 30 1.19 0.59 to 2.37 
0.99
* adjusted for age-groups (6 categories), sex and urban-rural indicator 
Table 39: Coffee consumption and PD
9.5.6 Intake o f vitamin tablets
Subjects were asked if they had ever taken vitamin tablets on a regular basis and the 
duration of their intake. If they responded positively, cases were asked if  their intake 
preceded the onset of their disease to avoid reverse causality. All subjects were asked 
about the duration of their intake.
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Vitamin
tablets
cases controls adjusted* 
odds ratio
95% Cl
Ever taken
No 151 159 1.00
Yes 57 52 1.18 0.74 to 1.87
Ever taken 
(before PD)
No 177 159 1.00
0.49
Yes 31 52 0.49 0.28 to 0.85
0.01
* adjusted for age group, sex and current residence urban or rural 
Table 40: Vitamin intake and PD
There was no evidence that cases had any different intake of vitamins than controls. 
However, 26 cases reported that intake was subsequent to disease onset. The 
reanalysis indicated that cases were less likely to have taken vitamins than controls 
i.e. vitamin intake is associated with reduced risk of PD. However, this analysis may 
be misleading. This is because cases have had their possible person years of exposure 
truncated, at disease onset, whilst controls have not and so will simply be more likely 
to be exposed as a function of time. This is consistent with the results for duration of 
vitamin intake. Cases reported slightly longer duration of vitamin intake (0.41 years, 
95% Cl -2.4 to 3.2, p-value on transformed data 0.22) adjusted for age group, sex 
and urban-rural indicator).
9.6 Medical history
9.6.1 Past operations and non-specific illnesses
There was no evidence that cases were more likely to have ever had an operation, 
hospital admission or another illness requiring outpatient or general practitioner care. 
Cases were less likely to report an appendicectomy, which is consistent with better
^  J A
sanitary conditions in childhood * , though this may have been due to chance. 
Cases were slightly more likely to report more than two episodes of a general 
anaesthetic but there was no evidence of a significant trend.
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general
morbidity
cases controls adjusted*
odds
ratio
95% Cl
any operation
No 53 54
Yes 157 158 0.99 0.63 to 1.55
p-value 0.96
Tonsillectomy
No 163 177
Yes 47 35 1.42 0.87 to 2.32
p-value 0.16
Appendicectomy
No 172 164
Yes 38 48 0.74 0.45 to 1.24
p-value 0.26
Inguinal hernia
repair
No 183 192
Yes 27 20 1.46 0.81 to 2.64
p-value 0.2
No. of
GA
0 50 57 1.00
1 54 63 1.01 0.59 to 1.71
2 106 92 1.26 0.77 to 2.08
p-value for trend 0.18
hospital
admission
No 114 109
Yes 95 101 0.91 0.61 to 1.37
p-value 0.66
Other illness
No 72 87
Yes 137 125 1.41 0.94 to 2.11
p-value 0.09
* adjusted for age group, sex and current residence urban or rural
Table 41: Co-morbidity and PD
9.6.2 Past cardiovascular diseases, high blood pressure and diabetes 
Cases were less likely to report either a past history of a doctor diagnosis of angina, 
myocardial infarction, stroke, high blood pressure and diabetes, though the p-values 
indicated very weak evidence against the null hypothesis. A composite 
cardiovascular disease variable, which also included Rose angina, did however show
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a 53% relative reduction amongst cases (p=0.04). This reduction of cardiovascular 
disease would be consistent with the reduced frequency of smoking amongst cases as 
compared to controls, however it was independent of smoking status (odds ratio for 
cardiovascular disease 0.46, 95% Cl 0.22 to 0.96, p=0.04, after adjustment for sex, 
age group, urban-rural and smoking status).
cardiovascular
disease
cases controls adjusted* 
odds ratio
95% Cl
Doctor
diagnosis
Angina
No 200 196
Yes 7 16 0.43 0.16 to 1.13
p-value 0.08
MI
No 205 201
Yes 4 11 0.38 0.12 to 1.20
p-value 0.09
Stroke
No 207 208
Yes 2 4 0.40 0.06 to 2.53
p-value 0.32
HBP
No 178 172
Yes 31 40 0.79 0.46 to 1.36
p-value 0.4
diabetes
No 203 204
Yes 6 8 0.78 0.27 to 2.23
p-value 0.64
cardiovascular
disease**
No 198 188
Yes 12 24 0.47 0.22 to 1.00
p-value 0.04
* adjusted for age group, sex and current residence urban or rural 
** includes doctor angina, Rose angina, MI, stroke 
Table 42: Cardiovascular disease and PD
9.6.3 Head trauma
Subjects were asked if they had “ever had an injury to the head”. All respondents 
who answered positively were then asked about the frequency of head injuries and
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whether any of these episodes were severe enough to result in any of the following 
symptoms: loss of consciousness, dizziness, blurred or double vision, seizures or fits, 
memory problems, weakness or paralysis. At the end of the interview cases were 
specifically asked if they had any “lay beliefs” about the cause of their illness, which 
were then classified into a variety of aetiological categories, including trauma. It was 
therefore possible to then repeat the analyses excluding any case who reported that 
they believed that trauma had caused their disease. Male subjects were specifically 
asked if they ever boxed as a sport and how long this lasted.
Cases were more than 3 times as likely to report any injury, although there was no 
obvious dose-response so that 2 episodes had less risk than one episode. Restricting 
the analysis to only episodes which were accompanied by any of the above 
symptoms attenuated the association some what. This may be either chance or the 
likelihood that cases would be more likely to report more trivial episodes as 
compared to controls because of recall bias. Again there was no obvious dose- 
response effect. Limiting episodes to those with loss of consciousness, which would 
be unlikely to be differentially recalled, still indicated an excess risk amongst cases. 
After excluding cases, who reported trauma as a possible cause of their disease, the 
odds ratio was again attenuated but remained significant, even when examining only 
serious episodes.
There was no evidence however that cases were more likely to box as a sport. Cases 
reported, if anything, a shorter duration of boxing exposure (-0.7 years, 95% Cl 
-2.0 to 0.5, p-value = 0.26), adjusted for age group and urban-rural residence.
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Head injury cases controls adjusted* 
odds ratio
95% Cl
Any head injury
No
Yes
109
101
162
50 3.20 1.99 to 5.15
p-value
Any head injury
0 109 162 1.00
<0.0001
1 78 30 4.22 2.41 to 7.40
2+ 23 19 1.79 0.88 to 3.64
p-value
Any serious injury
No
Yes
153
57
183
29 2.21
0.0001 
1.33 to 3.69
p-value
Any serious injury
0 153 183 1
0.001
1 46 15 3.45 1.81 to 6.56
2+ 11 13 1.06 0.46 to 2.45
p-value 
Any loss of 
consciousness
No
Yes
179
31
199
13 2.44
0.03 
1.23 to 4.83
p-value
Any head injury
(excluding lay 
beliefs)
No
Yes
107
74
162
50 2.36
0.008 
1.45 to 3.85
p-value
Any serious head 
injury
(excluding lay 
beliefs)
No
Yes
140
41
183
29 1.73
0.0004 
1.00 to 2.99
p-value
Boxing (males)
No
Yes
163
17
147
26 0.54
0.05 
0.28 to 1.05
p-value 0.07
* adjusted for age group, sex and current residence urban or rural 
Table 43: Head trauma and PD
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9.6.4 Vaccinations
Subjects were asked if they “ever remember being vaccinated”. If they responded 
positively, they were then systematically asked about vaccinations for the following 
infectious diseases: tuberculosis, smallpox, whooping cough, tetanus, diphtheria, 
measles, polio. Subjects were allowed to respond that they could not recall whether 
they had received a specific vaccination which was coded as don’t know.
Overall there was hardly any difference in the odds ratio associated with any 
vaccination. However, cases were less likely to report having received a specific 
vaccination. Only diphtheria showed moderate evidence against the null hypothesis 
(pO.OOOl) This inverse association did not seem to be the result of failing to recall 
the type of vaccination as cases were less likely to report don’t know.
Vaccinations cases controls adjusted* 
odds ratio
95% Cl
Any vaccination
No 33 31
Yes 173 181 0.94 0.55 to 1.62
p-value 0.83
tuberculosis
No 69 58
Yes 58 74 0.49 0.28 to 0.85
p-value 0.01
D/K** 44 49 0.74 0.42 to 1.29
p-value 0.29
smallpox
No 51 41
Yes 83 90 0.82 0.47 to 1.42
p-value 0.48
D/K** 37 50 0.63 0.34 to 1.15
p-value 0.13
whooping cough
No 107 89
Yes 24 39 0.49 0.27 to 0.91
p-value 0.02
D/K** 40 53 0.63 0.37 to 1.05
p-value 0.08
164
Vaccinations cases controls adjusted* 
odds ratio
95% Cl
tetanus
No 57 48
Yes 84 92 0.74 0.44 to 1.24
p-value 0.26
D/K** 30 41 0.63 0.33 to 1.20
p-value 0.16
diphtheria
No 92 62
Yes 40 69 0.33 0.19 to 0.58
p-value <0.0001
D/K** 39 50 0.46 0.26 to 0.81
p-value 0.006
measles
No 116 101
Yes 14 27 0.47 0.23 to 0.97
p-value 0.04
D/K** 41 53 0.67 0.41 to 1.09
p-value 0.11
polio
No 82 72
Yes 54 62 0.61 0.35 to 1.06
p-value 0.07
D/K** 35 47 0.70 0.40 to 1.23
p-value 0.21
* adjusted for age group, sex and current residence urban or 
rural
** Don't know
Table 44: Vaccinations and PD
9.7 Exposures over the life course
9. 7,1 Residential history
The distribution of all subjects by whether their current District Electoral Division 
(DED) was “officially” classified as urban or rural, according to population density 
was as follows: urban - 261 (61.8%), rural -161 (38.2%). This was similar to the 
self-reported classification of current residence: 58% urban, 42% rural.
The degree of population mobility can be seen from Table 45, which cross-tabulates 
type of first residence with current residence, according to self-reported urban or 
rural classification. These results confirm the degree of internal migration that has
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occurred over the last 50-60 years. As expected, around 35% of subjects who were 
bom in rural areas are now living in urban areas, whilst only around 10% have 
migrated the other way around. The Spearman correlation between first and current 
residence was 0.53 (p<0.0001), indicating a moderately strong correlation between 
the type of residence a subject was bom into and where they currently live.
current residence
initial residence urban rural
urban 155 19
(%> 63.5 10.7
rural 89 158
(%) 36.5 89.3
Table 45: Association between initial and current residential classification
The mean number of years of rural residence was 26.7 (median 23) and of urban 
residence was 31.0 (median 33). Because of the skewness and kurtosis of the 
distributions, significance testing was based on a non-parametric test, however the 
means are presented for simplicity. There was no significant difference between 
mean urban years of residence: cases 30.6 years, controls 31.3 (p=0.67). This 
analysis was then repeated after dividing the number of years into categories to
examine for non-linear relationships.
residential cases controls adjusted*
history 210 212 odds ratio 95% CIs
Rural residence
0 years 60 62 1.00
1-25 years 52 49 1.13 0.65 to 1.96
26-50 years 48 48 1.08 0.62 to 1.86
50 + years 50 53 1.10 0.63 to 1.91
p-value 0.89
Urban residence
0 years 46 48 1.00
1-30 years 56 48 1.13 0.62 to 2.05
31-55 years 58 63 0.95 0.54 to 1.66
55 + years 50 53 0.91 0.49 to 1.67
p-value 0.75
* adjusted for age group and sex
Table 46: Residential history and PD
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It is possible that exposure to a rural environment during early life may be more 
important than years of exposure. If subjects are classified by their residence of birth 
then the odds ratio associated with rural residence is 1.18 (95% CIs 0.80 to 1.75, p- 
value=0.40).
9.7.2 Source o f drinking water
Amongst all the subjects, the source of drinking water for their initial place of 
residence was as follows: mains -171 (40.6%), public pump or well - 218 (51.8%), 
stream or river - 14 (3.3%), other sources 2 (0.5%), can’t remember 16 (3.8%). This 
is similar to official data from the 1946 census: mains - 38.7%, public pump or well - 
47.6%, stream - 7.7 %, other source - 6.1 %. The census data reflects percentage of 
households rather than individuals and this will result in some differences.
Patterns of consumption of well water were, as expected, associated with urban and 
rural residence. The Spearman correlation coefficient between years of rural living 
and well water exposure was 0.73 (p<0.0001).
Table 47 shows the distribution of well water consumption categorised into years of 
exposure by case-control status. Categories were chosen to divide the distribution 
into relatively even sized groups, except for the baseline group of zero years 
exposure. To test the possibility that type of water is only important in early life, the 
distribution of water supply was analysed based on the main source of water up to 
age 5 or 15 years.
There is a modest increased risk associated with well water, which increases with 
duration of exposure in a dose response fashion (test for trend p=0.26). A stratified 
analysis by age group shows that the risk is greater for younger subjects (<55 years) 
(odds ratio 1.0,1.04,2.41, 2.61, p for trend =0.09) whilst for older subjects (> 55) 
there is no effect (odds ratio 1.0, 1.20, 0.86, 0.90, p for trend=0.79). A formal test for 
interaction however was not significant (p=0.15). There is little difference in the 
distribution of cases and controls and all the odds ratios are close to unity for mains 
water. Exposure in either the first five or fifteen years of life is associated with a 
similar modest increase in risk.
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Water
consumption
cases
210
controls
212
adjusted 
odds ratio 95% CIs
Well water
0 years 78 81 1.00
1-20 years 53 51 1.20 0.71 to 2.04
21-40 years 43 42 1.35 0.72 to 2.53
40 + years 36 38 1.51 0.50 to 4.58
p-value for trend 0.26
Mains water
0 years 13 18 1.00
1-20 years 32 30 1.37 0.52 to 3.64
21-40 years 56 54 1.21 0.48 to 3.09
40 + years 109 110 1.09 0.34 to 3.49
p-value for trend 0.92
Well water
in first 5 years
No 84 90
Yes 120 118 1.36 0.86 to 2.16
p-value 0.18
Well water
in first 15 years
No 91 95
Yes 116 116 1.31 0.83 to 2.06
p-value 0.24
Table 47: Water consumption and PD 
9.7.3 Social mobility
There was only a moderate correlation between father’s social class in childhood and 
adult social class (rho 0.38, p<0.001). This was because there was reasonable upward 
social mobility over this time period as might be expected from changes in the labour 
market. This is most marked for subjects from parental social class IV&V moving to 
social class III and for those from parental social class III moving to social class 
I&II.
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adult SES
I&II III IV&V
parental I&II 68 25 4
ses III 69 76 24
IV&V 39 57 53
Table 48: Distribution of cases and controls across childhood and adult social 
position
Social mobility over the life course was examined in two ways. Firstly subjects were 
identified that either remained in the same social class at both time periods (static) or 
either went up or down a category. In addition a cumulative social class variable was 
created that simply summated social position over both time points. Hence a score of 
between 2 (highest) and 6 (lowest) was created.
Social mobility cases controls adjusted* 
odds ratio
95% Cl
Socially mobile
static 102 95 1.00
upward 78 87 0.86 0.56 to 1.31
downward 27 26 0.93 0.50 to 1.72
p-value for trend
Cumulative
SES
2 41 27 1.00
0.49
3 52 42 0.81 0.42 to 1.57
4 60 59 0.74 0.41 to 1.35
5 32 49 0.41 0.20 to 0.84
6 22 31 0.49 0.21 to 1.11
p-value for trend 0.006
* adjusted for age group, sex and current residence urban or rural 
Table 49: Social mobility and cumulative social position
Although there was no evidence that cases were either more or less likely to be 
socially mobile they showed a significantly higher social score across their life 
course indicating that they were more likely to start off in more affluent homes and 
remain so into adulthood.
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9. 7.4 Geographical mobility
All subjects were asked about travel abroad from birth until the age of thirty years. 
This has broken down into three periods that could be recalled reasonably reliably (a) 
before starting school (< 5 years), (b) during school years (5-18 years), and (c) as an 
adult until the age of 30 years. This upper age limit was taken so that most cases 
would not have yet developed clinical disease, which may have limited the likelihood 
of travelling.
As can be seen from the table, there was no significant difference between cases and 
controls. If anything, cases were less likely to have been abroad than controls.
Travel
abroad
cases controls adjusted*
odds
ratio
95% Cl
Travel any age
No 79 76
Yes 131 136 0.80 0.53 to 1.22
p-value 0.31
Travel preschool
No 204 205
Yes 6 206 0.83 0.26 to 2.70
p-value 0.77
Travel school years
No 195 196
Yes 15 15 0.76 0.33 to 1.73
p-value 0.51
Travel either preschool
or school period
No 192 193
Yes 18 19 0.72 0.34 to 1.52
p-value 0.38
Travel during
adulthood up to 30
years
No 81 80
Yes 129 132 0.85 0.56 to 1.29
p-value 0.44
* adjusted for age group, sex and current residence urban or rural
Table 50: Travel abroad from birth until the age of 30 years
170
9.8 Family history of disease
Three subjects reported either an adoptive parent (2 subjects) or a step-mother (1 
subject). For all these subjects, their respective maternal or paternal family history 
was recoded as missing as these parents were not genetically linked to the subject. 
Because of the possible role of consanguinity, especially in remote rural areas, all 
subjects were asked if their parents were in any way related before they got married. 
14 cases reported either a possible (11 subjects) or definite (3 subjects) relationship. 
This was more common amongst cases than controls (9 versus 5) but the increased 
odds ratio may have been due to chance (odds ratio 2.06, 95% Cl 0.63 to 6.66, p- 
value = 0.22).
9,8.1 Parental history o f chronic diseases
There was no real evidence that the parents of cases were more likely to have died 
and to have suffered age-related diseases such as cardiovascular disease, 
hypertension and cancer.
Parental
morbidity
cases controls adjusted* 
odds ratio
95% Cl
Mother dead
No 41 39
Yes 167 173 1.03 0.59 to 1.80
p-value 0.91
Mother angina
No 178 185
Yes 22 24 0.91 0.49 to 1.69
p-value 0.76
Mother
MI
No 163 177
Yes 40 33 1.16 0.70 to 1.92
p-value 0.57
Mother stroke
No 179 183
Yes 24 26 1.06 0.57 to 1.96
p-value 0.86
Mother CVD
No 140 142
Yes 70 70 1.00 0.69 to 1.50
p-value 1.00
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Parental
morbidity
cases controls adjusted* 
odds ratio
95% Cl
Mother HBP
No 141 142
Yes 62 63 0.94 0.61 to 1.46
p-value 0.79
Mother cancer
No 162 176
Yes 42 33
p-value 1.38 0.83 to 2.30
Father dead 0.21
No 18 14
Yes 190 197
p-value 0.90 0.42 to 1.93
Father angina 0.79
No 178 187
Yes 22 22 1.07 0.54 to 2.10
p-value 0.85
Father MI
No 153 164
Yes 48 46 1.16 0.73 to 1.85
p-value 0.52
Father stroke
No 176 180
Yes 26 30 0.88 0.51 to 1.54
p-value 0.66
Father CVD
No 133 134
Yes 77 78 1.03 0.69 to 1.54
p-value 0.88
Father HBP
No 172 174
Yes 28 30 0.99 0.55 to 1.78
p-value 0.97
Father cancer
No 164 161
Yes 36 49 0.73 0.45 to 1.19
p-value 0.21
* adjusted for age group, sex and current residence urban or rural
Table 51: Parental chronic disease and PD
A survival analysis of maternal and paternal risk of death showed that parents of PD 
cases were if anything less likely to have died, after adjusting for age group, sex, 
rurality, parental smoking and father’s social class (hazard ratio for maternal death
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0.81, 95% Cl 0.12 to 1.05, p=0.12 and for paternal death 0.87, 95% Cl 0.68 to 1.11, 
0.26)
9.8.2 Parental history o f diseases possibly linked to PD 
There was some evidence of an increased risk of a positive family history for PD 
amongst cases, although it failed to reach statistical significance. This was more 
marked for simply a history of familial tremor. It is not possible to know to what 
degree this group represents possible recall bias amongst cases or under diagnosed 
cases of PD. In rural parts of Ireland in the past, with limited access to specialist care, 
it is possible that late onset PD may have either not presented to a health care 
professional or have been misdiagnosed. A combined family history of PD and/or 
tremor had a 2.5 fold excess risk. This risk was however attenuated if only maternal 
cases were included thereby failing to support a possible role of maternal 
transmission of risk. There was no evidence of any increased risk of other 
neurological diseases, in particular dementia, which may have a common aetiological 
origin. Thyroid disease was more often reported amongst cases but this failed to 
reach statistical significance.
Parental
PD related diseases
cases controls adjusted* 
odds ratio
95% Cl
PD
No 193 203
Yes 16 9 1.80 0.80 to 4.08
p-value 0.15
Maternal PD
No 201 205
Yes 9 7 1.35 0.52 to 3.52
p-value 0.54
Tremor
No 192 206
Yes 17 6 3.42 1.24 to 9.42
p-value 0.01
PD or tremor
No 176 197
Yes 33 15 2.50 1.31 to 4.77
p-value 0.004
Maternal PD or
tremor
No 195 200
Yes 15 12 1.42 0.66 to 3.07
p-value 0.37
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Parental
PD related diseases
cases controls adjusted* 
odds ratio
95% Cl
MS
No 208 212
Yes 1 0 **
p-value 0.48
MND
No 209 209
Yes 0 2 **
p-value 0.23
Dementia
No 197 198
Yes 12 13 1.01 0.46 to 2.23
p-value 0.98
Thyroid disease
No 195 205
Yes 4 6 2.42 0.89 to 6.57
p-value 0.07
Diabetes
No 192 194
Yes 17 17 0.89 0.43 to 1.86
p-value 0.76
Scoliosis
No 206 210
Yes 3 1 3.02 0.32 to 28.4
p-value 0.31
* adjusted for age group, sex and current residence urban or rural 
** not possible to calculate odds ratio
Table 52: Parental history of possibly related diseases and PD 
9.8.3 Sibling history o f chronic diseases
Similar to the results for parents, there was no real evidence that cases were more 
likely to have a sibling with either a history of cardiovascular disease and/or cancer. 
This again fails to support any generic link between PD and other age-related 
disorders.
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Sibling
morbidity
cases controls adjusted* 
odds ratio
95% Cl
Sibling angina
No 183 184
Yes 21 22 1.01 0.52 to 1.93
p-value 0.98
Sibling
MI
No 179 175
Yes 25 28 0.97 0.53 to 1.79
p-value 0.92
Sibling stroke
No 199 197
Yes 6 9 0.62 0.23 to 1.70
p-value 0.35
Sibling CVD
No 164 162
Yes 46 50 0.98 0.61 to 1.58
p-value 0.94
Sibling HBP
No 174 173
Yes 29 31 1.01 0.58 to 1.76
p-value 0.98
Sibling cancer
No 176 177
Yes 28 28 1.09 0.61 to 1.95
p-value 0.78
* adjusted for age group, sex and current residence urban or rural
Table 53: Sibling chronic disease and PD
9.8.4 Sibling history o f diseases possibly linked to PD
Again, as seen for parents, cases were more likely to report a positive sibling history 
for PD and/or tremor. The number of tremor cases wase smaller than PD cases for 
siblings as compared to the parental history. This is surprising as parents would be 
more likely to have developed PD given their older age as compared to siblings. This 
further supports the likelihood that tremor cases amongst parents may have been 
misdiagnosed cases of PD. Once again thyroid disease was specifically reported 
more often amongst cases but failed to reach statistical significance.
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Sibling
PD related diseases
cases controls adjusted*
odds
ratio
95% Cl
PD
No 195 203
Yes 10 3 3.56 0.87 to 14.5
p-value 0.06
Tremor
No 198 205
Yes 6 1 6.84 0.66 to 70.5
p-value 0.06
PD or tremor
No 194 208
Yes 16 4 4.73 1.35 to 16.6
p-value 0.007
MS
No 199 204
Yes 6 2 2.86 0.65 to 12.6
p-value 0.15
MND
No 204 205
Yes 1 1 1.03 0.07 to 15.8
p-value 0.98
Dementia
No 205 206
Yes 0 0 **
p-value
Thyroid disease
No 194 202
Yes 11 4 2.68 0.69 to 10.4
p-value 0.14
Diabetes
No 194 193
Yes 11 13 0.84 0.38 to 1.88
p-value 0.67
Scoliosis
No 204 205
Yes 1 1 1.12 0.06 to 20.7
p-value 0.94
* adjusted for age group, sex and current residence urban or rural 
** not possible to calculate odds ratio
Table 54: Sibling history of possibly related diseases and PD
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9.8.5 Other relatives with history o f diseases possibly linked to PD 
Subjects were asked to report any uncles, aunts or cousins with a range of possible 
diagnoses. PD was again more often reported amongst cases but there was little 
increased risk for tremor. Thyroid disease emerged as more common amongst cases 
but diabetes was less common amongst 2nd degree relatives.
Other relative cases controls adjusted* 95% Cl
PD related diseases odds ratio
PD
No 185 201
Yes 23 11 2.04 0.97 to 4.28
p-value 0.06
Tremor
No 204 208
Yes 5 4 1.44 0.35 to 5.84
p-value 0.66
MS
No 205 208
Yes 4 4 1.16 0.28 to 4.89
p-value 0.84
MND
No 209 211
Yes 0 1 **
p-value 0.25
Dementia
No 201 205
Yes 8 6 1.36 0.46 to 4.01
p-value 0.57
Thyroid disease
No 205 211
Yes 3 1 3.10 0.27 to 35.9
p-value 0.33
Diabetes 205 205
No 2 6 0.24 0.05 to 1.24
Yes 0.06
p-value
Scoliosis
No 206 208
Yes 2 4 0.73 0.15 to 3.55
p-value 0.69
* adjusted for age group, sex and current residence urban or rural 
** not possible to calculate odds ratio
Table 55: Other relative history of possibly related diseases and PD
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9.8.6 First degree relatives with history o f diseases possibly linked to PD 
Pooling the data across all first degree relatives (parents and siblings) resulted in 
statistically significant increased risk of PD (odds ratio 2.14, 95% Cl 1.02 to 4.50, p- 
value 0.04), tremor 3.47, 95% Cl 1.35 to 8.87, p-value 0.006) and either PD and/or 
tremor (odds ratio 2.51,95% Cl 1.36 to 4.61, p-value 0.002). A history of thyroid 
disease was also now increased (odds ratio 2.41, 95% Cl 1.02 to 5.69, p-value=0.04).
9.9 Summary of main results
The following tables provides a broad qualitative summary of the results for each 
exposure group.
Exposure(s) Broad conclusions
perinatal exposures No evidence of any differences
familial SES increased risk associated with higher familial SES
pets and farm animals Evidence of less contact with pets; no real 
difference with farm animals
childhood infections Some suggestion of reduced illness or contact with 
childhood infections. No difference for age at 
infection
Sanitation No birth order; Slightly less overcrowding and no 
outside toilet. Increased risk of boarding school
diet No marked differences though slightly less fruit 
consumption
adult SES Very little difference in adult SES or marital status
high risk occupations No real differences; cases 50% more likely to have 
been farmers
occupational exposures No real difference
general neurotoxic exposures Less likely or equally likely to be exposed to 
chemicals and metals; partially associated with 
disease severity
smoking behaviour reduced smoking behaviour. No difference in 
external peer influences. No difference in disease 
severity associated with smoking behaviour
alcohol, tea and coffee Alcohol and tea also reduced intake; no real 
difference for coffee
other illness and hospital 
admissions
No difference in other illness or GA
cardiovascular disease Less CVD for cases and independent of smoking 
status
head trauma Increased risk even after adjustment for lay beliefs
vaccinations No overall difference, but diphtheria less reported 
for cases
residence and rurality No difference
well water modest increased risk but may be chance
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life course SES higher cumulative SES
travel abroad No differences in travelling
Exposure(s) Broad conclusions
Parental neurological history Increased risk of reporting PD/tremor ? thyroid 
disease
Sibling general disease history No real differences
Sibling neurological history Increased risk of reporting PD/tremor ? thyroid 
disease
Other family diseases Increased risk for PD
Table 56: Summary of results for all the exposure groups 
9.10 Further analyses
9.10.1 Adjusting for disease severity as an indicator o f bias
It was previously observed that the apparent “protective” effect associated with
domestic neurotoxic exposures may have been artefactual due to under-reporting of
exposures by more disabled cases compared to controls. It is necessary to therefore
check whether any other “significant” associations were also consistent with this
explanation. Exposure to pets and smoking status was asked systematically to all
subjects. For well water exposure and alcohol consumption, subjects had to choose
one descriptor from a list so this should not have been affected by under-reporting
due to disability. The only category of exposure variable that may have been affected
was childhood infections where again subjects were asked “can you recall having
one of these diseases at any time in your life?” from a list that was shown to them.
To test the hypothesis that cases under-report due to disease severity influencing
spontaneous reporting, the associations were repeated but the case group were
dichotomised into mild disease, (NUDS score > 45/50) or moderate, severe disease
(NUDS < 45). It was predicted that under the null hypothesis, the mild group should
show no difference to controls as their disease would still be well controlled by
medication and their should be little if any speech problem.
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childhood
infections
severe
cases
mild
cases
controls adjusted* 
odds ratio
95% CIs
measles ill 98 80 189 1.00
no 17 8 23 1.23*
0.72**
(0.52 to 2.92) 
(0.36 to 1.41)
whooping ill 34 39 91 1.00
cough no 81 49 121 1.18
0.56
(0.70 to 2.00) 
(0.34 to 0.92)
chicken ill 39 30 95 1.00
pox no 76 58 117 0.55
0.67
(0.32 to 0.95) 
(0.41 to 1.08)
polio ill 2 2 5 1.00
no 113 87 207 0.65
0.88
(0.12 to 3.53) 
(0.16 to 4.85)
mumps ill 58 47 118 1.00
no 57 41 40 0.91
0.82
(0.55 to 1.52) 
(0.52 to 1.30)
glandular ill 2 3 9 1.00
fever no 110 83 27 0.59
0.34
(0.15 to 2.34) 
(0.07 to 1.64)
* odds ratio of mild cases versus controls; ** odds ratio of moderate/severe cases 
versus controls.
Table 57: Re-analysis of childhood infection exposure comparing mild with more 
severe cases.
The results generally support the hypothesis of an artefactual association. For 
measles and whooping cough, mild cases have the same risk of reporting exposure as 
controls. For polio and glandular fever the risk is still diminished for mild cases but 
in both cases the number of cases exposed is very small. It is only chicken pox, 
where even mild cases report reduced exposure similar to moderate and severe cases, 
and the 95% confidence interval does not include unity. One cannot totally dismiss 
this association as artefactual and it is therefore included in the further analyses.
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9.10,2 domestic neurotoxic exposures
The category of domestic neurotoxic exposures contained a list of 10 potential 
agents. These exposures may either confound each other or more likely may be 
associated due to clustering as they relate to common activities. The most obvious 
example would be the association of gardening with exposure to herbicides, 
pesticides and fertilisers. To examine this issue, an exploratory factor analysis was 
undertaken to examine whether the loadings clustered exposures into independent 
groups. This identified 3 groupings (a) weed killers, insecticides and fertilisers 
(gardening factor), (b) wood preservatives, glues, paints solvents (DIY factor) (c) 
solvents, print, dry cleaning agents (?occupational factor). However, factor analysis 
is intended to be used with normally distributed continuous variables and hence 
modelling a series of dichotomous variables may not be appropriate. Further analysis 
was therefore undertaken with the specific exposures rather than the factor scores 
adjusting for age group, sex, rurality and the cumulative social class score. The 
results indicated that the following variables may be independent predictors: 
insecticide exposure (odds ratio 0.60, 95% Cl 0.35 to 1.02, p=0.06) glues (odds ratio 
0.62, 95% Cl 0.36 to 1.08, p=0.09) and paints (odds ratio 0.44, 95% Cl 0.28 to 0.68, 
p<0.0001). These variables were therefore retained for further analysis.
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9.10.3 Life course influences on PD risk
PD personality
Rural residence
Risk of PD
childhood
infections
contact 
with pets
Well water over life course
Head trauma
Family 
history 
of PD
Smoking and 
alcohol
general
adult
neurotoxic
exposures
Life course socioeconomic position
Figure 17: Schematic representation of inter-relationships between explanatory 
variables across the life course
The above figure is a simplified schematic representation o f how the key groups of 
explanatory variables could inter-relate across the life course in determining risk of 
PD. Each solid box represents a measured group of variables that may be important 
according to the data in this study. The dotted box, incorporating “PD personality” is 
a latent variable, not directly measured, that may link various observed variables. A 
family history of PD may influence PD either through a direct genetic pathway or 
indirectly through determining personality and in turn other related exposures. Life 
course socioeconomic position may either confound the associations observed with
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other variables or be the antecedent that determines exposure. For example, 
socioeconomic position may influence the risk of head injury either through an 
occupationally related hazard or through sociocultural influences on hobbies and 
leisure pursuits that may influence exposure. A “PD personality” type may influence 
smoking and alcohol consumption, contact with pets, exposure to generic 
neurotoxins through hobbies and leisure pursuits and head injury.
9.10.4 Results o f  final multivariable models
The association between all the main exposures and/or confounders was first 
examined using a simple correlation matrix. The purpose of this was to highlight if 
there was an undue collinearity between variables that may produce misleading 
estimates from the multivariable model. Pearson correlation coefficients were 
calculated but the results from the Spearman non-parametric correlation were very 
similar (data not shown).
Most of the correlations are weak (<0.3 0) except for the positive association between 
rurality and well water consumption which is moderately strong. Not surprisingly 
several exposures are correlated with gender so women are less likely to report 
serious head injury, and greater consumption of cigarettes and alcohol. Smoking and 
alcohol consumption are positively correlated. Contact with a dog was positively 
associated with both rurality and even more strongly with well water consumption. 
Presumably more remote residences in the past were more likely to have had well 
water and also keep a dog either as a pet or to help around the farm.
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contact 
with dog
chicken
pox
serious
head
injury
pack
years
smoking
alcohol
status
insecticide
exposure
glue
exposure
paint
exposure well water age group sex rurality cumulative
contact with dog
1.00
chicken pox 0.03 1.00
serious head
injury 0.04 -0.01 1.00
pack years
smoking 0.07 -0.01 -0.06 1.00
alcohol status 0.00 0.01 0.11 0.14 1.00
insecticide
exposure 0.08 0.12 0.10 -0.04 -0.05 1.00
glue exposure 0.04 -0.02 0.02 0.03 0.05 0.07 1.00
paint exposure 0.12 -0.01 0.01 0.00 0.08 0.07 0.27 1.00
well water
consumption 0.25 -0.01 -0.07 0.11 -0.21 0.12 -0.10 0.09 1.00
age group -0.08 -0.13 -0.15 0.07 -0.14 -0.02 -0.06 -0.11 0.12 1.00
sex -0.14 0.11 -0.18 -0.18 -0.23 -0.05 -0.05 -0.03 -0.07 -0.01 1.00
rurality 0.14 0.05 -0.10 0.14 -0.10 0.12 -0.12 0.10 0.63 -0.07 -0.03 1.00
cumulative SEP 0.05 -0.10 -0.05 0.15 -0.02 -0.04 -0.06 0.04 0.21 0.02 -0.20 0.18 1
Table 58: Correlation matrix of key exposures and/or confounding factors to examine for collinearity
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Initially only childhood exposures, having adjusted for the stratification variables 
(age group, rurality, and sex), were included (model 1). Then an extended model was
created including adult life style exposures (model 2).
Exposures
OR
model 1 
95% Cl OR
model 2 
95% Cl OR
model 3 
95% Cl
Family history of PD 2.59 (1.42 to 4.73) 2.30 (1.19 to 4.44) 2.15 (1.09 to 4.27)
contact with dog 0.51 (0.32 to 0.80) 0.51 (0.30 to 0.86) 0.44 (0.25 to 0.78)
chicken pox 0.60 (0.40 to 0.91) 0.58 (0.37 to 0.92) 0.51 (0.32 to 0.83)
serious head injury 2.74 (1.52 to 4.92) 3.08 (1.66 to 5.71)
smoking status
never 1.00 1.00
ex-smoker
1 to 10 0.96 (0.49 to 1.9) 0.86 (0.42 to 1.77)
10 or more 0.85 (0.48 to 1.5) 0.77 (0.43 to 1.4)
current smoker
1 to 30 0.63 (0.27 to 1.47) 0.72 (0.3 to 1.71)
30 or more 0.18 (0.06 to 0.5) 0.19 (0.07 to 0.57)
Alcohol
Never drinker 1.00 1.00
Ex-drinker 1.42 (0.55 to 3.69) 1.11 (0.41 to 3.00)
>0 and <10 units 0.94 (0.54 to 1.66) 0.99 (0.54 to 1.79)
>=10 0.52 (0.26 to 1.04) 0.58 (0.27 to 1.22)
insecticides 0.51 (0.3 to 0.86) 0.44 (0.25 to 0.77)
glue 0.59 (0.34 to 1.03) 0.52 (0.29 to 0.93)
paints 0.40 (0.25 to 0.64) 0.37 (0.22 to 0.6)
Well water
0 years 1.00
1-20 years 1.19 (0.64 to 2.22)
21-40 years 2.45 (1.12 to 5.38)
40 + years 2.08 (0.84 to 5.15)
Cumulative SEP
2 (most affluent) 1.00
3 0.98 (0.46 to 2.07)
4 0.83 (0.4 to 1.72)
5 0.40 (0.18 to 0.89)
6 (most
deprived) 0.31 (0.12 to 0.78)
chi2(ll) chi2 (7)
74.03, 25.79,
Likelihood ratio test p<0.0001 p=0.0005
* All models have adjusted for age group, sex and rurality.
Table 59: Different models examining exposures across the life course
185
The likelihood ratio test is reported so it is possible to examine whether these 
additional adult variables improve the fit and hence prediction of the model. Finally 
the cumulative life course variables are added so that the effects of any exposures 
acting across childhood and adulthood can be examined. In this case, it is important 
to see if the earlier odds ratios are attenuated or enhanced by further adjustment. 
Again evidence for improvement of the model fit is presented.
The results from Table 59 demonstrate variables across the life course all seem to 
have some predictive power. Each subsequent model is more predictive than the 
earlier one. A family history, whether reflecting genetic or environmental factors is 
associated with a doubling of risk. Both lack of contact with a dog and not reporting 
chicken pox in childhood are associated with PD risk. Adjustment if anything makes 
these associations slightly stronger. In adulthood, a serious head injury is associated 
with a threefold risk. Both smoking status (p value for trend =0.006) and alcohol 
consumption (p value for trend =0.22) showed an inverse association with PD though 
only the association with smoking status had strong evidence against the null 
hypothesis. There were inverse associations with insecticide, glue and paint 
exposure. These may or may not be artefactual. The association with cumulative well 
water exposure (p value for trend =0.05) was enhanced, compared to the simpler 
model (see section 9.7.2), after adjustment for other covariates, though the trend was 
not totally linear, with an increased risk being seen only after 20 years exposure. As 
before, the cumulative socioeconomic position measure showed a significant inverse 
association (p value for trend =0.002) so that more affluent subjects were more likely 
to develop PD.
186
9,10.5 Comparing models for all cases and those with mild PD
We have previously noted that some associations may have been artefactual due to
cases with more marked disability reporting fewer items for a list of exposures . A
sensitivity analysis was therefore undertaken with the full model shown above
(model 3) being repeated for all controls and the subset of cases with mild disability
(NUDS > 45). This also reduces any
Potential “survivor” bias as PD mortality is rare as such an early stage of the disease. 
These results are fairly consistent with most estimates being hardly altered. Only 
alcohol consumption is reversed so that what was a possible reduced risk is now 
increased. It is possible therefore that the inverse association observed with the 
complete dataset reflects reverse causality. Both family history, well water 
consumption and cumulative socioeconomic position now show an even stronger 
association.
187
Exposures Full dataset Partial dataset
210 cases 89 cases
OR 95% Cl OR 95% Cl
Family history of PD 2.15 (1.09 to 4.27) 3.13 (1.37 to 7.17)
contact with
dog 0.44 (0.25 to 0.78) 0.44 (0.2 to 0.98)
chicken pox 0.51 (0.32 to 0.83) 0.43 (0.22 to 0.82)
serious head
injury 3.08 (1.66 to 5.71) 3.19 (1.46 to 6.95)
smoking status
never 1.00 1.00
ex-smoker
1 to 10 0.86 (0.42 to 1.77) 1.07 (0.44 to 2.62)
10 or more 0.77 (0.43 to 1.4) 0.74 (0.32 to 1.68)
current smoker
1 to 30 0.72 (0.3 to 1.71) 0.88 (0.29 to 2.67)
30 or more 0.19 (0.07 to 0.57) 0.15 (0.03 to 0.78)
Alcohol
Never drinker 1.00 1.00
Ex-drinker 1.11 (0.41 to 3) 0.90 (0.17 to 4.71)
>0 and <10 units 0.99 (0.54 to 1.79) 1.77 (0.73 to 4.27)
>=10 0.58 (0.27 to 1.22) 1.51 (0.53 to 4.25)
insecticides 0.44 (0.25 to 0.77) 0.48 (0.23 to 0.99)
glue 0.52 (0.29 to 0.93) 0.51 (0.23 to 1.12)
paints 0.37 (0.22 to 0.6) 0.37 (0.19 to 0.73)
Well water
0 years 1.00 1.00
1-20 years 1.19 (0.64 to 2.22) 1.29 (0.57 to 2.94)
21-40 years 2.45 (1.12 to 5.38) 3.35 (1.16 to 9.62)
40 + years 2.08 (0.84 to 5.15) 3.00 (0.85 to 10.55)
Cumulative SEP
2 (most affluent) 1.00 1.00
3 0.98 (0.46 to 2.07) 0.60 (0.24 to 1.52)
4 0.83 (0.4 to 1.72) 0.54 (0.22 to 1.31)
5 0.40 (0.18 to 0.89) 0.26 (0.1 to 0.7)
6 (most deprived) 0.31 (0.12 to 0.78) 0.12 (0.03 to 0.44)
Table 60: Full multivariable models with all or just mild cases
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10. Discussion
The results for this study highlight the importance of considering exposures 
acting across the life course. Some of the results were expected and are 
consistent with the existing literature. For other exposures, the associations were 
either relatively novel or in the opposite direction to what might have been 
expected.
10.1 Main results
The main findings demonstrate associations with a wide range of variables. 
Increased risk of PD was associated with (a) a positive reported family history of 
PD, (b) head injury serious enough to cause some symptoms (c) cumulative years 
of well water consumption and (d) higher cumulative socioeconomic position. 
Decreased risk of PD was associated with (a) childhood contact with a pet dog 
(b) reported childhood chicken pox infection (c) pack years of smoking, (d) 
current consumption of alcohol, (e) exposure to insecticides (f) exposure to glue 
and (g) exposure to paints.
10.2 Limitations of current study
Before considering whether the associations noted above are causally related to 
the development of PD, it is important to consider the limitations of the study 
and in particular whether some or all of the associations reflect chance, bias, 
confounding or reverse causality.
10,2.1 Completeness o f case ascertainment
We attempted to reduce selection bias by ascertaining all early-onset cases. It 
was assumed that few early onset cases would have not been seen by a consultant
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neurologist and/or not be on any form of medication. These cases therefore 
should have been picked up by our various case ascertainment sources. 
Obviously cases who have only just developed symptoms may not yet have 
sought medical care or those who are waiting to be seen by a consultant 
neurologist may have also been missed. It is hard to empirically gauge how well 
or badly this objective was achieved and hence whether our sample of cases 
represents all such cases.
There are no empirical data from Ireland on the prevalence of PD. Assuming the 
rates are equivalent to those observed in the United Kingdom, then we can 
attempt a crude quantification. Applying the age-specific rates from a recent 
London-based survey16 to routine Census data on the age-structure of the 
population, we would have expected 93 prevalent cases under the age of 50 
years in the whole Republic of Ireland. In the study, we recruited 27 cases or 
around 29% of all cases. However, the rates for 30 to 39 and 40 to 49 year olds 
are based on only 2 cases respectively and hence are statistically very unstable. 
We would have only expected 11 cases using the lower 95% confidence interval. 
We cannot unfortunately use the rates for 50 to 59 year olds as some cases aged 
above 55 years would have been ineligible as their disease onset may not have 
been under the age of 56 years. Realistically, despite the good response rate for 
cases, it is likely that not all cases were recruited. In this case, it is possible that 
rural cases may have been more likely to have been underascertained, but this is 
speculative. Whether any selection bias could have influenced the results will be 
discussed.
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10.2.2 Completeness o f control selection
The method of control selection used a valid population sampling frame. 
However, not all eligible controls agreed to participate in the study potentially 
biasing the results. The response rate was probably in the area of between 65 to 
75%. This rate is acceptable by epidemiological standards but may still be 
problematic. No differences were observed in the response rates for urban and 
rural areas, so it is unlikely that controls were any more or less atypical in each 
area as compared to the eligible population.
10.2.3 Exposure measurement
Exposure measurement was dependent on self-reported data on either 
retrospective or current exposures. This may result in non-differential 
misclassification, which may mask “true” associations or differential 
misclassification which may produce spurious associations in either direction; 
both protective or adverse association. In hindsight, the use of flashcards for 
prompting subjects to report exposures was inappropriate as cases with more 
severe disease reported fewer items presumably due to difficulties with initiating 
speech. This would have been particularly relevant for the childhood infections 
and neurotoxic exposure list. It is likely that the apparent “protective effect” of 
some of these exposures is artefactual due to this “under-reporting bias”. This 
problem deserves highlighting in the methodological literature as it is not 
explicitly recognised. Limiting analyses to those cases with mild disease should 
overcome this problem though results in less precise estimates of risk.
Recall bias remains a concern particularly for exposures that may be obviously 
related to PD in a lay epidemiological perspective. Incorporating lay beliefs is a
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relatively new approach for controlling for recall bias, however its validity as 
compared to objective exposure data is yet to be established.
Some of the exposure measurements were based on current consumption due to 
concerns with the validity of reporting past exposure. This was relevant to 
alcohol, tea and coffee consumption. For these exposures, it is possible that 
exposure has altered secondary to the disease so that cases now consume more or 
less than they did before disease onset. Restricting analyses to cases who report 
no change in consumption or who have mild early disease should help 
differentiate any associations that are due to reverse causality.
10.3 Comparing results from current study with existing literature
10.3.1 Perinatal exposures
We failed to find any evidence to support the hypothesis that intra-uterine 
exposures could be associated with future PD risk. Neither birth weight, 
prematurity, handedness or birth complications showed any association. In fact, 
cases were if anything slightly heavier at birth. These results are consistent with 
very limited existing data which also fails to note an association. In this study, all 
the perinatal measures were self-reported and so it is possible that due to non­
differential misclassification, we have masked a true association. Until this 
hypothesis is tested using recorded data, one cannot totally reject it.
10.3.2 Contact with domestic and farm animals
PD cases were less likely to have contact with either pets or farm animals and 
this persisted even after adjustment for father’s social class, living on a farm and 
having older siblings (data not shown). These associations are unlikely to be due
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to reporting bias as there is no reason for cases to under report these exposures or 
controls to over report them. As cases were asked about each animal 
systematically there should have been no bias in relation to difficulties with 
speech production. For most of the farm animals, except exposure to chickens, 
there was no clear dose response relationship with frequency of contact; the 
pattern was more U-shaped. Both contact with a dog and contact with chickens 
remained strongly associated with a reduced risk of PD in the final multivariable 
models and were also unchanged by restricting the analyses to mild cases of PD.
These results could reflect chance but the small p-values and consistency of the 
inverse association across many similar exposures make this unlikely. The 
remarkable similarity of these results to the data from Finland198 also may further 
support the veracity of this association. In both studies no specific animal contact 
is identified as there is a general trend for reduced exposure amongst cases. 
Several possible explanations remain to be considered. A zoonotic infectious 
agent may provide some immunological priming and hence protection against 
future PD. This is highly speculative and has little support from basic science 
research. Given the association across many animals, it still remains possible that 
these exposures are indicative of another related confounding exposure.
However, adjusting for other confounders seemed to have little effect on 
attenuating these relationships. A “hygiene” hypothesis, that less exposure to 
dirty environments in early life is generally harmful is consistent with these 
results and the socioeconomic data found in this study. The Finnish study 
however failed to find much evidence for increased risk with higher educational 
level, their marker of socioeconomic position, though they did not measure
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father’s occupation. Alternatively, direct contact with animals may reflect some 
aspect of premorbid personality as cases may be less interested or willing to have 
contact with such animals. In this study, associations for contact were stronger 
than mere presence or absence of a domestic pet. However, ownership of farm 
animals is more likely to be related to familial characteristics, such as wealth, 
occupation and area of residence. In this case, premorbid personality cannot 
really explain why cases had less animals in the household, unless one argues 
that such a trait can be found across generations and hence parents of PD cases 
are less likely to own such animals. In both this and the Finnish study, any 
association, if real, supports the importance of childhood exposure and hence a 
long latency disease. Alternatively early exposure may alter immune 
responsiveness to a later exposure.
10,3.3 Childhood infections
Cases generally reported fewer childhood infections than controls. As both cases 
and controls had to affirmatively report which infection they recalled from a list 
of eight items shown on a card, one must first consider whether this association 
was secondary due to an under reporting bias in cases. The reanalysis of this 
exposure comparing mild cases (NUDS score >45-50) with controls found no 
evidence of an increased risk for measles, whooping cough or mumps (see 
section 9.10.1) though the inverse association persisted for chicken pox (few 
cases or controls reported polio or glandular fever). It is therefore likely that the 
general pattern of reduced exposure is artefactual due to biased reporting but the 
association with chicken pox remains intriguing. This association was robust to 
adjustment for other life course exposures and become slightly stronger (odds
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ratio 0.51, 95% Cl 0.32 to 0.83). There was weak evidence that amongst 
exposed cases and controls, cases may have contracted their illness at an older 
age as the odds ratio for exposure during school years was elevated in 
comparison to pre-school exposure, however this failed to reach conventional 
levels of statistical significance.
Previous studies are unhelpful due to the marked inconsistencies observed with a 
wide variety of infections. Reported odds ratios for herpes booster infection have 
varied from 1.05 to 0.73. However one point to be considered is the degree of 
misclassification across specific infections. For example, to what degree are 
childhood exanthematous infections confused by respondents? It is possible that 
the correct classification of childhood measles, rubella and chicken pox is poor 
so that one disorder is misclassified as another. If one believes that such 
misclassification may occur then it is possible that the lack of association seen in 
some studies may reflect misclassification. For example, Sasco and 
Paffenbarger341 noted the following odds ratios for measles (0.47), chicken pox 
(0.83) and German measles (1.4). It is likely that if one reanalysed these data for 
any childhood infection associated with a rash, there would be an inverse 
association as German measles is less common than the other two diseases. This 
may partially explain the discordant findings seen across studies.
10.3.4 Family size, crowding and sanitation in childhood
These variables were chosen as proxy measures of infection risk in early life. If
PD was associated with fewer or later exposure to infectious agents, then one
would have expected to show that cases were more likely to be first bom and
have better sanitary conditions. The data failed to find any birth order effect,
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consistent with the existing literature, though there was some evidence of better 
sanitary conditions as cases were less likely to report an outside toilet. This 
exposure was asked systematically to cases and controls for all recorded 
residences. This is internally consistent as cases came from slightly more affluent 
homes and would have been expected to have better sanitary conditions. The 
results however are inconsistent with those reported by Martyn and Osmond 
form a case control study in Hertfordshire. This may reflect true population 
differences in heterogeneity of exposure (reported indoor toilet was 39% for this 
study as compared to 18% for Hertfordshire study). This study examined a more 
recent birth cohort and hence indoor toilets would have been expected to be more 
common. Interestingly, the Hertfordshire study noted that cases were poorer at 
birth, yet found almost identical sanitary conditions. It is likely that further 
adjustment for social class at birth would result in a similar inverse association as 
poorer subjects would be more likely to have an outside toilet and hence there is 
a negative association between exposure (outdoor toilet) and childhood social 
class.
The positive association between boarding school and PD is intriguing and 
original. It supports the possible role of early infection but is imprecise based on 
relatively small numbers. It may clearly reflect confounding by socioeconomic 
position and requires replication before one considers it to be an important proxy 
indicator of disease risk.
10.3,5 Childhood diet
Many non-specific associations were found with childhood diet. In most cases 
these associations were weak (p-values between 0.01 to 0.05) and may simply
196
reflect chance due to multiple testing. It is possible to try and convert the simple 
food frequency data into more refined measures of macro and micro-nutrients. 
This is complex and would involve assumptions about food portions but would 
enable a better test of a specific hypothesis such as dietary anti-oxidant intake. 
However, given the problems with accurately reporting such retrospective data, 
this endeavour seems inappropriate. The poor quality of such data make it hard to 
consider any association as genuinely causal, though clearly the hypothesis that 
early diet may play a role in disease aetiology cannot be refuted from these 
meagre results.
10.3.6 Specific occupations and exposures
There was no evidence that overall cases undertook “high risk” occupations with 
any greater frequency than controls. Cases did report more occupations involving 
farming and working at a saw mill plant, but these associations were weak. These 
weak findings are consistent with the literature which finds inconsistent 
associations with these occupations.
There was no evidence that occupational exposure to either pesticides or 
herbicides was greater for cases than controls amongst subjects that ever worked 
in any high risk occupation. Similarly, there were no real differences between 
cases and controls over whether they mixed the chemicals, applied them 
themselves or used a back-pack or tractor mounted device, (see discussion for 
further comments on neurotoxic exposure).
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10,3,7 Other exposure to toxic substances
Exposure to insecticides, glues and paints were all less often reported by cases 
than controls with strong evidence against the null hypothesis. No associations 
were seen with metal exposure. These significant associations must be treated 
with caution as there was evidence that under-reporting by cases may have 
occurred due to the mode of administering the questionnaire. However, these 
inverse associations were found even amongst mild cases of PD and were 
apparently independent of a wide variety of life course exposures. These findings 
mainly contradict the existing literature which suggest if anything, that such toxic 
exposures are more common amongst cases than controls. It is possible that 
reporting of previous studies over plays positive findings due to publication bias. 
In addition, the large German case control study highlighted the dangers of recall 
bias so that cases over reported exposure as compared to classifying exposure 
based on a job exposure matrix.144
It is difficult to know how to interpret these findings as it does not seem plausible 
that exposure to such agents are genuinely protective. They are unlikely to be due 
to chance and adjustment for confounding did little to attenuate the associations. 
This only leaves the possibility that they still remain artefactual or reflect an 
underlying pre-morbid personality that is less likely to indulge in hobbies, DIY 
or leisure pursuits that involve contact with such substances. Without having any 
direct measure of such pursuits, it is not possible to explore this hypothesis any 
further.
Bell and colleagues reported an association between a shy and defensive 
personality, reduced smoking behaviour and reported illness to a variety
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xenobiotic agents including pesticides and drying paint.293 They argue that initial 
olfactory hypersensitivity in subjects prone to future PD may explain these 
observations and that cell loss may occur via over activation by endogenous 
excitatory amino acids. If this was true, then voluntary exposure to such agents 
in cases may be less common than in controls as cases would avoid such contact 
as it is more likely to produce unpleasant side effects. Whilst, occupational 
exposure may be associated with increased risk as cases cannot afford to avoid 
exposure as this is their main source of income.
10.3.8 Smoking behaviour and alcohol, tea and coffee consumption 
Cases were far less likely to have ever smoked and smoked for fewer pack years.
These results are consistent with large number of previous studies. The strength
of these associations was if anything stronger than many other studies. This is
important as it precludes the possibility of the “selective mortality” hypothesis,
which would predict that the inverse association with smoking would be absent
or weaker when tested in younger subjects.
In addition there was evidence that cases, despite being non-smokers, were no 
less or more likely to come from non-smoking households. Parental non-smoking 
was only slightly less for cases as was exposure to best friends who smoked. By 
the time cases were in early adulthood and married they were less exposed to 
smoking friends or a spouse who smoked. However, it is likely that in adulthood, 
choice of friends and/or partner may be partially influenced by similar smoking 
behaviour. This observation is helpful as it is recognised that parental smoking 
does have an influence on offspring smoking behaviour independent of 
educational level, though the latter is stronger. The CARDIA study reported that
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the odds ratio for offspring smoking associated with either parent smoking was 
1.80 (95% Cl 1.22 to 2.66) for men and 1.47 (95% Cl 1.04 to 2.07) for women 
having adjusted for age and offspring educational level.342 In the current study, 
the association between parental and offspring smoking for all subjects was only
1.10 or 0.91 for non-smoking, a much weaker association. If this is correct, it 
implies that the choice of never or quitting smoking is independent of external 
parental and probably peer influences. Like other studies, there was no evidence 
that cases who smoked prior to onset of disease and continued to smoke either 
had a later age of onset or a more benign prognosis. These results fail to support 
the “protective” hypothesis that cigarette smoking is genuinely protective, but 
given the sample size, it is not possible to exclude a mild protective effect.
The observation that cases were not more exposed to external socio-cultural 
influences for non-smoking supports the hypothesis that the inverse smoking 
association most likely reflects a pre-morbid personality, less novelty seeking, or 
some other influence such as slower metabolism so that early experimentation 
with smoking is an unpleasant experience and not maintained.
If reduced novelty seeking behaviour is associated with less exposure to agents 
such as nicotine, caffeine and alcohol then one would expect to see less exposure 
to these other substances. Cases were less likely to be heavy drinkers, however 
this was not observed when the analysis was restricted to mild cases suggesting 
that this may have been due to reverse causality. Amongst subjects who claimed 
that their current consumption was “about the same” as when they were 25 years 
old, there was an inverse dose response relationship between units per week and
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risk of PD but only weak evidence against the null hypothesis (p=0.14). The odds 
ratio for never drinking alcohol, hence avoiding any problems with reverse 
causality, for cases compared to controls was 1.67, (95% Cl 0.58 to 4.77, p=0.34) 
having adjusted for age group, gender, rurality, smoking status and cumulative 
social class. This provides some but limited support for the notion that cases 
were less likely to ever drink alcohol. Similarly there was some suggestion that 
tea consumption was less for cases but no real difference for coffee consumption. 
These results are generally consistent with the existing literature although some 
studies have found associations with coffee consumption and not with tea. It is 
unclear whether these associations reflect specific dietary constituents or an 
underlying pre-morbid personality. Again, there is no empirical way this can be 
untangled with these data though the most parsimonious explanation would 
favour the latter hypothesis.
10,3.9 Cardiovascular co-morbidity
There was weak evidence that cases were if anything less likely to report a 
history of cardiovascular disease or high blood pressure. This is consistent with 
some other studies and may be due to smoking behaviour and/or autonomic 
effects on the cardiovascular system so that PD cases may have lower blood 
pressure. The results from the Honolulu Heart Program follow-up study noted 
that a diagnosis of hypertension was associated with a slightly greater risk of PD 
(odds ratio 1.25, 95% Cl 0.68 to 2.28) though they did not present any data for 
blood pressure.148 This cohort has much older PD cases and the detection of 
hypertension by a doctor may be confounded by socioeconomic status.
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10.3.10 Head trauma
This study, like several other studies, noted an elevated risk for past head trauma. 
Because of the concerns of recall bias, we used two approaches to try and adjust 
for this. Firstly, head injuries were classified as serious on the basis of other 
symptoms. This attenuated the association. Secondly, lay beliefs of cases were 
used to exclude subjects who thought their disease was caused by a physical 
trauma. This further attenuated the association, however there was still a 70% 
increased risk. It is possible that better classification of both seriousness and lay 
beliefs may have even further attenuated these associations so that there was no 
effect. However, it can be argued that exclusion of cases who have had a genuine 
and serious head injury simply because they associate this with their disease is 
overly severe and under-estimates the true risk associated with exposure, as the 
same restriction is not applied to controls. This study adds to the existing 
literature which generally report a positive association. The failure to note a dose 
response relationship suggests a biased association but it is possible that a single 
injury amongst susceptible subjects may be sufficient to trigger a 
pathophysiological cascade of events resulting in cell death. This hypothesis still 
remains speculative.
10.3.11 Rural residence and well water consumption
No association was observed with years of rural or urban residence. There was
little evidence that rural exposure in early life was associated any differently than 
total years of rural residence. This finding is similar to other population-based 
case control studies were cases have been recruited from non-specialist centres 
and controls have been sampled from the general population. It is possible to 
explain some of the previous published studies on the basis of biased control
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ascertainment so that controls, as compared to cases, were more likely to 
represent local urban populations whilst cases came from a broader geographical 
distribution. In this study, controls were sampled on the basis of case urban/rural 
status, so that current status was partially matched. This would potentially 
overmatch controls but would prevent any selection bias and still enable 
heterogeneity in childhood residence to emerge given the inflow of rural to urban 
migrants. Despite this matching, well water consumption did show an association 
with PD. The simple associations were relatively modest (1.51 for 40 + years 
exposure) but this was further increased after adjustment for other life course 
exposures (2.08 for 40 + years). There was no simple dose-response effect but 
rather a stepped relationship so that risk only appeared to increase after 20 years 
exposure. This association is unlikely to be confounded by other factors 
associated with rural living and it is hard to imagine that classification of this 
exposure was differentially biased between cases and controls.
One possible explanation for the association between well water and PD risk is 
that cases who were bom in rural areas and hence exposed to well water were 
less likely to migrate to urban areas or lived in more distant areas so that it took 
long for mains water to reach them. Examination of rural to urban migration 
from first to last residence does not support the former hypothesis (odds ratio for 
urban migration; 1.27, 95% Cl 0.79 to 2.05).
If such an association is causal then it is remains unclear as to the exact nature of 
any aetiological mechanism. Whilst indirect exposure to pesticides or herbicides 
has been suggested, most of these toxic substances have only been introduced
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relatively recently in Ireland so that exposure would be short term rather than 
cumulative. It is possible that subjects with more than 20 years well water 
exposure are actually those who have continued to consume the water in more 
recent times. Another more plausible explanation is that inorganic metals or 
sulphur compounds, at relatively low levels, contaminate this water and result in 
long term damage. There is no doubt that variations exist in the quality of 
ground water. A Canadian survey in Alberta noted that 32% percent of 816 farm 
water wells exceeded the recommended guidelines for Canadian drinking water 
quality.343 A detailed study of 41 subjects exposed to up to 40 years of well water 
with high manganese levels, however, failed to find any evidence of neurological 
deficit compared to a control group.344 However this sample may not have had a 
sufficient number of susceptible subjects and more subtle methods, such as PET 
scanning, may have demonstrated less marked sub-clinical deficits. Perhaps 
coincidentally, but intriguingly, rainbow trout who are exposed to sublethal 
copper in their water supply exhibit abnormalities of olfaction which are partially 
reversible after removal of the copper.345 Olfactory abnormalities have also been 
observed in PD cases, due to a supposed dopaminergic deficiency in the 
olfactory tubercles, and may even be present in subjects with early or pre-clinical 
disease.346’347
10,3.12 Cumulative socioeconomic position
This study found an inverse association between cumulative socioeconomic 
position and risk of PD so that cases grew up in more affluent childhood homes 
and were more likely to be of higher socioeconomic position in adulthood. 
However this pattern was mainly driven by childhood socioeconomic position as
|
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the differences in adulthood were small. In fact, cases were less educated than 
controls and less likely to own their home or car.
Most studies show either little social gradient or an inverse association but few 
have reported childhood circumstances. Retrospective measurement of paternal 
education and socioeconomic status has been shown to be reliable.348
The results from this study directly contradict that reported from the 
Hertfordshire study , which found weak associations but in the opposite 
direction i.e. cases were more likely to come from poorer backgrounds. It is 
possible that both results merely reflect chance differences across population. 
Alternatively, one must consider the role of selection bias. It is common that case 
control studies recruit more potential cases than controls. This is because cases 
have more motivation to take part in the research as the investigators are 
studying their disease. Controls have no direct benefit other than the altruistic 
motive of helping research. Where the demands on the controls get greater, for 
example having to be interviewed, controls are likely to be more selectively 
biased. In general terms, such selection will favour women and more affluent 
control subjects, 349,35() whilst cases are likely to be more representative of the 
true epidemiology of the disease. Under these circumstances, it is likely that the 
socioeconomic position of controls will be greater than cases and hence cases 
will appear poorer. In the Hertfordshire study both cases and controls had 
excellent response rates but cases were 14% more likely to be included (case 
response rate 92% versus control response rate 78%). In this study the response 
rates were more equivalent with around 70% of both cases and controls talking
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part. This may explain why the measures of adult socioeconomic status were 
fairly similar, though controls were slightly more educated.
Assuming the results from this study reflect the true risk associated with 
socioeconomic position, then in broad terms this result would favour an infective 
hypothesis as more affluent subjects are less likely to be exposed to an infective 
agent or at a later age. It is less compatible with an occupational neurotoxic agent 
though one cannot exclude a common substance. Similarly, a dietary anti-oxidant 
hypothesis is less supported as one would expect more affluent subjects to 
consume more fruit and vegetables.
10,3.13 Family history
Unsurprisingly, cases reported a greater risk of a first degree relative having 
either PD or tremor. Without personal examination of relatives for both cases and 
controls, it is impossible to estimate how much of this is true and/or reflects 
recall bias. There was no evidence of greater maternal than paternal cases failing 
to support the role of mitchondrial transmission. The association of tremor was
stronger than that for PD. This may reflect diagnostic misclassification so that 
some cases of PD were classified as “tremor” as there was almost an equal 
number of cases of tremor as PD reported for parents. One would have expected 
in the older parental group, that more cases of PD would have been reported than 
benign essential tremor. It is likely that some parental cases of tremor were 
indeed PD but had not been diagnosed. A positive association was also seen with 
a family history of thyroid disease. It is hard to evaluate this and it could be a 
type I error given the multiplicity of associations. It is also possible that some of 
the cases of tremor may have been due to thyrotoxicosis. One previous Spanish
206
case control study noted an elevated odds ratio for thyroid disease (4.14, 95% Cl
0.21 to 246) but this was only based on very small numbers.247 One small study 
measured thyroid function in 46 patients with PD and 46 age and sex matched 
controls. Whilst there were no differences in T4 or T3 uptake, it noted that 3 of 
the 46 PD cases were hypothyroid compared to none of the controls (difference 
of 6.5%, 95% Cl -1 to 13.7%, p=0.08). They hypothesis that cell death in PD 
may reflect an autoimmune mediated process is not new and some supporting 
evidence exists to support this idea. " The possible association with thyroid 
disease clearly requires further replication before it assumed to be of any causal 
significance.
There was no evidence that either parents or siblings of cases had any less risk of 
developing cancer. This is a useful observation as it suggests that reduced risk of 
cancer seen in PD cohorts does not reflect any underlying protective 
pathophysiological mechanism but rather reflects less smoking behaviour 
amongst PD cases.
There was also no evidence that parents of PD cases died at any younger age 
than controls. This refutes any simplistic model that PD is somehow linked to 
generic “ageing genes” as it would have been predicted that parents of cases 
should have had worse survival than control subjects.
10.4 Future work extending current hypotheses
These results add to the growing body of observational data on the epidemiology 
of PD. Like much observational epidemiology, there are often conflicting results
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from different studies. Most of these differences reflect a combination of chance 
and methodological variations. However, true heterogeneity can be aetiologically 
useful. It may point out important differences in the underlying confounding 
structure between exposure and disease outcome. Alternatively, there may be 
different temporal and/or sociocultural differences in the meaning of an 
exposure. For example, it is very likely that well water consumption in different 
populations and different time periods captures different specific exposures. 
Hence, the failure to replicate positive associations across studies may not be 
artefact but true differences in water composition. Similarly, pesticide exposure 
may be genuinely associated with PD risk if the type of agents, dose and mode of 
administration, and genetic pool of susceptibles differ across studies.
Many of the limitations inherent in case control studies can be overcome by 
cohort studies or high quality incidence studies using selected populations. For 
example, if well water truly increases the risk of PD, one would expect the 
incidence of PD to be greater in rural communities who consumed well water in 
the past as compared to a stable urban community, excluding rural migrants. 
Similarly, large occupational cohort studies of workers exposed to pesticides 
and/or herbicides should identify an increased risk of PD compared to an 
appropriate control group of manual workers not exposed. Both groups would 
require clinical examination by neurologists blinded to occupational status to 
avoid any detection or recall bias that may occur if simple questionnaire follow- 
up was used.
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The results from this study suggested that many of the reported associations 
could be due to a pre-morbid personality which in turn determines the likelihood 
of contact with animals, smoking behaviour and domestic exposure to toxic 
substances. It is not possible to test such a hypothesis with a randomised 
controlled trial design. We are therefore forced to examine this with 
observational studies such as large cohort studies with prospective measures of 
personality and unbiased measures of outcome.
10.5 Conclusions
Epidemiological research on PD has flourished over the last thirty years. 
However many findings are still tentative or inconsistent. Future work will need 
to build on these observations and find new methods to improve measurement of 
exposure, and using specific cohorts of interest. Our growing understanding of 
both the basic pathology and the possible role of genetic factors suggests that 
certain sub-groups of the population may be more susceptible to potential 
environmental factors. Epidemiologists will need to work collaboratively with 
laboratory-based researchers in an attempt to disentangle the relative importance 
of each risk factor and examine for potential interactions. There is little doubt 
that PD and other neurodegenerative diseases will increase in importance over 
the next few decades as the population continues to age and many of the other 
important causes of morbidity continue to decline.357 We are faced with a 
growing challenge in understanding what modifiable environmental factors exist 
to reduce the future burden of disease risk if we are to answer the question posed 
by James Parkinson.
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12. Appendices
12.1 Appendix 1: Variations in mains water supply for counties in Ireland
Percent mains Percent mains
urban aggregates* rural aggregates
Province/
county
1946 1961 1971 1946 1961 1971
Total 91.8 96.1 98.3 8.6 12.5 27.0
Leinster 94.2 97.6 98.1 11.6 12.6 29.5
Carlow 75.6 88.6 95.9 4.7 7.3 24.8
Dublin city 98.7 99.6 99.6 N/A N/A N/A
Dun Laoghaire 99.0 99.8 99.6 N/A N/A N/A
Kildare 68.0 84.5 94.7 7.5 17.7 39.0
Kilkenny 86.0 98.8 98.6 8.2 14 .4 33.7
Laois 62.4 86.6 95.9 7.8 12.2 30.3
Longford 58.9 94.7 98.1 2.5 9.6 28.9
Louth 86.8 94.6 98.4 7.5 11.9 31.5
Meath 78.0 86.1 88.4 6.5 6.4 13.2
Offaly 64.2 83.7 93.8 3.2 8.8 28.1
Westmeath 85.0 94.5 96.4 3.6 9.4 21.2
Wexford 80.3 89.6 95.5 6.8 6.7 27.1
Wicklow 92.0 95.6 98.3 16.9 22.2 36.4
Munster 87.9 95.1 97.6 9.8 14 .4 31.4
Clare 67.5 87.7 95.5 6.0 13.4 20.7
Cork city 98.8 99.7 99.0 N/A N/A N/A
Cork co. 80.6 90.6 94.9 13.2 16.9 34.8
Kerry 82.3 93.5 97.7 8.5 12.6 31.3
Limerick city 99.2 99.1 99.4 N/A N/A N/A
Limerick co. 45.0 81.7 92.4 11.0 14.9 29.7
Tipperary North 75.0 88.9 95.7 3.9 6.1 19.1
Tipperary South 80.7 94.7 97.1 4.8 11.9 41.8
Waterford city 93.2 99.4 99.4 N/A N/A N/A
Connacht 83.9 92.9 96.7 5.2 8.7 17.7
Galway 82.7 91.3 97.1 4.3 7.5 16.2
Leitrim N/A N/A N/A 7.2 13.3 24.3
Mayo 80.1 91.6 94.0 4.7 7.5 15.0
Roscommon 67.8 90.2 95. 9 5.3 7.4 16.0
Sligo 97.0 99.0 99.0 6.7 12.0 25.2
Ulster 
(part of)
83.4 95.3 98.1 5.4 13.9 25.3
Cavan 73.7 94.1 94.7 3.7 13.0 19.2
Donegal 87.6 94.9 97.3 7.6 17.9 34.2
Monaghan 85.6 96.1 98.1 2.4 4.6 10.4
* Data stratified by urban or rural aggregates from the 1946, 1961
and 1971 censuses. CSO definition of urban is a population cluster 
greater than 1500 inhabitants
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12.2 Appendix 2 - Case questionnaire
Serial Number
+ ----------------------------------------- +
I I I I II l I I I
+------------------------------------- +
EARLY-ONSET PARKINSON S DISEASE STUDY
Conducted by the Department of Community  
Health, Trinity College, Dublin
CONFIDENTIAL
+-- --+
CC status Case 1 l1 11
Control 2 1t I1
+-- --+
People present at interview
spouse 1 +-- --+
sibling 2 11 II
other family relative 3 11 11
non-family friend/carer 4 +-- --+
only case present 5
other ....................... 6
Time interview 
Time interview
Interviewer
q ] - a  r-t-
(durn 
-|-----------------
in mins)
finished ........... I 1 1 1
+----------------
+----
i
i
------------+
YBS 1 11 ii
FF 2 I1
+----
i
i
------------+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[247]
INSTRUCTIONS FOR INTERVIEWERS
Before beginning the interview please discuss the following points:
(1) Because it is very importanat that we ask everybody we interview the 
questions in the same way, we will be reading out all the questions in a standard 
fashion.
(2) Many of the questions refer to early childhood and therefore they should not 
worry if they can't remeber the answers. There are no right or wrong answers.
(3) For some questions, we will show you a card from which we want you to choose 
the category that most accurately reflects the answer for you.
(4) All the data is strictly confidential and no individuals we be indentified. 
All explain why we are taping some interviews and ask permission if appropriate.
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[248]
Parkinsonian History (Section 1)
I would like to start off by asking you some 
questions about the Parkinson's disease.
1.1 What were the first symptoms you noticed 
with your Parkinson's disease?
L e t  th e  ca se  respond  s p o n ta n e o u s ly  and mark a p p r o p r ia te  
d e s c r i p t o r
cannot remember 1st symptom 99
unilateral tremor (hands or legs)
left side 1
right side 2
bilateral tremor (hands or legs) 3
left side worse 4
right side worse 5
equally bad 6
difficulty or abnormality in walking 7
general slowness 8
difficulty initiating movement 9
difficulty turning 10
loss of dexterity 11
change in handwriting 12
change in voice 13
drooling 14
loss of arm swing 15
loss of facial expression 16
other (please specify)____________________  17
Add in  i f  n e c e s s a r y  "Am I  r i g h t  in  s a y in g  t h a t  y o u r  f i r s t  
symptom was ............."
1.2 Can you tell me when you or others first noticed this 
symptom? Prompt f o r  month o r  season  o f  d i a g n o s i s . I f  th e  
case  canno t  r e c a l l  th e  m o n th /sea so n  s im p ly  r e c o r d  th e  y e a r .
month: or season winter
autumn
13
15
spring
summer
14
16
Year:
1.3 (a) Can you tell me when you were diagnosed as having 
Parkinson's Disease. Prompt f o r  month o r  season  o f  
d ia g n o s i s  (NOT SIMPLY SEEN BY A DOCTOR)
(Code 99 99 i f  m is s in g )
month: or season winter
autumn
13
15
spring
summer
14
16
Year:
Check what th e  gap betw een  f i r s t  symptom and d ia g n o s i s
1.3 (b) So there was ______  years/months between your
first symptom and being diagnosed (code in months)
+-------
1
------- -1-
1 11
+-------
1 1 
------- +
- 
+ 1 1 1 1 ------- +
1 11
+-------
1 1 
------- +
+-------
1 1
------- +
 11 t 
+-------
1
------- +
+-------
1 1
------- +
11 1 
+-------
11
1
------- +
11
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[249]
1.4 (a) Have you ever seen any of these neurologist? 
(Show Card A) I f  case  has seen more than one o n ly  re co rd  
t h e i r  c u r r e n t  n e u r o lo g i s t
N.C. 1 R.G. 2 H.H. 3 !---- +------- +
M.H. 4 E.M. 5 J.M. 6 ! ! ! !
R.M. 7 S.M. 8 H.S. 9 !---- +------- +
II
Other 10 Never seen neurologist 11 !
II
I f  NEVER f o l l o w  w ith  1 .4  (h) e l s e  go to  1 .4  (c) \
1.4 (b) Is your PD cared for by your general practitioner |
or a hospital consultant ! +-----+
G.P. 1 ! ! !
Consultant 2 ! ! !
! +---------------- +
1.4 (c) Are you still under their care, that is do you have !
a regular appointment to see them in their clinics, or do !
you only see them when necessary? (If they s a y  n e v e r  s e e  \
them code as  2) !
I + -------------------------+
Regular 1 1 !  !
As necessary 2 | | !
I f  REGULAR ! +---------- +
1.4 (d) How often do you see them? !
Do you have  a f u t u r e  a ppo in tm en t?  !
; + ------------------ +
months:_ ! ! ! !
j +--------------+
I f  AS NECESSARY
1.4 (e) How long ago is it since you last saw them?
months:
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[250]
1.5 (a) Have you ever been on any of these drugs?
Show card  B. I f  more than  one drug  i d e n t i f i e d  ask  
"Which one o f  t h e s e  d ru g s  d id  you ta k e  f i r s t ? "
Yes 1
No 2
I f  NO go to  1 .6  (a)
1.5 (b) When you were first started on the .....
did you notice a
marked improvement 1
moderate improvement 2
mild improvement 3
or no improvement 4
N/A 8
D/K 9
in your symptoms?
(N/A i f  d ia g n o s i s  made i n c i d e n t a l l y  and p a t i e n t  had no 
symptoms)
1.6 (a) Six months before you developed your first symptoms 
were you taking any regular medication or receiving 
injections
Yes 1 l1 11
No 2 I1 11
D/K 9 +----- -----+
I f  YES
1.6 (b) Can you remember the name of the tablets or 
injections and why you were getting them
Probe i f  p a t i e n t s  s a y s  f o r  n e r v e s  o r  m en ta l  p rob lem s ask  
"Was t h i s  f o r  a n x i e t y , a d e p r e s s i v e  i l l n e s s  or  
s c h iz o p h r e n ia ? "
Drug Name (only code this) Reason for medication
1.7 (a) Did any of the doctors who have 
ever mention a cause for your illness.
1
dealt with your PD !
11
1
t I 
+---------
I I 1 
-----+
Yes
1
1 ! +-- --+
No 2 ! II II
D/K 9 ! ll Il
I f  YES 1i +-- --+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[251]
1.7 (b) What did they think it was and how long was the 
period between .......  and your first symptoms?
Agent How long before onset
in months
+----++---- +
1 1 II 1 1 1 1 II 1 1
1 1 II 1 1 1 1 II 1 1
♦---- + +---- +
1.8 (a) Were you ever diagnosed as having sleeping sickness
or "encephalitis", that is an inflammation of the brain,
when you were a child?
Yes 1 +-----+
No 2 1 1 1 1
D/K 9 1 1 1 1
I f  YES ♦-----+
1.8 (b) How old were you when you were ill?
+--------+
age: 1 1 1 1 1 1
+--------+
1.9 Have you ever had episodes when your eyes are not under
your control and are either starring up to the ceiling or
down at the floor for no apparent reason for minutes or
hours?
Yes 1 +-----+
No 2 1 1 1 1
D/K 9 1 1 1 1
♦----- +
1.10 (a) Did the P.D. develop suddenly or gradually
over a period of time ( i f  s u d d e n ly -p ro b e  i f  o v e r n ig h t )
suddenly 1 +-----+
gradually 2 1 1 1 1
D/K 9 1 1 1 1
+-----+
1.10 (b) Would you say that the disease has progressed
since you first developed symptoms? ♦----- +
Yes 1 1 1 1 1
No 2 1 1 1 1
I f  YES ♦----- +
1.10 (c) Has it progressed in a stepwise fashion, or in
a fairly gradual fashion? ( I f  n e c e s s a r y  d e f i n e  " s te p w is e "
as r e m a in in g  c o n s ta n t  f o r  p e r i o d s  then  fo l lo w e d  b y  a
sudden d e t e r i o r a t i o n ) ♦----- +
stepwise 1 1 1 1 1
gradual 2 1 1 1 1
D/K 9 ♦-----+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[252]
Personal History (Section 2)
I am now going to ask you a series of questions about
your life, for example where your were born and your
family.
2.1 Code se x  o f  s u b je c t  w i th o u t  a s k in g  q u e s t io n +-----------+
Male 1 1 1 1 1
Female 2 1 1 1 1
+-----------+
2.2 (a) Would you describe yourself as right, left handed
or ambidextrous?
Right 1 +-----------+
Left 2 1 1 1 1
Ambidextrous 3 1 1 1 1
+-----------+
2.2 (b) Would you use the right or left limb to do the
following activities:
( I f  th e  s u b j e c t  sa y s  th e y  do n o t  do any o f  th e  a c t i v i t i e s
now, a sk  "What abou t  in  th e  p a s t " )  (Add up no. of tasks
done with R score from 0-3)
write with a pen R L +-----------+
kick an object R L 1 1 1 1
lift a magnifying glass 1 1 1 1
to your eye R L +-----------+
2.3 (a) What is your date of birth?
(code 99 f o r  m i s s in g  data)
day month year
i ___ _l_
1 1 1 1 1 1 1 1 l 1 1 1 l 1
_i_ i
i r
1 1 1 1 1 1 1 1 1 1 1 1 l 1
i _ _ __ 1T i
2.3 (b) What was your age at your last birthday
C a lc u la te  f o r  s u b j e c t  i f  n e c e s s a r y
+-----------------+
age: 1 1 1 1 1 1
+-----------------+
2.4 When you were born was your family home
owned, with or without a mortgage, 1
rented from the council 2 +-----------+
rented from a private landlord 3 1 1 1 1
rent-free as part of the job 4 1 1 1 1
or you can't remember 9 +-----------+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[253]
2.5 (a) What was your father's name (Both first and surname)
father's name:
2.5 (b) What did you father do for a living when you were 
a child?
I f  f a t h e r  had d ie d  j u s t  p r i o r  to  b i r t h  a sk
what was y o u r  f a t h e r ' s  l a s t  j o b  p r i o r  to  h i s  dea th
Title of job:
I f  u n c le a r  add in  "what p o s i t i o n  d id  he have in  t h i s  jo b ? "
or  "what k in d  o f  work d i d  he do?"
position/ activity:__________________________
2.5 (c) Did your father have any special apprenticeship 
or higher qualifications
( I f  th e  answer i s  o b v io u s  a sk :  Am I  r i g h t  in  t h in k in g  
t h a t  he had to  have s p e c i a l  q u a l i f i c a t i o n s  to  be a ............ )
No special training 
Apprenticeship
Certificate, degree, diploma etc. 
D/K
2.6 (a) Was he running his own business or working for an 
employer?
Self-employed 1
Working for an employer 2
D/K 9
I f  he was SELF-EMPLOYED
2.6 (b) Did he employ anyone else excluding his own 
family?
Yes 1
No 2
D/K 9
I f  h i s  main a c t i v i t y  was as a fa rm er  and he was n o t  working  
f o r  an em ployer  ask
2.6 (c) Did he own his own farm and if so how large was the 
size of the farm? Was it
under 30 acres 1
30-49 acres 2
50-99 acres 3
100-199 acres 4
200 or more acres 5
D/K 9
+ -------------------------------- +
I I I  l1 1 1 * 1
+ -------------------------------- +
SEG (derived)
+ -------------------------------- +
I I I  I1 1 1 * 1
+ -------------------------------+
social class
+-------+
l II l
+-------+
+-------- +
l II I
I Il l
+-------- +
+-------- +
I II I
I II I
+-------- +
+-------- +
I li l
I II l
+-------- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[254]
2.7 (a) Can you remember whether you were born in home 
or hospital?
home delivery 1
hospital delivery 2
D/K 9
I f  HOSPITAL "can you remeber th e  name o f  th e  h o s p i t a l ?  
hospital:_____________________________
2.7 (b) Did you know how old your mother was when you were 
born?
age:
2.7 (c) Can you remember or were you ever told how much you 
weighed when you were born?
Yes
No
birthweight 
I f  NO
2.7 (d) Do you recall whether it was mentioned that you 
were
average weight 1
less than average 2
more than average 3
D/K 9
2.8 As far as you know, were you born early or prematurely 
or around the normal time?
early 1
normal 2
D/K 9
2.9 (a) Was your mother ill at all with your pregnancy
I f  YES
Yes 1 +-- --+
No 2 11 11
D/K 9 l1 11
+-------- +
I II I
I II I
+ ---------------4-
lbs ounces 
+---------------
I I I II I l I
+---------------
+-------- +
l II I
I II I
+-------- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[255]
2.9 (b) can you describe what the problem was
Pre-ecalmpsia 1 eclampsia 2 infection 3 
possible miscarriage 4 Antepartum haemorrhage 5
post-partum haemorrhage 6
2.10 (a) Where there any problems with the delivery
long labour, normal delivery 1 breech 2 
forceps/vacuum 3 Caesarian Section 4
School Years (Section 3)
Animal contact
3.1 Did you ever have any pets as a child such as a 
I f  YES Probe: d i d  you  have  p h y s i c a l  c o n ta c t  w i th  th e  
t h a t  i s  s t r o k e  o r  p e t  i t .
Y
No pets
Dog
Cat
Birds (pigeon, budgie) 
Rabbit
Other please specify
contact
Y
1
1
1
1
Yes 1 +-- --+
No 2 11 11
D/K 9 11 11
+-- --+
I f  YES
+-- --+
2.10 (b) can you describe what the problem was 11
1
11
1
delivery problem:
1
+-----
1
-----+
3.2 (a) Did you ever have any physical contact with these 
farm animals as often as once a year as child?
(Show card  C)
Yes 1
No 2
+ + + +
+-----
+ +
+ +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[256]
If YES
(Show ca rd  D)
3.2 (b) From this card, could you please say how often you 
came in contact with
Horses Cows Pigs Sheep Chickens Other
less than once a year 1 1 1 1  1 1
1-2 times a year 2 2 2 2 2 2
1-2 times a month 3 3 3 3 3 3
a few times per week 4 4 4 4 4 4
once a day 5 5 5 5 5 5
+----- +
i ii i
+------!
i ii i
i ii i
i ii i
i ii i
+------1
i ii i
+----- +
Past Dietary History
I would like to ask you about some of the foods you 
may have eaten as a child between the ages of 5-15 years.
3.3 From the card could you say how often in a typical
year in your childhood you would have eaten the following 
vegetables. For seasonal vegetables, how often when the 
vegetable was in season.
(Show card E)
Coding i s  as  f o l l o w s :
n e v e r  o r  < than once a m onth= l, at  l e a s t  lx /m o n th  = 2,  
a t  l e a s t  lx /w e e k = 3 , a t  l e a s t  l x /d a y = 4 , D/K=9
< 1 m
Broccoli
Brussels sprouts
cabbage
carrots
cauliflower
green beans, broad
beans or runner
beans
leeks
lettuce
marrow or
courgette
mushrooms
onions
peas
potatoes
spinach
tomatoes
turnips
lx/m
2
2
2
2
2
lx/w
3
3
3
3
3
lx/d D/K + +
+----- +
+----- +
+ +
+ +
+ +
+ +
+ +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[257]
3.4 Again in a typical year in /our childhood how often
would you have eaten the following fruit. For seasonal
fruit such as strawberries, estimate your average use
when the fruit is in season (use card  D)
< 1 m lx/m lx/w lx/d D/K +— — +
apples 1 2 3 4 9 ii +-------+
bananas 1 2 3 4 9 +— — i i i i
grapefruit 1 2 3 4 9 ii +-------*
oranges 1 2 3 4 9 +— — i i I l
peaches 1 2 3 4 9 ii +------- j
plums 1 2 3 4 9 +— — I l 1 l
raspberries 1 2 3 4 9 ii +------- !
strawberries 1 2 3 4 9 +— — +! !
+ +
Educational and occupational history (Section 4
4.1 (a) At what age did you leave school? 
age: 
4.1 (b) Did you ever
go into an apprenticeship 
go onto third level education 
go into any further training 
other
no further education
+  +
+ +
+ +
+ +
I would like to ask you a few questions about the jobs you 
have had over the years
4.2 (a) Are you currently employed?
Yes
No
I f  YES go to  q u e s t i o n  4 .3  (a)
I f  NO
4.2 (b) Could you tell me what is the main reason that you 
are unemployed
L e t  s u b j e c t  r e sp o n d  s p o n ta n e o u l s y  and code re sp o n se
+ +
+ +
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you cannot work/retired because of the P.D. 1 !
you cannot work because of another illness 2 !
you are prevented by temporary sickness !
from seeking work 3 ! +----- +
you cannot find a job but you are seeking work 4 ! ! I
you are retired (but not because of ill-health 5 ! ! !
you are waiting to take a job, which you ! +----- +
have already accepted 6 !
(Females o n ly )  \
you are occupied as a housewife 7 !
you have sufficient income from other sources ! +------------- +
and do not need to work 8 ! ! ! ! • !
any other reason __________________________  9 ! +--------------+
! SEG (derived)
I +------------------------------+
4.3 (a) What would you say has been your main occupation ! ! ! ! • !
over the years, that is the job you held longest? ! +------------- +
j social class
Title of job:___________________________  ! +-----+
! +  +
4.3 (b) Is this your current job or the last job you had? !
J + -------+
current/last job 1 1 !  !
previous job 2 | ! i
| +------ +
I f  u n c le a r  add in  "What p o s i t i o n  d o / d id  you h o ld  in  t h i s  \
j o b ? ” !
position/activity:_______________________  !
Il
4.3 (c) Do/did you supervise other workers? ! +-----+
Yes 1 ! !
No 2 ! ! !
• +-------- +
4.3 (d) Are/did you run(ning) your own business or work(ing)! +-----+
for an employer? ! i i
Self-employed 1 1 !  j
Working for an employer 2 !---- +----- +
II
I f  SELF-EMPLOYED !
4.3 (e) Do/did you employ anyone else excluding your own i
family? j +-----+
Yes 1 ! ! i
No 2 | | !
I + -----------+
I f  main a c t i v i t y  i s /w a s  as fa rm e r  a sk  I
4.3 (f) How large is/was the size of the farm I +-----+
under 30 acres 1 30-4 9 acres 2 \ \ \
50-99 acres 3 100-199 acres 4 ! ! |
200 or more acres 4 D/K 9 !---- +----- +
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+ ++ +
Yes
No
+ +-----
4.4 (a) Have you ever had any of the following occupations 
in the past? (show card F)
YES
farmer
farm labourer 
gardner, landscaper 
or other horticultural job 
road worker
chemical industry worker 
saw millworker 
carpenter or wood-worker 
paper or pulp mill worker 
builder, painter or decorator 
metal worker
NO
2
Years
If NO to all above and not FARMER or GARDNER go to 
question 5.11 (a) box of asterixes
I f  YES fo l l o w - u p  w ith
4.4 (b) How many years were you a .....
I f  YES to  any o f  above e x c e p t  FARMER/GARDNER e t c .  a sk  
f o l l o w i n g  q u e s t i o n s
4.5 (a) Were you exposed to any chemicals or noxious 
substances in your job as a ......
+ +-----
+  + ------
+ + -----
+ +-----
+  + ------
+ ++ + +
I f  YES
4.5 (b) Can you remember the name of the substance and how 
many years were you exposed
chemical no. of years
+ ++ +
+ — + —
4.5 (c) Did you use any protective clothing or equipment 
when mixing or applying the herbicide such as rubber masks 
or gloves
substance
substance
substance
+ — + —
+  + +  +
+  +
+  +
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I f  YES to  FARMER or  GARDNER e t c .  e i t h e r  as main 
o c c upa t ion  from q u e s t i o n  4 .3  (a) or  q u e s t i o n  above  
ask  f o l l o w i n g  q u e s t i o n s
Else go to question 5.11 (a)
Pesticides and other chemicals (section 5)
5.1 (a) Did you use herbicides, that is weed killers or 
defoliants?
Yes 1
No 2
I f  YES
5.1 (b) Can you tell me the names of any herbicides you 
have used and for how many years you have been using them
Herbicide Years use
5.2 (a) Did you usually mix the herbicide or was it mixed 
by someone else?
yourself 1
someone else 2
5.2 (b) Did you usually apply the herbicide or was it 
someone else?
yourself 1
someone else 2
I f  YOURSELF to  e i t h e r  q u e s t i o n  5 .5  (a) o r  q u e s t i o n  5 . 5  (b) 
ask
5.3 Did you use any protective clothing or equipment when 
mixing or applying the herbicide such as rubber masks or
gloves Yes No
Substance 1 1  2
Substance 2 1 2
Substance 3 1 2
Substance 4 1 2
5.4 How was the herbicide applied? Was it using
backpack or handsprayer 1
tractor mounted or mist blower sprayer 2
another method 3
+-------- +
I II I
I II I
+-------- +
+-------+ +----------- +
I I I I I II I I I  I • I
I I I I I II I II I • I
I I I I I II I II I • I
+-------+ +----------- +
+-------+ +----------- +
I I I I I II I II I • I
+-------+ +----------- +
+-------- +
I II I
I II I
+-------- +
+-------- +
I II I
I II I
+-------- +
+ +
+ +
+-------- +
I II I
I II I
+-------- +
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5.5 How many acres would have been treated with herbicides?
No. of acres
5.6 (a) Did you use any insecticides or pesticides on the 
land?
Yes
No
I f  YES
5.6 (b) Can you tell me the names of any insecticides or 
pesticide you have used and for how many years you have 
been using them
Insecticide 
or pesticide
Years use
5.7 (a) Did you usually mix the insecticide or pesticide 
was it someone else?
yourself 1
someone else 2
5.7 (b) Did you usually apply the insecticide or pesticide 
or was it someone else?
yourself 
someone else
I f  YES t o  e i t h e r  q u e s t i o n  5 . 6  (a) o r  q u e s t i o n  5 . 7  (b) 
a s k
5.8 Did you use any protective equipment when mixing 
or applying the insecticide or pesticide such as rubber 
masks, gloves etc.
Yes No
Substance 1 1  2
Substance 2 1 2
Substance 3 1 2
Substance 4 1 2
5.9 How was the insecticide or pesticide applied? Was it 
using
backpack or handsprayer 1
tractor mounted or mist blower sprayer 2
another method 3
+------- ++----
+------- ++----
+------- ++----
+------- ++----
+ ++----
+ ++---
+ +
+ +
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5.10 How many acres would have been treated with insecticide 
or pesticides?
No. of acres
************************
* CONTINUE INTERVIEW * 
************************
5.11 (a) Have you ever in your life used or come in contact 
with any of the following substances more than twice a year 
(Show card G)
Yes 1
No 2
If YES
5.11 (b) Can you tell me the names of any of these 
substances.
Code group of substance 
and write name if known
5.11 (c) How often would you say you came into contact 
with the ...........  (1) (2) (3) (4) (5)
1-2 times a year 1 1 1 1 1
1-2 times a month 2 2 2 2 2
a few times per week 3 3 3 3 3
once a day 4 4 4 4 4
5.11 (d) How many years were you exposed to ....
If exposed rarely <=l-2x/yr ask On how many occasions were 
you exposed to ....
years for 
years for 
years for 
years for 
years for
5.11 (e)
(1)
(2)
(3)
(4)
(5)
Did you use any protective clothing or equipment 
such as rubber gloves, masks when coming into contact with 
the .............
(1) (2) (3) (4) (5) 1 J _ _ _ _ _ _ _ _ _ _ _ _ 1 1 11 ' I I  1
Y Y Y Y Y : i ! +--- +
N N N N N i +— +
--+
ii
ii
--+
+—  
i
--+
i ii
+--
-L.
i i
--+
ii
ii
_i_
i I i i
i
i _ _ _
r
i
i 1 1i
+--
I 1 
--+
+--
i |
--+
1 1i i 
+--
1 1 
--+
+--
i i
--+
1 1i i 
+--
1
--+
+—+
+—
+—
+—+
+—
+—+
+—+
+-------+—+
+ +
+ +
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5.12 (a) Have you ever come into contact with any of 
the following heavy metals as either part of your job 
or at home more than twice a year (show card H)
Yes No
Lead
Mercury
Zinc
Manganese
Copper
Aluminium
Other
5.12 (b) How often would you say you came into contact 
with the ...........  (1) (2) (3) (4)
less than once a year 1 1 1 1
1-2 times a year 2 2 2 2
1-2 times a month 3 3 3 3
a few times per week 4 4 4 4
once a day 5 5 5 5
5.12 (c) How many years were you exposed to ....
years for (1) 
years for (2) 
years for (3) 
years for (4)
5.12 (d) Did you use any protective clothing or equipment 
such as rubber gloves, masks when coming into contact with
the ............... Yes No
substance 1 1  2
substance 2 1 2
substance 3 1 2
substance 4 1 2
* ★★★★★★•A-**************************************************
* Now go to RESIDENTIAL HISTORY sheet at the back and ask*
* the questions on sanitation and water supply *
'k'kr'k'k'k'k'k'k'k'k'k'k'ic'k'k'k'k'k'k'k'ie'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'k'ic'k'k'k'k'k'k'k'k'k'k'k'k'k
+----- +
I II l
I II I
I II I
l lI I
I II I
I II I
I II l
+----- +
+----------+
I i I I II l l I I
+----------------+
+------ + +
I I Il l • I
+— ! — ! —!
i i ii i • i
+— ! — ! — !
i i ii i • i
+—  J —  J —  |
i i i
i i * i 
+ ------------+ — +
+----- +
i ii i
i ii i
i ii i
i ii i
+----- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[264]
5.12 (e) Were any of your homes within a 5 mile radius of a 
large industrial area or factory?
Yes 1
No 2
If yes, note the no. from the back of the residence and 
ask what product the factory produced no. resid.
Travel abroard (Section 6)
6.1 Did you ever travel abroad for a holiday or
spend a period living abroad from birth until the age of 
thirty?
Yes 1
No 2
D/K 9
I f  YES
6.2 (a) Was this before you started school?
Yes 1
No 2
I f  NO go to  q u e s t i o n  6 .3  (a) o t h e r w i s e  c o n t i n u e  
(Show ca r d  J)
6.2 (b) From the card, could you say which parts of the 
world you visited before you started school?
If you are not sure which is the correct category, just
mention the name of the country.
6.2 (c) How many times have you visited this part of the 
world? What is the longest period you spent there?
{ I f  more than 5 t im e s  s i m p l y  code 6) (code in months) 
Area No. of times Max. Period away
6.3 (a) Was this during your school years?
Yes 1
No 2
I f  NO go t o  q u e s t i o n  6 .4  (a) o t h e r w i s e  c o n t i n u e
6.3 (b) Could you please tell me which areas you visited 
during your school years?
__ i__
—  4.4. ---------
! "i !
— | h |
—  4-4------------
—+ 
I
+ ++—++ +
4— 4- _
+ - + -
+ —
+ —
+ -
+ -
+ - + - + + — + + - +----+
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6.3 (c) How many times have you visited this part of the 
world? What is the longest period you spent there?
(If more than 5 times simply code 6)
Area No. of times Max. Period away
6.4 (a) Was this after you left school up to the age of 30
Yes
No
If NO continue with 7.1 (a) otherwise continue
6.4 (b) Could you please tell me where you travelled after ! j j ii ii
you left school until the age of 30 years ! +-+- 
1 I 1
+—  
i
+-
i
- -
6.4 (c) How many times have you visited this part of
l l I
the ! h— i—
i
+—
i
+- - -
world? What is the longest period you spent there? l l l 1 1 1 ii ii
(If more than 5 times simply code 6) ! +-+- +— +- - -
Area No. of times Max. Period away i i i i i i ii ii
! +-+- +— +- - -
i i i i i i ii ii
: +-!- +— +- - -
i i i i i i ii ii
! +-+- +— +- - -
i i i i i i ii •i
! +-+- +— +- - -
i i ii i i ii ii
! +-+- +— +- - -
i i i t i i ii ii
! +-+- +— +- - -
Medical history (Section 7) i i i i i i ii ii
I would now like to ask some questions about your past 
medical history
7.1 (a) Have you ever had any operations?
Yes 1 ii ii
No 2 ii ii
D/K 9 +----- -----+
If YES ask "what type of operations have you had"
If obvious check by asking "I assume you had a general 
anaesthetic.
+ + + — ++ +
+-+-
+-+-
+—
+—
+-
+-
+-+-++—++-+ +
+ ++—++ +
+-+-++—++-+ +
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7.1 (b) "Did you have a local or general anaesthetic"
If necessary explain by asking "where you put to sleep?"
Type of operations no. of G.A./L.A.
times (1) (2)
1. ___________________________________________
2. ___________________________________________
3. _________________________________________
4. _________________________________________
5.
Total no. of GA operations .........
7.2 (a) Apart from the operations, have you ever been 
admitted to hospital for any conditions other than P.D.
Yes 1
No 2
D/K 9
If YES ask what was the problem
7.2 (b)
list all admissions
1 .  ___________________________________________________________________________________
2. ___________________________
3. __________________________
4 . __________________________
5. __________________________
6.
7.3 (a) Apart from what you have already told me have you 
seen a hospital doctor in a clinic or your general 
practitioner for any other illnesses, but excluding 
minor colds or flus?
Yes 1
No 2
D/K 9
If YES
7.3 (b) What was the medical problem
list all conditions
1. _______________
2. _______________
3. ______________
4 . ______________
5.
+----------- ++—+
i i i ii ii i i ii i
i i i ii ii i i ii i
+—! — ! — ! +— !
i i i ii ii i i ii i
i i i ii ii i i ii i
i i i ii ii i i ii i
+----------- ++—+
+----------+
+----------+
+-------- +
i ii i
i ii i
+-------- +
+----------- +
+
+
+
+
+-
+ +
+-------- +
i ii •
i ii i
+-------- +
+----------- +
+
+
+
+
+ +
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7.3 (c) Can I just check and ask if your doctor has ever 
diagnosed you as having ......
YES NO
angina 1 2
heart attack 1 2
stroke 1 2
H.B.P. 1 2
diabetes 1 2
7. 4 (a) Have you ever had any pain or discomfort 
in your chest?
+  +
Yes
No
If NO go to question 7.5 
If YES
7.4 (b) do you get this pain or discomfort when you 
walk uphill or hurry?
Yes
No
7.4 (c) do you get it when you walk at ordinary pace on 
the level?
Yes
No
7.4 (d) When you get any pain or discomfort in your chest 
what do you do?
stop 1
slow down 2
continue at the same pace 3
7.4 (e) Does it go away when you stand still?
Yes
No
7.4 (f) how soon?
(i) in 10 minutes or less?
(ii) more than 10 mins
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7.4 (g) Where do you get this pain or discomfort 
(mark the place(s) with an X on the diagram)
RIGHT LEFT
FRONT VIEW
7.5 (a) Did you ever had an injury to the head? !
(If NO go to question 7.6 (a)) \ +----- +
Yes 1 ! ! !
No 2 ! | !
D/K 9 ! +-----+
If Yes !
7.5 (b) How many times has this happenend. Would you say....!
II
1-2 times 1 I +-----+
3-4 times 2 ! ! !
5-6 times 3 ! ! !
7 or more times 4 ! +-----+
II
7.5 (c) Have any of these head injuries been severe enough !
to cause any of the following: ! +--- + +----+
(Show subject card K) ! ! i ! !
no. of ! +----! +---
YES NO times ! i ! ! !
loss of consciousness 1 2   ! + ! +---- !
dizziness 1 2   ! ! I ! !
blurred or double vision 1 2   ! +----1 +---- !
seizures or fits 1 2   { j ! ! !
memory problems 1 2   ! +----! +---- !
weakness or paralysis 1 2   ! ! ! ! !
I I  II II I  II I
If YES to any of the symptoms ask ! +--- + +----+
”How many many times was the head injury followed b y ...... I
II
If subject is male \
7.6 (a) Did you ever box as a sport? !
;-----+----- +
Yes 1 I ! !
No 2 I ! !
!--------+-------- +
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If YES
7.6 (b) How many years did you do this for? 
years boxing:________
7.7 (a) I would like to ask you some questions about 
childhood infections. Can you recall having one of these 
diseases at any time in your life?
Show card L Yes No Age Age period
measles
whooping cough 
chicken pox 
polio 
mumps
glandular fever 
childhood 
influenza 
other
2 3 4
2 3 4
If YES
7.7 (b) Can you remember how old you were when you got this 
infection?
pause, if subject cannot or is having difficulty add
If you cannot remember how old you were would you say it was
before you started school 1, during your school years 2 
when you started work or 3rd level education 3, D/K 4
7.7 (c) Did you ever have any childhood illnesses either as 
a child or adult, but which you don't know the name
Yes 1
No 2
If YES
Could you please describe the symptoms and the tell me the
age at which you got this illness.
symptoms
+----------- +
i i ii i i
+-------- +
+—++-------++—+
11
— 
+ 
-
11
+—  
1
11
— 
+ 
-
11
{
+—
1
1
+—  
1
1 1 1 
1 1 11
-1-—  
1
1
+—  
1
1 1 1 
1 1 11
+—
1
1
+—  
1
1 1 1 
1 1 11
+—  
1
1
+—  
1
1 1 1 
1 1 11
+—  
1
1
+—
1
1 1 1 
1 1 11
+—
11
1
+—
11
1 1 1
1 1 1 1 1 1
+—++ ++—+
+----- +
i ii i
i ii i
+-------- +
+ +
+—+—+
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For illnesses which the subject reports not having got 
as a child ask
7.7 (d) Do you recall ever coming in close contact with 
someone who had ......
Yes
measles
whooping cough 
chicken pox 
polio 
mumps
glandular fever 
childhood 
influenza 
other
No
2
2
2
2
2
2
2
2
N/A
3
3
3
3
3
3
3
3
Age Age period 
2 3 4
If YES
7.7 (e) Can you remember how old you were when they 
got their infection?
(If more than one sibling got the disease at different 
periods, take the age when the first one got ill)
If you cannot remember how old you were would you say it
was
before you started school 1
during your school years 2
when you started work or 3rd level education 3
D/K 4
+ --++ ++-- +
+—
+—
+—
+—
+—
+—
+—
1 1 1 1
! +—  
i i
ii
— 
+ 
-
ii
i i
! +—  
i i
i i i 
i i ii i
! +—  
i i
i i i 
i i ii i
! +—  
• i
i i i 
i i i
ii
- 
+ 
-
i i i 
i i i1 !
! +—
i i
i i i 
i i i
i i
i i i
i i i i i i
+—++------- ++—+
Drug History (Section 8)
8.1 (a) Are you currently on any drugs prescribed by 
doctor? Yes
No
If YES
8.1 (b) Could you please tell me their names and dosages
(calculate daily dose) 
Drug name Dosage frequency total
(mgs) (times) mgs/d
+- 
+----
+-
— + 
-++-
+-
+-
+-
+-
+-
+-
+-
+-
+-
+-
+-
+-
+-
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8.2 (a) Have you ever taken any vitamin tablets on a 
regular basis?
Yes 1
No 2
If YES
When did you start taking them and how long have you been 
taking them?
(code year started l=before, 2=after PD onset) 
remedy Year started B/A PD Duration
Vaccinations
8.3 (a) Do you ever remember being vaccinated
Yes 1
No 2
If YES
8.3 (b) Can you remember whether your vaccination was 
against .........  (probe if in adulthood/childhood)
Yes No D/K A/C N/A
tuberculosis 1 2 9 A C 8
smallpox 1 2 9 A C 8
whooping cough 1 2 9 A C 8
tetanus 1 2 9 A C 8
diphtheria 1 2 9 A C 8
measles 1 2 9 A C 8
polio 1 2 9 A C 8
can't remember 1 2 9 A C 8
Family History (Section 9)
9.1 I would like to ask you some questions about your family 
Were your parents your natural parents, or adoptive parents 
or did you have a step-mother or step-father.
Mother natural 1
adoptive 2
step-mother 3
Father natural 1
adoptive 2
step-father 3
Add in: If subjects responds step-mother/father, ask 
details only about natural parent, if known. Otherwise 
omi t
+------- +
I I
l I
I I
I I
+-------- +
+----+ + - + +---- +
I I I I l l I
I I I I  I I  • I
i i i i i i i
i i i i  i i  • i
+-!-!+-!+-!-!
i i i i * i i
i i i i  i i  • i
+----++-++---- +
+-------- +
i i
i i
i i
i i
+-------- +
+
+—
+—
+—
+
+ +
+
+ +
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9.2 Do you know if your parents were in any way related
to one other before they got married? For example
first or second cousins
No relation 1 +--- —  +
possible relation 2 11 ii
definite relation 3 11 ii
Don't Know 9 +--- —  +
+-- - +
nature of relationship 11 ii
+___.- +
9.3 (a) Are they both still alive?
Alive Cause of Current age
death +— ++------+
Mother Yes 1 1 1 1 1 1 1 ii ii
No 2 +-+ +------+
Father Yes 1 +-+ +----- —  +
No 2 1 1 1 1 1 1 ii ii
+-+ +------+
(ask as appropriate)
9.3 (b) How old is your .....  / a n d......
If NO then
9.3 (c) Do you know what your ...  died of?
If natural mother alive continue with
9.4 (a) Could you tell me whether your mother has any of
the following conditions?
(show card M)
else
Could you tell me whether your mother had any of the +--+
following conditions? 11
(show card M) Y N DK
1
No health problems 1 2 9
1
Angina 1 2 9 11
heart attack 1 2 9 +--
stroke 1 2 9 11
H.B.P. 1 2 9 +--
diabetes 1 2 9 11
cancer 1 2 9 +--
specify 11
other 1 2 9
11
11
+--H
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If natural father alive continue with
9.4 (b) Could you tell me whether your father has any of 
the following conditions?
(show card M)
else
Could you tell me whether your father had any of the 
following conditions?
(show card M)
No health problems 
Angina
heart attack 
stroke 
H.B.P. 
cancer
specify__________
other
N DK
+  +
+-----
+ ------
+ ------
+ ------
+  +
9.4 (c) Did you mother or father have any of the following 
conditions? (show card N)
+  + +  +
+ --------
mother/father
P.D. 1
Tremor 1
Multiple Sclerosis 1
Motor Neurone Disease 1
Thyroid disease 1
Dementia or
Alzheimer's Disease 1
Diabetes 1
Curvature of the 
spine (scoliosis) 1
9.5 (a) How many brothers and sisters do you have? Don't 
forget to include any that may have passed away 
(If only child go to question 10.1)
+ + + +
no. of siblings:
Are you a twin? (If YES ask "Would you say that you and your 
twin are as similar as two peas in a pod?")
Yes
No
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nearest
[274]
Could you tell me their names starting with the 
oldest If any of them have passed away could you 
please still mention them. Don’t forget to mention 
your own position in the family. How many years 
younger/older was your brother/sister?
If sibling dead note cause of death
Siblings Sex years status
(M)/(F) diff. (A)/(D)
1. 
2. 
3. 
4 .
5.
6. 
7.
9. _
10v 
1 1. 
1 2 . 
13. 
14 .
Cause of Death
1 .______________
2 . _____________
3.___________
4 .___________
5 .___________
6  . ________________
7.
9._
1 0 *.
1 1 .
1 2 .
1 3. 
14 .
9.5 (b) Position of case in family 
No. of older siblings 
No. of younger siblings
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ - + - + - + - + | 
+ - + - + - + - +
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ -
+ --------------- +
+ --------------- +
+--------+
+ --------------- +
+ --------------- +
+ --------------- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[275]
9.6 (a) Do you know if your brothers and sisters have any
no. of sibof the following conditions? (show card M) 
No health problems 
Angina
heart attack 
stroke 
H.B.P. 
cancer
specify_______________________
other 1
9.6 (b) In particular do any of them have 
(show card N)
P.D. 1 2
Tremor 1 2
Multiple Sclerosis 1 2
Motor Neurone Disease 1 2
Thyroid disease 1 2
Dementia or 
Alzheimer's Disease 
Diabetes
Curvature of the 
spine (scoliosis)
(If PD ask if diagnosed by a doctor or a neurologist)
no. with PD diagnosed by a neurologist
9.7 Do you know if any of your uncles, aunts or cousins 
have any of the conditions on the card (Show card N) 
(list all relatives. put mother or father's borther etc
Condition Yes
P.D. 1
Tremor 1
Multiple Sclerosis 1
Motor Neurone Disease 1
Thyroid disease 1
Dementia or
Alzheimer's Disease 1
Diabetes 1
Curvature of the 
spine (scoliosis) 1
No DK relationship 
to subject 
(no. affected)
Probe: If subject reports relative with PD ask 
"Has there P.D. been diagnosed by a doctor?"
+  +
I
+-+  -
+ -
+ -
+ -
+ -
+ -
+ -
+-
+ -
+ -
+-
+  +
+ -
+ -
+ - + + - +  + -
+ -
+ -
+-
+-
+-
+--
+ +
+—+ +—+
+—
+—
+—
+—
+ —
+—
+—
+ —
+ —
+ —
+ —
+—
+—
+—
+—+ +—+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[276]
Next I would like to ask you a few questions 
about what your personal habits.
Personal Habits (Section 10) 
Coffee and Tea consumption
****** II
*10.1* (a) Do you drink coffee at least once a month? !
* * * * * *  • -j- —____
Yes 1 ! ! !
No 2 ! ! !
| +-------- +
If YES go to question 10.4 !
If NO |
II
10.1 (b) Did you ever drink coffee more frequently than at !
least once a month? !---- +----- +
Yes 1 ! ! !
No 2 j ! !
If NO go to question 11.1 (a) !---- +----- +
If YES !
II
10.2 How many years is it since you used to drink coffee !
more often? ! +--------+
Years:  ! ! ! !
j + ------------------ +
lI
10.3 Why did you stop drinking coffee so often? !
Let subject respond spontaneously then code !
illness 1 !
doctor's advice 2 ! +----- +
concerns about your health 3 ! ! !
you stopped liking it 4 ! ! !
or another reason 5 ! +----- +
(please specify) __________________________  !
If CURRENT COFFEE DRINKER 
******
*10.4* Would you drink a cup at least.... 
****** (show card O)
at least once a day 1
5-6 times a week 2 +-- --+
2-4 times a week 3 11 11
once a week 4 11 11
1-3 times a month 5 +-- --+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[277]
10.5 How many cups of coffee would you drink !
on average per day? i
;----+--------+
cups of coffee:_ ! ! ! !
j--------- +------------------+
10.6 Would you say your current consumption of i
coffee is ... . ! +----- +
more than 1 I ! !
less than 2 \ \ \
about the same 3 | +----- +
II
as it was before you developed the Parkinson's Disease !
******* ii
*11.1 * (a) Do you drink tea at least once a month? !
Yes 1 ! ! !
No 2 ! !  !
• +-------- +
If YES go to question 11.4 \
If NO !
II
11.1 (b) Did you ever drink tea more frequently than at !
least once a month? i +-----+
Yes 1 ! ! !
No 2 ! ! !
If NO go to question 14.1 (a) ! +-----+
If YES !
II
II
11.2 How many years is it since you used to drink tea more !---+--------+
often? ! ! ! !
Years: i-+--------+
11.3 Why did you stop drinking tea so often? !
Let subject respond spontaneously then code !
illness 1 !
doctor's advice 2 ! +----- +
concerns about your health 3 ! ! !
you stopped liking it 4 S S S
or another reason 5 ! +----- +
(please specify) _____________________________  i
II
If CURRENT TEA DRINKER j
11.4 Would you drink a cup at least.... !
(show card O) \
II
at least once a day 1 !
5-6 times a week 2 i +----- +
2-4 times a week 3 ! ! !
once a week 4 | | !
1-3 times a month 5 ! +----- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[278]
11.5 How many cups of tea would you drink 
on average per day? 
cups of tea:_______
11.6 Would you say your current consumption of 
tea is ....
more than 1
less than 2
or about the same 3
as it was before you developed Parkinson's Disease
DRINKING HABITS (Section 12)
12.1 (a) In the past 12 months have you had any 
alcoholic drinks?
Yes
No
If YES go to question 12.3 (a)
If NO
12.1 (b) Have you always been a non-drinker or did you 
drink in the past?
Non-drinker 1
past drinker 2
If NON-DRINKER go to question 13.1 (a)
If PAST DRINKER
12.1 (c) Which of the following phrases would best 
describe the amount you used to drink?
I would ....
hardly drink at all 
drink a little 
drink a moderate amount 
drink quite a lot 
drink heavily
12.2 What was the reason you stoppped drinking? 
Was it....
Illness
doctor's advice 
Health precautions 
Too expensive 
Another reason 
(please specify)__
Go to Question 13.1 (a)
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[279]
*12.3* (a) How often would you have a drink of beer, stout 
****** or cider during the last 12 months?
(Show card P)
not at all in the last 12 months 1 
1-2 times a year 2
1-2 times a month 3
1-2 times per week 4
3-4 times per week 5
more than 5 days a week 6
12.3 (b) When you have had a drink of beer or cider
how many pints would you usually drink on any 
one occasion?
pints:
12.4 (a) How often would you have a drink of wine, or 
similar drinks such as sherry, port or dubonnet 
during the last 12 months?
(Show card P)
not at all in the last 12 months 1 
1-2 times a year 2
1-2 times a month 3
1-2 times per week 4
3-4 times per week 5
more than 5 days a week 6
12.4 (b) When you have had a drink of wine or any 
of the other drinks I have just mentioned, 
how many glasses would you usually drink 
on any one occasion?
glasses: or bottles:
(Note down either no. of glasses or as 
proportion of bottles e.g. 1/4, 1/2, 1)
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[280]
12.5 (a) How often would you have a drink of spirits such !
as gin, whiskey, rum, brandy or vodka during the I
last 12 months? !
(Show card P) !
not at all in the last 12 months 1 !
1-2 times a year 2 i----- +-----+
1-2 times a month 3 j ! !
1-2 times per week 4 1 !  !
3-4 times per week 5 ! +-----+
more than 5 days a week 6 I
lI
12.5 (b) When you have had a drink of spirits, !
how many glasses would you usually drink !
on any one occasion? ! +------------- +
I I I  III I • I
glasses:_________ or bottles:_______  ! +-------------+
(Note down either no. of glasses or as !
proportion of bottles e.g. 1/4, 1/2, 1) \
II
12.6 (a) Comparing now with how much you used to drink '
when you were 25 years old, would you say !
that you are !
II
Drinking about the same 1 !----- +-----+
Drinking more now 2 1 !  !
Drinking less now 3 S ! !
J + -----------------+
If DRINKING LESS !
II
12.6 (b) Is this because of . . . . !
II
Illness 1 !
doctor's advice 2 ! +-----+
health precautions 3 | ! !
the cost of drinking 4 ! ! !
another reason 5 ! +-----+
(please specify) __________________________  !
II
Smoking habits (section 13) !
II
13.1 (a) Do you currently smoke cigarettes? !
(i.e. not cigars/pipe) !----- +-----+
l^es 1 j ! !
No 2 1 1  !
If NO go to Question 13.3 (a) ! +----- +
If YES !
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[281]
13.1 (b) what kind of cigarettes do you smoke? Are they 1
circle all !
that apply !
Manufactfured with filters 1 ! +-----+
Manufactured without filters 2 \ \ \
Hand rolled 3 1 !  !
I----------+----------+
If ringed 1 or 2 then !
13.2 (a) How many cigarettes do you smoke per day i--- +-------+
I I I I II I I I I
no. of cigarettes per day:______________ !---+-------+
if ringed 3 !
13.2 (b) About how many ounces of tobacco per week !
do you use for hand-rolled cigarettes? !
I +------------ +
ounces tobacoo:___________________________  ! i ! 
j + ----------------- +
13.2 (c) How old were you when you started smoking !
cigarettes !---+--------+
age started:____________________________  ! ! 
! +  +
Now go to question 13.8 i
II
If NOT a present cigarette smoker !
* * * * * *  II
*13.3* (a) Did you ever smoke in the past? !
****** I  |-
Yes 1 ! ! !
No 2 ! ! !
j +---------+
If NO go to question 13.8 !
II
If YES !
13.3 (b) Where these !
circle all !
that apply !
| +------ +
Manufactfured with filters 1 1 1  !
Manufactured without filters 2 ! ! !
Hand rolled 3 ! +----- +
II
If ringed 1 or 2 then !
II
13.4 (a) How many cigarettes did you smoke per day !
I---------- + ---------------- +
no. of cigarettes:________________________ ! ! ! 
I---------- + ---------------- +
If ringed 3 then !
II
II
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[282]
13.4 (b) About how many ounces of 
tobacco per week do you use 
for hand-rolled cigarettes?
ounces:
13.5 (a) How old were you when you started smoking 
cigarettes
age started:____________
13.5 (b) How old were you when you stopped 
smoking?
age stopped:
13.6 What would you say was the main 
reason you gave up smoking?
Illness 1
doctor's advice 2
Health precautions 3
Too expensive 4
Another reason 5
(please specify)__________________________________
*13.8* Do you smoke cigars?
Yes 1
No 2
If YES go to question 13.12 (b)
13.9 (b) Have you ever smoked cigars?
Yes 1
No 2
If NO go to question 13.14 (a)
If YES
13.10 How many cigars did you smoke per week?
no.
13.11 What age did you start smoking cigars? 
age  
+ ----------------- +
l l l II I l l
+ ----------------- +
+ ------------------- +
I I II I I
+ ------------------- +
+ ------------------- +
I I II I I
+ ------------------- +
+ -------------+
I II I
I II I
+ -------------+
+ -------------+
I II I
I II I
+ -------------+
+ -------------+
I II I
I II I
+ -------------+
+ ------------------- +
l I II l I
+ ------------------- +
+ ------------------- +
I I II I I
+ ------------------- +
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[283]
13.12 (a) What age did you stop smoking cigars?
+------- +
age 1 1 1 1 1 1
+--------+
If YES
13.12 (b) How many cigars per week? +--------+
1 1 1
no. of cigars:
1 1 1 
+--------+
13.13 What age did you start smoking cigars? +--------+
1 1 1
age
1 1 1 
+--------+
*13.14* (a) Do you smoke a pipe? +-----+
******* 1 1 1 1
Yes 1 1 1 1 1
No 2 +-----+
If YES go to question 13.18
If NO
13.14 (b) Have you ever smoked a pipe? +-----+
Yes 1 1 1 1 1
No 2 1 1 1 1
+-----+
If NO go to question 13.19 (a)
If YES
13.15 How many ounces of tobacco did you smoke per week?
+--------+
ounces 1 1 1 1 1 1
+--------+
13.16 What age did you start smoking a pipe?
+--------+
age 1 1 1 1 1 1
+--------+
13.17 What age did you stop smoking a pipe? +--------+
t 1 1
age
1 1 1 
+--------+
13.18 How many ounces of tobacco
do you smoke per week? +--------+
i i i
ounces tobacco:
i i i 
+--------+
+--------+
At what age did you start smoking a pipe? i i i i i i
+--------+
age
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[284]
*13.19* (a) Did your parents smoke when you were a child? !
★ ★★★★★★ I
Yes 1 ! ! !
No 2 ! ! !
D/K 9 ! +-----+
II
13.19 (b) When you were at school, did your closest friends !
smoke? ! +----- +
Yes 1 ! ! !
No 2 | | i
D/K 9 ! +-----+
II
13.19 (c) At the time you were at college/your first job, !
did your closest friends smoke? !
I +-------- +
Yes 1 ! ! !
No 2 ! ! !
D/K 9 ! +-----+
lI
iI
Basic Demographic details (Section 15) !
Finally I would like to ask you a few background questions. !
II
If you know that the subject is married from question.... \
do not repeat this question i
II
15.1 Are you currently !
married 1 ! +-----+
cohabiting 2 | | !
single (never married) 3 ! ! !
widowed 4 ! +-----+
divorced/separated 5 !
If MALE go to question 15.6 \
For married women ask following !
15.2 What is your husband's occupation? ! +---------- +
I I I I Il I l I I
occupation:  ! +---------- +
If necessary add in "What position does he hold"? !
15.3 Does he run his own business or work for an !
employer? !
Working for an employer 1 ! +----- +
Self-employed 2 \ \ \
D/K 9 ! ! ;
[ + ---------------- +
II
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[285]
If he is SELF-EMPLOYED !
15.4 Does he employ anyone else excluding his own !---- +----- +
family? ! ! '
Yes 1 ! ! !
No 2 ! +----- +
D/K 9 !
If his main activity was as a farmer and he was not working 
for an employer ask
15.5 Does he own his own farm and if so how large is it
under 30 acres 1 !
30-4 9 acres 2 i +-----+
50-99 acres 3 ! !  !
100-199 acres 4 ! ! !
200 or more acres 5 ! +-----+
D/K 9 :
II
15.6 Is your home !
| +--------+
owned by you 1 ! ! !
rented from a private landlord 2 \ \ \
rented from the council 3 ! +-----+
other:  4 !
II
15.7 Do you or your household own a car? I-----+----- +
Yes 1 ! ! !
No 2 ! ! !
j +----------- +
15.8 (a) Is your health care covered by !
II
a medical card 1 ! +-----+
V.H.I. 2 1 !  !
or you have to pay directly 3 ! ! !
! +----------- +
Il
15.8 (b) Is the cost of your medication covered by !
Il
GMS card 1 | +-----+
LTIS 2 ! ! !
Paid by yourself 3 1 !  !
Other scheme 4 ! +-----+
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[286]
It would be useful for us to have a broad idea of your 
household income. This is to compare the financial 
situation of families with P.D. to those without 
P.D. Because of the sensitive nature of this question, I 
understand if you do not wish to answer this question.
Show Card S
17.0 Which number on the card would best describe your 
joint household income before tax per year?
£ 0-■4999 1
£ 5,999- 9,999 2
£ 10,000-19, 999 3
£ 20,000-29, 999 4
£ 30,000-39, 999 5
£ 40,000-49, 999 6
£ 50,000-59, 999 7
> than £ 60,000 8
I would like to thank you for your help in answering 
our questions.
Ask now whether either their parents or an older 
brother/sister could be interviewed by us by phone.
Name of relative _____________________________
relationship to case _________________________
address
tel no.
To be completed after interview 
proportion of interview completed by case
less than 25% 
26-49%
50-74%
75-99%
1 0 0%
probes: how do you mean, can you explain that?: closed probes: On the whole, which comes
nearest
[287]
Residential history
I would like to ask you a series of questions about the places you lived in 
throughout your life. For your childhood residences, I will ask some more 
detailed questions about sanitary conditions.
Can you tell me the names of all the areas you have lived in. (For each named 
residence ask (A) and (B))
(A) How many years did you live in ..................
(B) Would you describe .....  as a city (1) town (2) village (3) or a rural
area (4).
Childhood Residences ONLY
(C) Can you remember the no. of bedrooms in the house (If in boarding school 
omit question on no. of rooms and record boarding school)
(D) Did the house/flat have a flush toilet (1) a closet or privy (2) no 
special facilities (3) don't remember (4)
(E) Was the toilet inside (I) or outside the house (0)
(A) (B)
Dates no. of Type of area
years
 1  1 2  3 4
 2________________________________________________________  1 2  3 4
 3________________________________________________________  1 2  3 4
 4________________________________________________________  1 2  3 4
 5________________________________________________________  1 2  3 4
 6________________________________________________________  1 2  3 4
 7________________________________________________________  1 2  3 4
 8________________________________________________________  1 2  3 4
 9________________________________________________________  1 2  3 4
1 0_______________________________________________________  1 2  3 4
11 1 2  3 4
288
Residential history cont.
Ask for ALL residences
(Show card I)
(F) From the card, which would describe the source of water you received
when you lived in .......
mains piped water (1) a public pump (2) a private pump or well (3) a
stream or river (4) another source (5) or don't remember (6)
If water supply is only (1) ask:"Can I check, did you ever drink well-water
or water from a river or stream apart from on a rare occasions?"
If water supply is (2)-(5) ask
(G) Do you know whether the water was treated in any way?
(H) Did the method of water supply change whilst you were living in ....
If YES How did it change?
(I) How long had you been living there when it changed?
(C) (D) IE) (F) (G)
no of Toilet inside water supply water water supply no of
rooms /outside (initial) Rx
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
1 2 3 4 1 0  1 2 3 4 5 6 1 2
(H) (I!
(secondary) years
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
2 3 4 5 6
1 2 3 4 1 0  1 2 3 4 5 6 1 2  1 2 3 4 5 6
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